Turmeric References - Section vi

  1. Ravindran, P. N. Turmeric - The Golden Spice of Life. [ed.] P. N. Ravindran, K. Nirmal Babu and K. Sivaraman. Turmeric: The Genus Curcuma. Boca Raton: CRC Press: Taylor & Francis Group, LLC, 2007, 1, pp. 1-14. ISBN-13: 978-0-8493-7034-2.
  2. Curcumin―The Paradigm of a Multi-Target Natural Compound with Applications in Cancer Prevention and Treatment. Teiten, Marie-Hélène, et al., et al. [ed.] Florian Lang. 1, Basel: MDPI - Open Access Publishing, January 21, 2010, Toxins, Vol. 2, pp. 128-162. DOI: 10.3390/toxins2010128; http://www.mdpi.com/2072-6651/2/1/128. ISSN: 2072-6651.
  3. Mitchell Fry. Genes and medicine. Essential Biochemistry for Medicine. Chichester: Wiley-Blackwell: John Wiley & Sons Ltd., 2010, 19. ISBN: 978-0-470-74328-7.
  4. Marcovitch, Harvey. Black's Medical Dictionary. 41. London: A & C Black Publishers Limited, 2005. ISBN: 0-7136-6146-1.
  5. Aggarwal, Bharat B., et al., et al. Curcumin — Biological and Medicinal Properties. [ed.] P. N. Ravindran, K. Nirmal Babu and K. Sivaraman. Turmeric: The Genus Curcuma. Boca Raton: CRC Press: Taylor & Francis Group, 2007, 10, pp. 298-348. ISBN-13: 978-0-8493-7034-2.
  6. Curcumin Suppresses the Paclitaxel-Induced Nuclear Factor-KB Pathway in Breast Cancer Cells and Inhibits Lung Metastasis of Human Breast Cancer in Nude Mice. Aggarwal, Bharat B., et al., et al. [ed.] William Neil Hait. 20, Boston: American Association for Cancer Research, October 15, 2005, Clinical Cancer Research, Vol. 11, pp. 7490-7498. DOI: 10.1158/1078-0432.CCR-05-1192; http://clincancerres.aacrjournals.org/content/11/20/7490. ISSN: 1078-0432.
  7. Curcumin Inhibits Carcinogen and Nicotine-Induced Mammalian Target of Rapamycin Pathway Activation in Head and Neck Squamous Cell Carcinoma. Clark, Cheryl A., et al., et al. [ed.] Scott M. Lippman. 12, Philadelphia: American Association for Cancer Research, December 2010, Cancer Prevention Research, Vol. 3, pp. 1586-1595. DOI: 10.1158/1940-6207.CAPR-09-0244; http://cancerpreventionresearch.aacrjournals.org/content/3/12/1586. ISSN: 1940-6215.
  8. Phase I Clinical Trial of Curcumin, a Chemopreventive Agent, in Patients with High-risk or Pre-malignant Lesions. Cheng, Ann-Lii, et al., et al. [ed.] Masahide Kuroki. 4b, Fukuoka: The International Institute of Anticancer Research, July-August 2001, Anticancer Research, Vol. 21, pp. 2895-2900. ISSN: 0250-7005.
  9. The nontoxic natural compound Curcumin exerts anti-proliferative, anti-migratory, and anti-invasive properties against malignant gliomas. Senft, Christian, et al., et al. [ed.] Christna Chap. London: BioMed Central Ltd., September 14, 2010, BMC Cancer, Vol. 10. DOI: 10.1186/1471-2407-10-491; http://www.biomedcentral.com/1471-2407/10/491. ISSN: 1471-2407.
  10. A Cancer Treatment in the Spice Cabinet? American Cancer Society. [ed.] Harmon J. Eyre. 2, Salt Lake City: American Cancer Society, March/April 2006, CA: A Cancer Journal for Clinicians, Vol. 56, pp. 67-68. DOI: 10.3322/canjclin.56.2.67; http://onlinelibrary.wiley.com/doi/10.3322/canjclin.56.2.67/full. eISSN: 1542-4863.
  11. Anand, Preetha, Kunnumakkara, Ajaikumar B. and Aggarwal, Bharat B. Curcumin: The Biochemistry Behind Its Anticancer Effects. [ed.] Cesar G. Fraga. Plant Phenolics and Human Health: Biochemistry, Nutrition, and Pharmacology. Hoboken: John Wiley & Sons, Inc., 2010, 16, pp. 361-400. ISBN: 978-0-470-28721-7.
  12. Perspectives for Cancer Prevention With Natural Compounds. Amin, A.R.M. Ruhul, et al., et al. [ed.] Daniel G. Haller. 16, Philadelphia: American Society of Clinical Oncology, June 1, 2009, Journal of Clinical Oncology, Vol. 27, pp. 2712-2725. DOI: 10.1200/JCO.2008.20.6235; http://jco.ascopubs.org/content/27/16/2712. ISSN: 0732-183X.
  13. Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma. Wilken, Reason, et al., et al. [ed.] Christophe Nicot and Alan Storey. 12, Kansas City; Oxford: Biomed Central Ltd., February 7, 2011, Molecular Cancer, Vol. 10, pp. 1-57. DOI: 10.1186/1476-4598-10-12; http://www.molecular-cancer.com/content/10/1/12#. ISSN: 1476-4598.
  14. Clark, Cheryl, Ekshyyan, Oleksandr and Nathan, Cherie-Ann O. Effects and Therapeutic Potential of Targeting Dysregulated Signaling Axes in Squamous Cell Carcinoma: Another Kinase of Transcription and Mammalian Target of Rapamycin. [ed.] Adam B. Glick and Carter Van Waes. Signaling Pathways in Squamous Cancer. New York: Springer Science+Business Media, LLC, 2011, 18, pp. 383-406. ISBN: 978-1-4419-7202-6.
  15. American Academy of Otolaryngology -- Head and Neck Surgery. Curcumin May Inhibit Nicotine-induced Activation Of Head And Neck Cancers. ScienceDaily. [Online] October 5, 2009. [Cited: October 6, 2014.] http://www.sciencedaily.com/releases/2009/10/091004140953.htm.
  16. Surh, Young-Joon and Chun, Kyung-Soo. Cancer Chemopreventive Effects of Curcumin. [ed.] Bharat B. Aggarwal, Young-Joon Surh and Shishir Shishodia. The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease. New York: Springer Science+Business Media, LLC, 2007, 2, pp. 149-172. ISBN-13: 978-0-387-46400-8.
  17. Prasad, Sahdeo and Aggarwal, Bharat B. Turmeric, the Golden Spice: From Traditional Medicine to Modern Medicine. [ed.] Iris F.F. Benzie and Sissi Wachtel-Galor. Herbal Medicine: Biomolecular and Clinical Aspects. 2. Boca Raton: CRC Press: Taylor and Francis Group, LLC, 2011, 13, pp. 263-288. ISBN: 978-1-4398-0713-2.
  18. Kumar, Addanki P., et al., et al. An Overview of Anticancer Herbal Medicines. [ed.] William C.S. Cho. Evidence-Based Anticancer Materia Medica. Dordrecht: Springer Science+Business Media B.V., 2011, 1, pp. 1-36. ISBN: 978-94-007-0525-8.
  19. Curcumin (diferuloylmethane) inhibits constitutive NF-kB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma. Shishodia, Shishir, et al., et al. [ed.] Sam J. Enna. 5, Kansas City: Elsevier B.V., September 1, 2005, Biochemical Pharmacology, Vol. 70, pp. 700-713. DOI: 10.1016/j.bcp.2005.04.043; http://www.sciencedirect.com/science/article/pii/S0006295205002418. ISSN: 0006-2952.
  20. Bar-Sela, G. and Schaffer, M. An Evidence-Based Perspective of Curcuma Longa (Turmeric) for Cancer Patients. [ed.] William C. S. Cho. Evidence-Based Anticancer Materia Medica. Dordrecht: Springer Science+Business Media B.V., 2011, 11, pp. 225-244. ISBN: 978-94-007-0525-8.
  21. Curcumin Inhibits Tumor Growth and Angiogenesis in Ovarian Carcinoma by Targeting the Nuclear Factor-κB Pathway. Lin, Yvonne G., et al., et al. [ed.] William Neil Hait. 11, Boston: American Association for Cancer Research, June 1, 2007, Clinical Cancer Research, Vol. 13, pp. 3423-3430. DOI: 10.1158/1078-0432.CCR-06-3072; http://clincancerres.aacrjournals.org/content/13/11/3423. ISSN: 1078-0432.
  22. Phase II Trial of Curcumin in Patients with Advanced Pancreatic Cancer. Dhillon, Navneet, et al., et al. [ed.] Kenneth C. Anderson. 14, Philadelphia: American Association for Cancer Research, July 15, 2008, Clinical Cancer Research, Vol. 14, pp. 4491-4499. DOI: 10.1158/1078-0432.CCR-08-0024; http://clincancerres.aacrjournals.org/content/14/14/4491. ISSN: 1078-0432.
  23. Curcumin acts as anti-tumorigenic and hormone-suppressive agent in murine and human pituitary tumour cells in vitro and in vivo. Schaaf, C., et al., et al. [ed.] James A. Fagin. 4, New York: Society for Endocrinology, December 1, 2009, Endocrine-Related Cancer, Vol. 16, pp. 1339-1350. DOI: 10.1677/ERC-09-0129; http://erc.endocrinology-journals.org/content/16/4/1339. Society for Endocrinology.
  24. Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapy. Bisht, Savita, et al., et al. [ed.] Mikhail Soloviev. 3, London: BioMed Central Ltd., April 17, 2007, Journal of Nanobiotechnology, Vol. 5. DOI: 10.1186/1477-3155-5-3; http://www.jnanobiotechnology.com/content/5/1/3. ISSN: 1477-3155.
  25. Epigallocatechin-3-gallate potentiates curcumin's ability to suppress uterine leiomyosarcoma cell growth and induce apoptosis. Kondo, Akiko, et al., et al. [ed.] Osamu Ogawa. 3, Kyoto: Springer Japan, June 1, 2013, International Journal of Clinical Oncology, Vol. 18, pp. 380-388. DOI: 10.1007/s10147-012-0387-7; http://link.springer.com/article/10.1007%2Fs10147-012-0387-7. ISSN: 1341-9625.
  26. Sarker, Satyajit D. and Nahar, Lutfun. Bioactivity of Turmeric. [ed.] P. N. Ravindran, K. Nirmal Babu and K. Sivaraman. Turmeric: The Genus Curcuma. Boca Raton: CRC Press: Taylor & Francis Group, LLC, 2007, 9, pp. 258-285. ISBN-13: 978-0-8493-7034-2.
  27. Hsu, Chih-Hung and Cheng, Ann-Lii. Clinical Studies with Curcumin. [ed.] Bharat B. Aggarwal, Young-Joon Surh and Shishir Shishodia. The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease. New York: Springer Science+Business Media, LLC, 2007, pp. 471-480. ISBN-13: 978-0-387-46400-8.
  28. Tenenbaum, Frances. Taylor's Encyclopedia of Garden Plants. New York: Houghton Mifflin Harcourt, 2003. ISBN: 0-618-22644-3.
  29. Strayer, David S. and Rubin, Emanuel. Neoplasia. [ed.] Raphael Rubin, David S. Strayer and Emanuel Rubin. Rubin's Pathology: Clinicopathologic Foundations of Medicine. 6. Philadelphia: Wolters Kluwer: Lippincott Williams & Wilkins, 2012, 5, pp. 157-212. ISBN: 978-1-60547-968-2.
  30. Fry, Mitchell. Intracellular Signalling. Essential Biochemistry for Medicine. Chichester: Wiley-Blackwell: John Wiley & Sons Ltd., 2010, 13, pp. 175-192. ISBN: 978-0-470-74328-7.
  31. Marks, Dawn B., Marks, Allan D. and Smith, Colleen M. Metabolic Fuels and Dietary Components. Basic Medical Biochemistry. Baltimore: Williams & Wilkins, 1996, 1, pp. 3-21. ISBN-13: 978-0683055955.
  32. Guyton, Arthur C. and Hall, John E. Functional Organization of the Human Body and Control of the "Internal Environment". Textbook of Medical Physiology. 11. Philadelphia: Elsevier Inc., 2006, 1, pp. 3-10. ISBN: 0-7216-0240-1.
  33. Fry, Mitchell. Inflammation. Essential Biochemistry for Medicine. Chichester: Wiley-Blackwell: John Wiley & Sons Ltd., 2010, 14, pp. 193-208. ISBN: 978-0-470-74328-7.
  34. The Molecular Targets for the Diagnosis and Treatment of Pancreatic Cancer. Strimpakos, Alexios S., Syrigos, Kostas N. and Saif, Muhammad Wasif. [ed.] Young S. Kim. 4, San Francisco: Korean Society of Gastroenterology, December 2010, Gut and Liver, Vol. 4, pp. 433-449. DOI: 10.5009/gnl.2010.4.4.433; http://www.gutnliver.org/journal/view.html?volume=4&number=4&spage=433. ISSN: 1976-2283.
  35. Curcumin and Cancer Cells: How Many Ways Can Curry Kill Tumor Cells Selectively? Ravindran, Jayaraj, Prasad, Sahdeo and Aggarwal, Bharat B. [ed.] Marilyn E. Morris. 3, Buffalo: Springer US: The American Association of Pharmaceutical Scientists, September 1, 2009, The AAPS Journal, Vol. 11, pp. 495-510. DOI: 10.1208/s12248-009-9128-x; http://link.springer.com/article/10.1208%2Fs12248-009-9128-x. ISSN: 1550-7416.
  36. Anti cancer effects of curcumin: cycle of life and death. Sa, Gaurisankar and Das, Tanya. [ed.] Philipp Kaldis and Michele Pagano. 14, Singapore; New York: BioMed Central Ltd., October 3, 2008, Cell Division, Vol. 3. DOI: 10.1186/1747-1028-3-14; http://www.celldiv.com/content/3/1/14. ISSN: 1747-1028.
  37. Curcumin: The story so far. Sharma, R.A., Gescher, A.J. and Steward, W.P. [ed.] John Smyth. 3, Edinburgh: Elsevier Ltd., September 2005, European Journal of Cancer, Vol. 41, pp. 1955-1968. [ed.] John Smyth. 3, Edinburgh: Elsevier Ltd., September 2005, European Journal of Cancer, Vol. 41, pp. 1955-1968. DOI: 10.1016/j.ejca.2005.05.009; http://www.ejcancer.com/article/S0959-8049(05)00477-6/abstract. ISSN: 0959-8049.
  38. Kuttan, Girija, et al., et al. Antitumor, Anti-Invasion, and Antimetastatic Effects of Curcumin. [ed.] Bharat B. Aggarwal, Young-Joon Surh and Shishir Shishodia. The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease. New York: Springer Science+Business Media, LLC, 2007, pp. 173-184. ISBN-13: 978-0-387-46400-8.
  39. Shishodia, Shishir, Singh, Tulika and Chaturvedi, Madan M. Modulation of Transcription Factors by Curcumin. [ed.] Bharat B. Aggarwal, Young-Joon Surh and Shishir Shishodia. The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease. New York: Springer Science+Business Media, LLC, 2007, pp. 127-148. ISBN-13: 978-0-387-46400-8.
  40. Sethi, Gautam, Sung, Bokyung and Aggarwal, Bharat B. The Role of Curcumin in Modern Medicine. [ed.] K.G. Ramawat. Herbal Drugs: Ethnomedicine to Modern Medicine. Berlin Heidelberg: Springer-Verlag, 2009, 7, pp. 97-114. ISBN: 978-3-540-79115-7.
  41. Curcumin: From Exotic Spice to Modern Anticancer Drug. Sa, Gaurisankar, et al., et al. [ed.] Kusal K. Das. 1, Bijapur: Al Ameen Charitable Fund Trust, January 2010, Al Ameen Journal of Medical Science, Vol. 3, pp. 21-37. ISSN: 0974-1143.
  42. Karunagaran, Devarajan, Joseph, Jeena and Kumar, Thankayyan R. Santhosh. Cell Growth Regulation. [ed.] Bharat B. Aggarwal, Young-Joon Surh and Shishir Shishodia. The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease. New York: Springer Science+Business Media, LLC, 2007, pp. 245-268. ISBN-13: 978-0-387-46400-8.
  43. Lin, Jen-Kun. Molecular Targets of Curcumin. [ed.] Bharat B. Aggarwal, Young-Joon Surh and Shishir Shishodia. The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease. New York: Springer Science+Business Media, LLC, 2007, pp. 227-244. ISBN-13: 978-0-387-46400-8.
  44. Curcumin in Cancer Chemoprevention: Molecular Targets, Pharmacokinetics, Bioavailability, and Clinical Trials. Shehzad, Adeeb, Wahid, Fazli and Lee, Young Sup. [ed.] Holger Stark. 9, Düsseldorf: WILEY-VCH Verlag GmbH & Co., September 2010, Archiv der Pharmazie, Vol. 343, pp. 489-499. DOI: 10.1002/ardp.200900319; http://onlinelibrary.wiley.com/doi/10.1002/ardp.200900319/abstract. eISSN: 1521-4184.
  45. Aggarwal, Bharat B., et al., et al. Curcumin: The Indian Solid Gold. [ed.] Bharat B. Aggarwal, Young-Joon Surh and Shishir Shishodia. The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease. New York: Springer Science+Business Media, LLC, 2007, pp. 1-76. ISBN-13: 978-0-387-46400-8.
  46. Bhandarkar, Sulochana S. and Arbiser, Jack L. The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease. New York: Springer Science+Business Media, LLC, 2007, pp. 185-196. ISBN-13: 978-0-387-46400-8.
  47. Curcumin: A component of the golden spice, targets multiple angiogenic pathways. Yadav, Vivek R. and Aggarwal, Bharat B. [ed.] Wafik S. El-Deiry. 2, Hershey: Landes Bioscience, January 15, 2011, Cancer Biology & Therapy, Vol. 11, pp. 236-241. DOI: 10.4161/cbt.11.2.14405; https://www.landesbioscience.com/journals/cbt/article/14405/. ISSN: 1538-4047.
  48. Gemcitabine Sensitivity Can Be Induced in Pancreatic Cancer Cells through Modulation of miR-200 and miR-21 Expression by Curcumin or Its Analogue CDF. Ali, Shadan, et al., et al. [ed.] George C. Prendergast. 9, Wynnewood: American Association for Cancer Research, May 1, 2010, Cancer Research, Vol. 70, pp. 3606-3617. DOI: 10.1158/0008-5472.CAN-09-4598; http://cancerres.aacrjournals.org/content/70/9/3606. ISSN: 1538-7445.
  49. Curcumin suppresses alpha-melanocyte stimulating hormone-stimulated melanogenesis in B16F10 cells. Lee, J.H., Jang, J.Y., Park, C., Kim, B.W., Choi, Y.H., Choi, B.T. [ed.] Demetrios A. Spandidos. 1, Athens: Spandidos Publications Ltd., July 2010, International Journal of Molecular Medicine, Vol. 26, pp. 101-106. DOI: 10.3892/ijmm_00000440; http://www.spandidos-publications.com/ijmm/26/1/101. ISSN: 1107-3756.
  50. Xu, Ying, Zhang, Chong and Ogle, William O. The Serotonergic System and Neuroplasticity are Implicated in the Effect of Phytochemicals on Mood and Cognitive Disorders. [ed.] Haixue Kuang. Recent Advances in Theories and Practice of Chinese Medicine. Harbin: InTech -- Open Access Company, 2012, 15, pp. 291-312. ISBN: 978-953-307-903-5.
  51. Blakemore, L. M. Curcumin-Induced G2/M Cell Cycle Arrest in Colorectal Cancer Cells. Department of Biochemistry, University of Leicester. Leicester: The British Library Board, 2010. pp. 1-271, PhD Thesis. uk.bl.ethos.551853.
  52. 1,2,3,4,6-penta-O-galloyl-β-D-glucose, quercetin, curcumin and lycopene induce cell-cycle arrest in MDA-MB-231 and BT474 cells through downregulation of Skp2 protein. Huang, H.C., Lin, C.L., Lin, J.K. [ed.] James N. Seiber. 12, Davis: American Chemical Society, June 22, 2011, Journal of Agricultural and Food Chemistry, Vol. 59, pp. 6765-6775. DOI: 10.1021/jf201096v; http://pubs.acs.org/doi/abs/10.1021/jf201096v. ISSN: 0021-8561.
  53. Multitargeting by curcumin as revealed by molecular interaction studies. Gupta, Subash C., et al., et al. [ed.] Richard Kelly. 12, Houston: The Royal Society of Chemistry, November 2011, Natural Product Reports, Vol. 28, pp. 1937-1955. DOI: 10.1039/c1np00051a; http://pubs.rsc.org/en/Content/ArticleLanding/2011/NP/c1np00051a#!divAbstract. ISSN: 1460-4752.
  54. Shpakov, Alexander, et al., et al. Hormonal Signaling Systems of the Brain in Diabetes Mellitus. [ed.] Raymond Chuen-Chung Chang. Neurodegenerative Diseases - Processes, Prevention, Protection and Monitoring. Hong Kong: InTech, 2011, 15, pp. 349-386. ISBN: 978-953-307-485-6.
  55. Panich, Uraiwan. Antioxidant Defense and UV-Induced Melanogenesis: Implications for Melanoma. [ed.] Ming Yu Cao. Current Management of Malignant Melanoma. Ottawa: InTech, 2011, 12, pp. 227-252. ISBN: 978-953-307-264-7.
  56. Molecular targets of dietary agents for prevention and therapy of cancer. Aggarwal, Bharat B. and Shishodia, Shishir. [ed.] Sam J. Enna. 10, Kansas City: Elsevier Inc., May 14, 2006, Biochemical Pharmacology, Vol. 71, pp. 1397-1421. DOI: 10.1016/j.bcp.2006.02.009; http://www.sciencedirect.com/science/article/pii/S0006295206000955. ISSN: 0006-2952.
  57. Curcumin induces pro-apoptotic endoplasmic reticulum stress in human leukemia HL-60 cells. Pae, Hyun-Ock, et al., et al. [ed.] W.J. Lennarz. 4, Stony Brook: Elsevier B.V., February 23, 2007, Biochemical and Biophysical Research Communications, Vol. 353, pp. 1040-1045. DOI: 10.1016/j.bbrc.2006.12.133; http://www.sciencedirect.com/science/article/pii/S0006291X06028166. ISSN: 0006-291X.
  58. Peroxisome proliferator-activated receptor gamma (PPARγ) overexpression suppresses growth and induces apoptosis in human multiple myeloma cells. Garcia-Bates, Tatiana M., Bernstein, Steven H. and Phipps, Richard P. [ed.] Kenneth C. Anderson. 20, Philadelphia: American Association for Cancer Research, October 15, 2008, Clinical Cancer Research, Vol. 14, pp. 6414-6425. DOI: 10.1158/1078-0432.CCR-08-0457; http://clincancerres.aacrjournals.org/content/14/20/6414. ISSN: 1078-0432.
  59. Curcumin suppresses PPARδ expression and related genes in HT-29 cells. Wang, Jin-Bo, et al., et al. [ed.] Lian-Sheng Ma. 11, Beijing: Baishideng Publishing Group Co., Limited, March 21, 2009, World Journal of Gastroenterology, Vol. 15, pp. 1346-1352. DOI: 10.3748/wjg.15.1346; http://www.wjgnet.com/1007-9327/15/1346.asp. ISSN: 1007-9327.
  60. PPAR 𝛾 and Apoptosis in Cancer. Elrod, Heath A. and Sun, Shi-Yong. [ed.] Dipak Panigrahy. Article ID 704165, Boston: Hindawi Publishing Corporation, July 2, 2008, PPAR Research, Vol. 2008, pp. 1-12. DOI: 10.1155/2008/704165; http://www.hindawi.com/journals/ppar/2008/704165/. ISSN: 1687-4757.
  61. Anti-proliferative and anti-metastatic effects of curcumin on oral cancer cells. Chen, Jiao-wen, et al., et al. [ed.] Xue-dong Zhou and Qing Wang. 1, Sichuan: Sichuan University, West China College of Stomatology, February 2011, West China Journal of Stomatology, Vol. 29, pp. 83-86. DOI: 10.3969/j.issn.1000-1182.2011.01.020; http://med.wanfangdata.com.cn/Paper/Detail?id=PeriodicalPaper_hxkqyxzz201101020. ISSN: 1000-1182.
  62. Chan, Marion and Fong, Dunne. Curcumin as Ligand of Peroxisome Proliferator Activated Receptor (PPAR). s.l.: Rutgers University: Center for Advanced Food Technology, 2008. Industrial Advisory Board Semiannual Meeting Presentations.
  63. Chen, Yi-Bin, Zieve, David and Ogilvie, Isla. Cholangiocarcinoma: Bile duct cancer. PubMed Health: A.D.A.M. Medical Encyclopedia. [Online] May 29, 2014. [Cited: October 6, 2014.] http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001336/.
  64. Dugdale, David C., Chen, Yi-Bin and Zieve, David. Hepatocellular carcinoma: Primary liver cell carcinoma; Tumor - liver; Liver cancer; Cancer - liver; HepatomaPubMed Health: A.D.A.M. Medical Encyclopedia. [Online] September 20, 2013. [Cited: October 3, 2014.] http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001325/.
  65. Aggarwal, Bharat B., et al., et al. Curcumin Derived from Turmeric ( Curcuma longa ): a Spice for All Seasons. [ed.] Debasis Bagchi and Harry G. Preuss. Phytopharmaceuticals in Cancer Chemoprevention. Boca Raton: CRC Press LLC, 2005, 23, pp. 349-388. ISBN: 0-8493-1560-3.
  66. Early Growth Response 1 - A Transcription Factor in the Crossfire of Signal Transduction Cascades. Pagel, Judith-Irina and Deindl, Elisabeth. [ed.] S.C. Sharma. 4, New Delhi: The Council of Scientific & Industrial Research, August 2011, Indian Journal of Biochemistry & Biophysics, Vol. 48, pp. 226-235. ISSN: 0301-1208.
  67. Targets of curcumin. Zhou, Hongyu, Beevers, Christopher S. and Huang, Shile. [ed.] Francis J. Castellino. 3, Notre Dame: Bentham Science Publishers, March 1, 2011, Current Drug Targets, Vol. 12, pp. 332-347. DOI: 10.2174/138945011794815356; http://www.eurekaselect.com/73202/article. ISSN: 1389-4501.
  68. Safe, Stephen, Chadalapaka, Gayathri and Jutooru, Indira. AHR-Active compounds in the Human Diet. [ed.] Raimo Pohjanvirta. The AH Receptor in Biology and Toxicology. Hoboken: John Wiley & Sons, Inc., 2012, 24. ISBN: 978-0-470-60182-2.
  69. Marks, Dawn B., Marks, Allan D. and Smith, Colleen M. Regulation of Gene Expression. Basic Medical Biochemistry. Baltimore: Williams & Wilkins, 1996, 16, pp. 274-296. ISBN-13: 978-0683055955.
  70. Ruddon, Raymond W. The Biochemistry and Cell Biology of Cancer. Cancer Biology. New York: Oxford University Press, Inc., 2007, 4. ISBN-13: 978-0-19-517543-1.
  71. Balakrishnan, K.V. Postharvest Technology and Processing of Turmeric. [ed.] P. N. Ravindran, K. Nirmal Babu and K. Sivaraman. Turmeric: The Genus Curcuma. Boca Raton: CRC Press: Taylor & Francis Group, LLC, 2007, 8, pp. 193-256. ISBN-13: 978-0-8493-7034-2.
  72. Rhizome and Leaf Oil Composition of Curcuma longa from the Lower Himalayan Region of Northern India. Raina, V.K. and Srivastava, S.K. [ed.] Brian M. Lawrence. 5, Winston-Salem: Taylor & Francis Group, September/October 2005, Journal of Essential Oil Research, Vol. 17, pp. 556-559. ISSN: 1041-2905.
  73. Inhibiting NF-κB activation by small molecules as a therapeutic strategy. Gupta, Subash C., et al., et al. [ed.] Joseph Reese. 10-12, Houston: Elsevier B.V., December 2010, Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, Vol. 1799, pp. 775-787. DOI: 10.1016/j.bbagrm.2010.05.004; http://www.sciencedirect.com/science/article/pii/S1874939910000659. ISSN: 1874-9399.
  74. Nahar, Lutfun and Sarker, Satyajit D. Phytochemistry of the Genus Curcuma. [ed.] P. N. Ravindran, K. Nirmal Babu and K. Sivaraman. Turmeric: The Genus Curcuma. Boca Raton: CRC Press: Taylor & Francis Group, LLC, 2007, 3, pp. 71-106. ISBN-13: 978-0-8493-7034-2.
  75. Aromatic-turmerone inhibits α-MSH and IBMX-induced melanogenesis by inactivating CREB and MITF signaling pathways. Park, Sun Young, et al., et al. [ed.] Ulrich Mrowietz. 10, Kiel: Springer-Verlag, December 1, 2011, Archives of Dermatological Research, Vol. 303, pp. 737-744. DOI: 10.1007/s00403-011-1155-7; http://link.springer.com/article/10.1007%2Fs00403-011-1155-7. ISSN: 0340-3696.
  76. Aromatic-turmerone attenuates invasion and expression of MMP-9 and COX-2 through inhibition of NF-κB activation in TPA-induced breast cancer cells. Park, Sun Young, et al., et al. [ed.] C. Fred Fox, Gary S. Stein and Max M. Burger. 12, Los Angeles; Burlington; Basel: Wiley Periodicals, Inc., December 2012, Journal of Cellular Biochemistry, Vol. 113, pp. 3653-3662. http://onlinelibrary.wiley.com/doi/10.1002/jcb.24238/abstract. eISSN: 1097-4644.
  77. Prasad, Sahdeo, Gupta, Subash C. and Aggarwal, Bharat B. Micronutrients and Cancer: Add Spice to Your Life. [ed.] Sharmila Shankar and Rakesh K. Srivastava. Nutrition, Diet and Cancer. New York: Springer Science+Business Media B.V., 2012, 2, pp. 23-48. ISBN: 978-94-007-2922-3.
  78. Molecular Targets of Nutraceuticals Derived from Dietary Spices: Potential Role in Suppression of Inflammation and Tumorigenesis. Aggarwal, Bharat B., et al., et al. [ed.] Steven R. Goodman. 8, Syracuse: SAGE: The Society for Experimental Biology and Medicine, August 2009, Experimental Biology and Medicine, Vol. 234, pp. 825-849. DOI: 10.3181/0902-MR-78; http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3141288/. ISSN: 1535-3699.
  79. Phytochemical flavonols, carotenoids and the antioxidant properties of a wide selection of Fijian fruit, vegetables and other readily available foods. Lako, Jimaima, et al., et al. [ed.] G.G. Birch. 4, Reading: Elsevier Ltd., 2007, Food Chemistry, Vol. 101, pp. 1727-1741. DOI: 10.1016/j.foodchem.2006.01.031; http://www.sciencedirect.com/science/article/pii/S0308814606000872. ISSN: 0308-8146.
  80. Siddiqui, Imtiaz A., et al., et al. Bioactive Food Components for Melanoma: An Overview. [ed.] Yaguang Xi. Skin Cancer Overview. Mobile: InTech, 2011, 9, pp. 191-214. ISBN: 978-953-307-746-8; DOI: 10.5772/2440.
  81. Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals. Gupta, Subash C., et al., et al. [ed.] Avraham Raz and Kenneth V. Honn. 3, Detroit: Springer Science+Business Media, LLC, September 1, 2010, Cancer and Metastasis Reviews, Vol. 29, pp. 405-434. DOI: 10.1007/s10555-010-9235-2; http://link.springer.com/article/10.1007%2Fs10555-010-9235-2. eISSN: 1573-7233.
  82. Prevention and Therapy of Cancer by Dietary Monoterpenes. Crowell, Pamela L. [ed.] John W. Suttie. 3, Bethesda: American Society for Nutrition, March 1999, The Journal of Nutrition, Vol. 129, pp. 775S-778S. ISSN: 0022-3166.
  83. Khan, Nasiruddin, et al., et al. Resveratrol and Bioactive Flavonoids in Immune Function. [ed.] Ronald Ross Watson, Sherma Zibadi and Victor R. Preedy. Dietary Components and Immune Function. New York: Springer Science+Business Media, LLC, 2010, 23, pp. 397-420. ISBN: 978-1-60761-061-1; DOI: 10.1007/978-1-60761-061-8.
  84. Dietary Polyphenols and Their Biological Significance. Han, Xiuzhen, Shen, Tao and Lou, Hongxiang. [ed.] Michael N. Hall. 9, Basel: MDPI - Open Access Publishing, September 12, 2007, International Journal of Molecular Sciences, Vol. 8, pp. 950-988. DOI: 10.3390/i8090950; http://www.mdpi.com/1422-0067/8/9/950. ISSN: 1422-0067.
  85. Chemopreventive effects of natural dietary compounds on cancer development. Pan, Min-Hsiung and Ho, Chi-Tang. [ed.] Robert D. Eagling. 11, Cambridge: The Royal Society of Chemistry, November 1, 2008, Chemical Society Reviews, Vol. 37, pp. 2558-2574. DOI: 10.1039/b801558a; http://pubs.rsc.org/en/content/articlepdf/2008/cs/b801558a. ISSN: 0306-0012.
  86. The Fatty Acid Composition and Properties of Oil Extracted from Fresh Rhizomes of Turmeric (Curcuma longa Linn.) Cultivars of Bangladesh. Paul, B.K., et al., et al. [ed.] Mamtaz Dawlatana. 1, Dhaka: Bangladesh Council of Scientific & Industrial Research, 2011, Bangladesh Journal of Scientific and Industrial Research, Vol. 46, pp. 127-132. DOI: 10.3329/bjsir.v46i1.8116; http://www.banglajol.info/index.php/BJSIR/article/view/8116. ISSN: 0304-9809.
  87. Murphy, Hedwig S. Inflammation. [ed.] Raphael Rubin, David S. Strayer and Emanuel Rubin. Rubin's Pathology: Clinicopathologic Foundations of Medicine. 6. Philadelphia: Wolters Kluwer: Lippincott Williams & Wilkins, 2012, 2, pp. 47-82. ISBN: 978-1-60547-968-2.
  88. Therapeutic potential of curcumin in gastrointestinal diseases. Rajasekaran, Sigrid A. [ed.] Lian-Sheng Ma. 1, Beijing: Baishideng Publishing Group Co., Limited, February 15, 2011, World Journal of Gastroenterology, Vol. 2, pp. 1-14. DOI: 10.4291/wjgp.v2.i1.1; http://www.wjgnet.com/2150-5330/full/v2/i1/1.htm. ISSN: 1007-9327.
  89. Newsholme, Eric A. and Leech, Tony R. Cancer: Genes, Cachexia and Death. Functional Biochemistry in Health and Disease. Chichester: Wiley-Blackwell: John Wiley & Sons, Ltd, 2010, 21, pp. 483-508. ISBN: 978-0-471-98820-5.
  90. Jagetia, Ganesh C. Radioprotection and Radiosensitization by Curcumin. [ed.] Bharat B. Aggarwal, Young-Joon Surh and Shishir Shishodia. The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease. . New York: Springer Science+Business Media, LLC, 2007, pp. 301-320. ISBN-13: 978-0-387-46400-8.
  91. Evaluation of in vitro anti-proliferative and immunomodulatory activities of compounds isolated from Curcuma longa. Yue, Grace G. L., et al., et al. [ed.] Joseph F. Borzelleca and Alan R. Boobis. 8-9, Richmond; London: Elsevier Ltd., Aug-Sep 2010, Food and Chemical Toxicology, Vol. 48, pp. 2011-2020. DOI: 10.1016/j.fct.2010.04.039; http://www.sciencedirect.com/science/article/pii/S027869151000253X. ISSN: 0278-6915.
  92. Menon, Venugopal P. and Sudheer, Adluri Ram. Antioxidant and Anti-Inflammatory Properties of Curcumin. [ed.] Bharat B. Aggarwal, Young-Joon Surh and Shishir Shishodia. The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease. New York: Springer Science+Business Media, LLC, 2007, pp. 105-126. ISBN-13: 978-0-387-46400-8.
  93. Gautam, Subhash C., Gao, Xiaohua and Dulchavsky, Scott. Immunomodulation by Curcumin. [ed.] Bharat B. Aggarwal, Young-Joon Surh and Shishir Shishodia. The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease. New York: Springer Science+Business Media, LLC, 2007, pp. 321-342. ISBN-13: 978-0-387-46400-8.
  94. A plant flavonoid fisetin induces apoptosis in colon cancer cells by inhibition of COX2 and Wnt/EGFR/NF-κB-signaling pathways. Suh, Yewseok, et al., et al. [ed.] Curtis C. Harris. 2, Bethesda: Oxford University Press, February 2009, Carcinogenesis, Vol. 30, pp. 300-307. DOI: 10.1093/carcin/bgn269; http://carcin.oxfordjournals.org/content/30/2/300. ISSN: 0143-3334.
  95. Tortora, Gerard J. and Derrickson, Bryan. Nervous Tissue. Principles of Anatomy & Physiology. 13th. Hoboken: John Wiley & Sons, Inc., 2012, 12, pp. 447-491. ISBN-13: 978-0470-56510-0.
  96. Thangapazham, Rajesh L., Sharma, Anuj and Maheshwari, Radha K. Beneficial Role of Curcumin in Skin Diseases. [ed.] Bharat B. Aggarwal, Young-Joon Surh and Shishir Shishodia. The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease. New York: Springer Science+Business Media, LLC, 2007, pp. 343-358. ISBN-13: 978-0-387-46400-8.
  97. Hyaluronidase: Both a Tumor Promoter and Suppressor. Lokeshwar, Vinata B. and Selzer, Marie G. [ed.] Eva Klein. 4, Stockholm: Elsevier Ltd., August 2008, Seminars in Cancer Biology, Vol. 18, pp. 281-287. DOI: 10.1016/j.semcancer.2008.03.008; http://www.sciencedirect.com/science/article/pii/S1044579X08000291. ISSN: 1044-579X.
  98. Is EGR1 a potential target for prostate cancer therapy? Gitenay, Delphine and Baron, Véronique T. [ed.] Ron Allison and Adam Dicker. 7, Greenville; Philadelphia: Future Medicine Ltd, September 2009, Future Oncology, Vol. 5, pp. 993-1003. DOI: 10.2217/fon.09.67; http://www.futuremedicine.com/doi/abs/10.2217/fon.09.67. ISSN: 1479-6694.
  99. Curcumin Effect on MMPs and TIMPs Genes in a Breast Cancer Cell Line. Hassan, Zeinab Korany and Daghestani, Maha Hassan. [ed.] Malcolm A. Moore. 7, Goyang-si Gyeonggi-do: Asian Regional Office and the National Cancer Center of Korea, 2012, Asian Pacific Journal of Cancer Prevention, Vol. 13, pp. 3259-3264. DOI: 10.7314/APJCP.2012.13.7.3259; http://koreascience.or.kr/article/ArticleFullRecord.jsp?cn=POCPA9_2012_v13n7_3259. ISSN: 1513-7368.
  100. Tumor Environment Dictates Medulloblastoma Cancer Stem Cell Expression and Invasive Phenotype. Annabi, Borhane, et al., et al. [ed.] Michael B. Kastan. 6, Durham: American Association for Cancer Research, June 2008, Molecular Cancer Research, Vol. 6, pp. 907-916. DOI: 10.1158/1541-7786.MCR-07-2184; http://mcr.aacrjournals.org/content/6/6/907. ISSN: 1557-3125.
  101. Curcumin, demethoxycurcumin and bisdemethoxycurcumin differentially inhibit cancer cell invasion through the down-regulation of MMPs and uPA. Yodkeeree, Supachai, et al., et al. [ed.] Bernhard Hennig. 2, Lexington: Elsevier Inc., February 2009, Journal of Nutritional Biochemistry, Vol. 20, pp. 87-95. DOI: 10.1016/j.jnutbio.2007.12.003; http://www.jnutbio.com/article/S0955-2863(08)00004-1/abstract. ISSN: 0955-2863.
  102. Duke, James A., Bogenschutz-Godwin, Mary Jo and duCellier, Judi. CRC Handbook of Medicinal Spices. Boca Raton: CRC Press LLC, 2003. ISBN: 0-8493-1279-5.
  103. Nutraceutical use in late-stage cancer. Wargovich, Michael J., et al., et al. [ed.] Avraham Raz and Kenneth V. Honn. 3, Detroit: Springer Science+Business Media, LLC, September 2010, Cancer and Metastasis Reviews, Vol. 29, pp. 503-510. DOI: 10.1007/s10555-010-9240-5; http://link.springer.com/article/10.1007%2Fs10555-010-9240-5. eISSN: 1573-7233.
  104. Gene expression profiling identifies activating transcription factor 3 as a novel contributor to the proapoptotic effect of curcumin. Yan, Chunhong, et al., et al. [ed.] Napoleone Ferrara. 2, Philadelphia: American Association for Cancer Research, Inc., February 2005, Molecular Cancer Therapeutics, Vol. 4, pp. 233-241. ISSN: 1535-7163.
  105. RNA Binding Protein CUGBP2/CELF2 Mediates Curcumin-Induced Mitotic Catastrophe of Pancreatic Cancer Cells. Subramaniam, Dharmalingam, et al., et al. [ed.] Wael El-Rifai. 2, Nashville: Public Library of Science, February 11, 2011, PLoS One, Vol. 6, p. e16958. DOI: 10.1371/journal.pone.0016958; http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0016958. ISSN: 1932-6203.
  106. Strayer, David S. and Rubin, Emanuel. Cell Adaptation, Cell Injury and Cell Death. [ed.] Raphael Rubin, David S. Strayer and Emanuel Rubin. Rubin's Pathology: Clinicopathologic Foundations of Medicine. 6. Philadelphia: Wolters Kluwer: Lippincott Williams & Wilkins, 2012, 1, pp. 1-46. ISBN: 978-1-60547-968-2.
  107. Proliferation Marker Ki-67 in Early Breast Cancer. Urruticoechea, Ander, Smith, Ian E. and Dowsett, Mitch. [ed.] Daniel G. Haller. 28, Philadelphia: American Society of Clinical Oncology, October 1, 2005, Journal of Clinical Oncology, Vol. 23, pp. 7212-7220. DOI: 10.1200/JCO.2005.07.501; http://jco.ascopubs.org/content/23/28/7212. ISSN: 0732-183X.
  108. Curcumin in combination with visible light inhibits tumor growth in a xenograft tumor model. Dujic, Jadranka, et al., et al. [ed.] Harald zur Hausen. 6, Heidelberg: John Wiley & Sons, Inc.: UICC, March 15, 2009, International Journal of Cancer, Vol. 124, pp. 1422-1428. DOI: 10.1002/ijc.23997; http://onlinelibrary.wiley.com/doi/10.1002/ijc.23997/abstract. ISSN: 1097-0215.
  109. Cell Cycle Arrest by the Isoprenoids Perillyl Alcohol, Geraniol, and Farnesol Is Mediated by p21Cip1 and p27Kip1 in Human Pancreatic Adenocarcinoma Cells. Wiseman, Dean A., Werner, Sean R. and Crowell, Pamela L. [ed.] Rick G. Schnellmann. 3, Columbia: American Society for Pharmacology and Experimental Therapeutics, March 2007, Journal of Pharmacology and Experimental Therapeutics, Vol. 320, pp. 1163-1170. DOI: 10.1124/jpet.106.111666; http://jpet.aspetjournals.org/content/320/3/1163. eISSN: 1521-0103.
  110. Composition and Antioxidant Properties of Essential Oils from Curcuma rhizome. Tsai, Snu-Yao, et al., et al. [ed.] Shian-Shyong Tseng. 1, Taichung City: Asia University, June 2011, Asian Journal of Arts and Sciences, Vol. 2, pp. 57-66. ISSN: 2221-4224.
  111. Molecular Mechanisms involved in Farnesol-Induced Apoptosis. Joo, Joung Hyuck and Jetten, Anton M. [ed.] Manfred Schwab. 2, Heidelberg: Elsevier Ireland Ltd., January 28, 2010, Cancer Letters, Vol. 287, pp. 123-135. DOI: 10.1016/j.canlet.2009.05.015; http://www.cancerletters.info/article/S0304-3835(09)00367-X/abstract. ISSN: 0304-3835.
  112. Attokaran, Mathew. Turmeric: Curcuma longa L (Zingiberaceae). Natural Food Flavors and Colorants. Ames: Blackwell Publishing Ltd. and Institute of Food Technologists, 2011, 98, pp. 391-398. ISBN: 978-0-8138-2110-8.
  113. Insulin-like growth factors are more effective than progastrin in reversing proapoptotic effects of curcumin: critical role of p38MAPK. Singh, Pomila, et al., et al. [ed.] Pauline Kay Lund. 4, Chapel Hill: American Physiological Society, April 1, 2010, American Journal of Physiology - Gastrointestinal and Liver Physiology®, Vol. 298, pp. G551-G562. DOI: 10.1152/ajpgi.00497.2009; http://ajpgi.physiology.org/content/298/4/G551. ISSN: 1522-1547.
  114. Curcumin suppresses proliferation and invasion in human gastric cancer cells by downregulation of PAK1 activity and cyclin D1 expression. Cai, Xin-Ze, et al., et al. [ed.] Wafik S. El-Deiry. 14, Austin: Landes Bioscience, July 15, 2009, Cancer Biology & Therapy, Vol. 8, pp. 1360-1368. DOI: 10.4161/cbt.8.14.8720; https://www.landesbioscience.com/journals/cbt/article/8720/. eISSN: 1555-8576.
  115. Beckerman, Martin. Cell Adhesion and Motility. Molecular and Cellular Signaling. Oak Ridge: Springer Science+Business Media, Inc., 2005, 10, pp. 221-246. ISBN-10: 0-387-22130-1.
  116. Fry, Mitchell. The Immune Response. Essential Biochemistry for Medicine. Chichester: Wiley-Blackwell: John Wiley & Sons Ltd., 2010, 15, pp. 209-230. ISBN: 978-0-470-74328-7.
  117. Bair, Elisabeth L. and Nagle, Raymond B. Changing Extracellular Matrix Ligands During Metastasis. [ed.] Anne E. Cress and Raymond B. Nagle. Cell Adhesion and Cytoskeletal Molecules in Metastasis. Tucson: Springer, 2006, 1, pp. 1-18. ISBN-13: 978-1-4020-5128-9.
  118. The Biological Role of mTOR in the Pathogenesis of Solid Tumors: An Overview. Koropouli, Eleftheria, et al., et al. [ed.] Dimitra Hadjipavlou-Litina. 1, Thessaloniki: Bentham Science Publishers, February 2009, Current Enzyme Inhibition, Vol. 5, pp. 51-65. ISSN: 1573-4080.
  119. Bright, John J. Curcumin and Autoimmune Disease. The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease. New York: Aggarwal, Bharat B.; Surh, Young-Joon; Shishodia, Shishir, 2007, pp. 425-452. ISBN-13: 978-0-387-46400-8.
  120. Bettelheim, Frederick A., et al., et al. Enzymes. Introduction to Organic and Biochemistry. 7. Belmont: Brooks/Cole, Cengage Learning, 2010, pp. 344-368. ISBN-13: 978-0-495-39116-6.
  121. The NF-κB Family of Transcription Factors and Its Regulation. Oeckinghaus, Andrea and Ghosh, Sankar. [ed.] Timothy W. Nilsen. 4, Cold Spring Harbor: Harbor Laboratory Press, October Richard Sever, 2009, Cold Spring Harbor Perspectives in Biology, Vol. 1, pp. 1-14. DOI: 10.1101/cshperspect.a000034; http://cshperspectives.cshlp.org/content/1/4/a000034. eISSN: 1943-0264.
  122. Curcumin Inhibits Skin Squamous Cell Carcinoma Tumor Growth In Vivo. Phillips, Jeffrey M., et al., et al. [ed.] Richard Rosenfeld. 1, Alexandria: American Academy of Otolaryngology--Head and Neck Surgery Foundation, July 2011, Otolaryngology-Head and Neck Surgery, Vol. 145, pp. 58-63. DOI: 10.1177/0194599811400711; http://oto.sagepub.com/content/145/1/58. ISSN: 0194-5998.
  123. Xanthorrhizol, a natural sesquiterpenoid from Curcuma xanthorrhiza, has an anti-metastatic potential in experimental mouse lung metastasis model. Choi, Min-Ah, et al., et al. [ed.] William J. Lennarz. 1, Stony Brook: Elsevier Inc., 2005, Biochemical and Biophysical Research Communications, Vol. 326, pp. 210-217. DOI: 10.1016/j.bbrc.2004.11.020; http://www.sciencedirect.com/science/article/pii/S0006291X04025331. ISSN: 0006-291X.
  124. Pharmaceutical and Therapeutic Potentials of Essential Oils and Their Individual Volatile Constituents: A Review. Edris, Amr E. [ed.] Elizabeth M. Williamson, et al., et al. 4, Reading: John Wiley & Sons, Ltd., April 2007, Phytotherapy Research, Vol. 21, pp. 308-323. http://onlinelibrary.wiley.com/doi/10.1002/ptr.2072/abstract. eISSN: 1099-1573.
  125. Spleen Tyrosine Kinase (Syk), a Novel Target of Curcumin, Is Required for B Lymphoma Growth. Gururajan, Murali, et al., et al. [ed.] Robert R. Rich. 1, Birmingham: The American Association of Immunologists, Inc., January 1, 2007, The Journal of Immunology, Vol. 178, pp. 111-121. DOI: 10.4049/jimmunol.178.1.111; http://www.jimmunol.org/content/178/1/111. ISSN: 1550-6606.
  126. Activation of ATM/Chk1 by curcumin causes cell cycle arrest and apoptosis in human pancreatic cancer cells. Sahu, R.P., Batra, S. and Srivastava, S.K. [ed.] Adrian L. Harris. 9, London: Nature Publishing Group, May 5, 2009, British Journal of Cancer, Vol. 100, pp. 1425-1433. DOI: 10.1038/sj.bjc.6605039; http://www.nature.com/bjc/journal/v100/n9/full/6605039a.html. ISSN: 0007-0920.
  127. Curcumin Attenuates β-catenin Signaling in Prostate Cancer Cells through Activation of Protein Kinase D1. Sundram, Vasudha, et al., et al. [ed.] Masaru Katoh. 4, Tokyo: Public Library of Science, April 16, 2012, PLoS ONE, Vol. 7, p. e35368. DOI: 10.1371/journal.pone.0035368; http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0035368. eISSN: 1932-6203.
  128. Scotti, Paul. Mayo Clinic Researchers Discover and Manipulate Molecular Interplay That Moves Cancer Cells. Mayo Clinic. [Online] March 29, 2009. [Cited: October 8, 2014.] http://www.eurekalert.org/pub_releases/2009-03/mc-mcr032709.php.
  129. PPAR Regulation of Inflammatory Signaling in CNS Diseases. Bright, John J., et al., et al. [ed.] Paul D. Drew. Article ID 658520, Little Rock: Hindawi Publishing Corporation, May 12, 2008, PPAR Research, Vol. 2008. DOI: 10.1155/2008/658520; http://www.hindawi.com/journals/ppar/2008/658520/. ISSN: 1687-4757.
  130. Roles of the Akt/mTOR/p70S6K and ERK1/2 Signaling Pathways in Curcumin-Induced Autophagy. Shinojima, Naoki, et al., et al. [ed.] Daniel J. Klionsky. 6, Ann Arbor: Landes Bioscience, November/December 2007, Autophagy, Vol. 3, pp. 635-637. ISSN: 1554-8627.
  131. The Antitumor Activities of Flavonoids. Kanadaswami, Chithan, et al., et al. [ed.] John G. Delinasios. 5, Athens: International Institute of Anticancer Research, Sep-Oct 2005, In Vivo, Vol. 19, pp. 895-910. ISSN: 0258-851X.
  132. Optimized Turmeric Extracts have Potent Anti-Amyloidogenic Effects. Shytle, R. Douglas, et al., et al. [ed.] Debomoy K. Lahiri. 6, Indianapolis: Bentham Science Publishers, December 2009, Current Alzheimer Research, Vol. 6, pp. 564-571. DOI: 10.2174/156720509790147115; http://www.eurekaselect.com/85201/article. ISSN: 1567-2050.
  133. Epigenetic changes induced by curcumin and other natural compounds. Reuter, Simone, et al., et al. [ed.] Giuditta Perozzi, et al., et al. 2, Rome; Lausanne; Utrecht: Springer-Verlag, May 1, 2011, Genes & Nutrition, Vol. 6, pp. 93-108. DOI: 10.1007/s12263-011-0222-1; http://link.springer.com/article/10.1007%2Fs12263-011-0222-1. ISSN: 1555-8932.
  134. Pharmacological and clinical properties of curcumin. Beevers, Christopher S. and Huang, Shile. [ed.] Ayse Kuruuzum-Uz. Ankara: Dove Medical Press Ltd., June 23, 2011, Botanics: Targets and Therapy, Vol. 1, pp. 5-18. DOI: 10.2147/BTAT.S17244; http://www.dovepress.com/pharmacological-and-clinical-properties-of-curcumin-peer-reviewed-article-BTAT. ISSN: 1179-9897.
  135. Linkage of Curcumin-Induced Cell Cycle Arrest and Apoptosis by Cyclin-Dependent Kinase Inhibitor p21/WAF1/CIP1. Srivastava, Rakesh K., et al., et al. [ed.] Mikhail V. Blagosklonny. 23, Buffalo: Landes Bioscience, December 1, 2007, Cell Cycle, Vol. 6, pp. 2953-2961. ISSN: 1538-4101.
  136. The chemopreventive and clinically used agent curcumin sensitizes HPV- but not HPV+ HNSCC to ionizing radiation, in vitro and in a mouse orthotopic model. Tuttle, Stephen W., et al., et al. [ed.] Wafik S. El-Deiry. 7, Hershey: Landes Bioscience, May 1, 2012, Cancer Biology & Therapy, Vol. 13, pp. 575-584. DOI: 10.4161/cbt.19772; https://www.landesbioscience.com/journals/cbt/article/19772/. ISSN: 1538-4047.
  137. Curcumin suppresses proliferation and induces apoptosis in human biliary cancer cells through modulation of multiple cell signaling pathways. Prakobwong, Suksanti, et al., et al. [ed.] Curtis C. Harris. 9, Bethesda: Oxford University Press, September 2011, Carcinogenesis, Vol. 32, pp. 1372-1380. DOI: 10.1093/carcin/bgr032; http://carcin.oxfordjournals.org/content/32/9/1372. ISSN: 0143-3334.
  138. Studies on Chemistry and Biological Activities of Curcuma Longa Linn - A Review. Reddy, Y. Surendra, et al., et al. [ed.] M. William Carey. 1, Andhra Pradesh: KMR Pharma Welfare Association, January 24, 2011, International Journal of Advances in Pharmaceutical Research, Vol. 2, pp. 26-36. eISSN: 2230-7583.
  139. Guo, X.M., Lu, Q., Liu, Z.J., Wang, L.F., Feng, B.A. Journal of experimental hematology / Chinese Association of Pathophysiology 14(4): [Effects of D-limonene on leukemia cells HL-60 and K562 in vitro]. PubMed: U.S. National Library of Medicine and the National Institutes of Health. [Online] August 2006. [Cited: October 3, 2014.] pp. 692-5. http://www.ncbi.nlm.nih.gov/pubmed/16928301. PMID: 16928301.
  140. Priyadarsini, Ramamurthi Vidya and Nagini, Siddavaram. Aberrant Signaling Pathways in Cancer: Modulation by the Dietary Flavonoid, Quercetin. [ed.] Sharmila Shankar and Rakesh K. Srivastava. Nutrition, Diet and Cancer. New York: Springer Science+Business Media B.V., 2012, 1, pp. 1-22. ISBN: 978-94-007-2922-3.
  141. Induction of apoptosis by d-limonene is mediated by a caspase-dependent mitochondrial death pathway in human leukemia cells. Ji, Jun, et al., et al. [ed.] Aaron Polliack, Koen Van Besien and John Seymour. 12, Jerusalem; New York; Victoria: Informa Plc, December 2006, Leukemia & Lymphoma, Vol. 47, pp. 2617-2624. DOI: 10.1080/00268970600909205; http://informahealthcare.com/doi/abs/10.1080/00268970600909205. ISSN: 1042-8194.
  142. Adam, Frank. microRNA: A Revolution in Gene Expression. The Journal of Young Investigators, Inc. [Online] August 2005. [Cited: October 8, 2014.] ISSN: 1539-4026. http://www.jyi.org/features/ft.php?id=392. ISSN: 1539-4026.
  143. Goel, Ajay and Chaturvedi, Gaurav. Diet-Induced Epigenetic Changes and Cancer Prevention: A Mantra for Healthy Living. [ed.] Sharmila Shankar and Rakesh K. Srivastava. Nutrition, Diet and Cancer. New York: Springer Science+Business Media B.V., 2012, 13, pp. 283-326. ISBN: 978-94-007-2922-3.
  144. USDA Database for Standard Reference. NutriBase 7 Clinical Edition. s.l.: CyperSoft, 2007.
  145. Sabikhi, Latha, et al., et al. Role of Food Micro-molecules in the Prevention of Cancer. [ed.] Sharmila Shankar and Rakesh K. Srivastava. Nutrition, Diet and Cancer. New York: Springer Science+Business Media B.V., 2012, 11, pp. 235-254. ISBN: 978-94-007-2922-3.
  146. Braun, Lesley and Cohen, Marc. Herbs & Natural Supplements: An Evidence-Based Guide. Marrickville: Elsevier Australia, 2007. ISBN-13: 978-0-7295-3796-4.
  147. Thakur, Vijay S. and Gupta, Sanjay. Dietary Phytochemicals as Epigenetic Modulators in Cancer. [ed.] Sharmila Shankar and Rakesh K. Srivastava. Nutrition, Diet and Cancer. New York: Springer Science+Business Media B.V., 2012, 19, pp. 493-520. ISBN: 978-94-007-2922-3.
  148. Servan-Schreiber, David. Anticancer: A New Way of Life. 3. New York: Viking: Penguin Group (USA) Inc., 2009. ISBN: 1-101-16242-2.
  149. Dietary Turmeric Potentially Reduces the Risk of Cancer. Hutchins-Wolfbrandt, Amanda and Mistry, Anahita M. [ed.] Malcolm A. Moore. 12, Korea: National Cancer Center, 2011, Asian Pacific Journal of Cancer Prevention , Vol. 12, pp. 3169-3173. ISSN: 1513-7368.
  150. Crude drugs as anticancer agents. Mou, Xiaoyang, et al., et al. [ed.] Ping Wang. 1, Manhasset: e-Century Publishing Corporation, January 1, 2011, International Journal of Clinical and Experimental Medicine, Vol. 4, pp. 17-25. eISSN: 1940-5901.
  151. Prostaglandin E2 Activates Mitogen-Activated Protein Kinase/Erk Pathway Signaling and Cell Proliferation in Non-Small Cell Lung Cancer Cells in an Epidermal Growth Factor Receptor-Independent Manner. Krysan, Kostyantyn, et al., et al. [ed.] Frank J. Rauscher III. 14, Philadelphia: American Association for Cancer Research, July 15, 2005, Cancer Research, Vol. 65, pp. 6275-6281. DOI: 10.1158/0008-5472.CAN-05-0216; http://cancerres.aacrjournals.org/content/65/14/6275. ISSN: 0008-5472.
  152. Effect of turmeric oil and turmeric oleoresin on cytogenetic damage in patients suffering from oral submucous fibrosis. Hastak, K., Lubri, N., Jakhi, S.D., More, C., John, A., Ghaisas, S.D., Bhide, S.V. 2, s.l.: Elsevier Ireland Ltd., June 24, 1997, Cancer Letters, Vol. 116, pp. 265-269. DOI: 10.1016/S0304-3835(97)00205-X; http://www.cancerletters.info/article/S0304-3835(97)00205-X/abstract. ISSN: 0304-3835.
  153. Volatile isoprenoid constituents of fruits, vegetables and herbs cumulatively suppress the proliferation of murine B16 melanoma and human HL-60 leukemia cells. Tatman, Dana and Mo, Huanbiao. [ed.] Manfred Schwab. 2, Heidelberg: Elsevier Ireland Ltd., January 25, 2002, Cancer Letters, Vol. 175, pp. 129-139. DOI: 10.1016/S0304-3835(01)00723-6; http://www.sciencedirect.com/science/article/pii/S0304383501007236. ISSN: 0304-3835.
  154. Biological effects of essential oils - A review. Bakkali, F., et al., et al. [ed.] Joseph F. Borzelleca and Alan R. Boobis. 2, Richmond; London: Elsevier Ltd., February 2008, Food and Chemical Toxicology, Vol. 46, pp. 446-475. DOI: 10.1016/j.fct.2007.09.106; http://www.sciencedirect.com/science/article/pii/S0278691507004541. ISSN: 0278-6915.
  155. Ajila, C.M. and Brar, S.K. Role of Dietary Antioxidants in Cancer. [ed.] Sharmila Shankar and Rakesh K. Srivastava. Nutrition, Diet and Cancer. New York: Springer Science+Business Media B.V., 2012, 16, pp. 377-412. ISBN: 978-94-007-2922-3.
  156. Effects of borneol on the level of DNA damage induced in primary rat hepatocytes and testicular cells by hydrogen peroxide. Horváthová, E., et al., et al. [ed.] A. Wallace Hayes. 6, Andover: Elsevier Ltd., June 2009, Food and Chemical Toxicology, Vol. 47, pp. 1318-1323. DOI: 10.1016/j.fct.2009.03.002; http://www.sciencedirect.com/science/article/pii/S0278691509001070. ISSN: 0278-6915.
  157. Shankar, Sharmila, Singh, Brahma N. and Srivastava, Rakesh K. Plant Polyphenols and Their Role in Cancer Prevention and Chemotherapy. [ed.] Sharmila Shankar and Rakesh K. Srivastava. Nutrition, Diet and Cancer. New York: Springer Science+Business Media B.V., 2012, 10, pp. 209-234. ISBN: 978-94-007-2922-3.
  158. Wishart, D.S., Knox, C., Guo, A.C., Cheng, D., Shrivastava, S., Tzur, D., Gautam, B., Hassanali, M. Cyclophosphamide (DB00531). DrugBank Version 4.1. [Online] September 13, 2013. [Cited: October 8, 2014.] http://www.drugbank.ca/drugs/DB00531. CAS number 50-18-0.
  159. Dietary Curcumin Attenuates Glioma Growth in a Syngeneic Mouse Model by Inhibition of the JAK1,2/STAT3 Signaling Pathway. Weissenberger, Jakob, et al., et al. [ed.] Kenneth C. Anderson. 23, Philadelphia: American Association for Cancer Research, December 1, 2010, Clinical Cancer Research, Vol. 16, pp. 5781-5795. DOI: 10.1158/1078-0432.CCR-10-0446; http://clincancerres.aacrjournals.org/content/16/23/5781. ISSN: 1557-3265.
  160. RB and cell cycle progression. Giacinti, C. and Giordano, A. 38, s.l.: Nature Publishing Group, August 28, 2006, Oncogene, Vol. 25, pp. 5220-5227. DOI: 10.1038/sj.onc.1209615; http://www.nature.com/onc/journal/v25/n38/full/1209615a.html. ISSN: 0950-9232.
  161. Neuroprotection by Spice-Derived Nutraceuticals: You Are What You Eat! Kannappan, Ramaswamy, et al., et al. [ed.] Nicolas G. Bazan. 2, New Orleans: Springer Science+Business Media, LLC, October 1, 2011, Molecular Neurobiology, Vol. 44, pp. 142-159. DOI: 10.1007/s12035-011-8168-2; http://link.springer.com/article/10.1007%2Fs12035-011-8168-2. ISSN: 0893-7648.
  162. Potential of the Dietary Antioxidants Resveratrol and Curcumin in Prevention and Treatment of Hematologic Malignancies. Kelkel, Mareike, et al., et al. [ed.] Derek J. McPhee. 10, Emeryville: MDPI AG, October 12, 2010, Molecules, Vol. 15, pp. 7035-7074. DOI: 10.3390/molecules15107035; http://www.mdpi.com/1420-3049/15/10/7035. ISSN: 1420-3049.
  163. Chemical Composition and Product Quality Control of Turmeric (Curcuma longa L.). Li, Shiyou, et al., et al. [ed.] Shiyou Li and Shilin Chen. Nacogdoches; Beijing: Bentham Open, 2011, Pharmaceutical Crops, Vol. 2, pp. 28-54. DOI: 10.2174/2210290601102010028; http://benthamopen.com/ABSTRACT/TOPHARMCJ-2-28. ISSN: 2210-2906.
  164. Inhibition of lung cancer cell growth by quercetin glucuronides via G2/M arrest and induction of apoptosis. Yang, Jen-Hung, et al., et al. [ed.] Eric Johnson. 2, La Jolla: American Society for Pharmacology and Experimental Therapeutics, February 2006, Drug Metabolism & Disposition, Vol. 34, pp. 296-304. DOI: 10.1124/dmd.105.005280; http://dmd.aspetjournals.org/content/34/2/296. ISSN: 1521-009X.
  165. Autophagy and cancer. Choi, Kyeong Sook. [ed.] Dae-Myung Jue. 2, Seoul: Nature Publishing Group; Korean Society for Biochemistry and Molecular Biology , February 29, 2012, Experimental & Molecular Medicine, Vol. 44, pp. 109-120. DOI: 10.3858/emm.2012.44.2.033; http://www.nature.com/emm/journal/v44/n2/full/emm201215a.html. eISSN: 2092-6413.
  166. Stressed to Death: Targeting Endoplasmic Reticulum Stress Response Induced Apoptosis in Gliomas. Johnson, Guyla G., White, Misti C. and Grimaldi, Maurizio. [ed.] William A. Banks. 3, Seattle: Bentham Science Publishers, February 16, 2012, Current Pharmaceutical Design, Vol. 17, pp. 284-292. DOI: 10.2174/138161211795049660; http://www.ingentaconnect.com/content/ben/cpd/2011/00000017/00000003/art00009. ISSN: 1381-6128.
  167. Natural Compounds with Proteasome Inhibitory Activity for Cancer Prevention and Treatment. Yang, H., et al., et al. [ed.] Ben M. Dunn. 3, Gainesville: Bentham Science Publishers, June 2008, Current Protein & Peptide Science, Vol. 9, pp. 227-239. DOI: 10.2174/138920308784533998; http://www.eurekaselect.com/82761/article. ISSN: 1389-2037.
  168. Resveratrol-induced cytotoxicity in human Burkitt's lymphoma cells is coupled to the unfolded protein response. Yan, Ying, et al., et al. [ed.] Christna Chap. 445, London: BioMed Central Ltd., August 20, 2010, BMC Cancer, Vol. 10. DOI: 10.1186/1471-2407-10-445; http://www.biomedcentral.com/1471-2407/10/445. ISSN: 1471-2407.
  169. Limtrakul, Pornngarm. Curcumin as Chemosensitizer. [ed.] Bharat B. Aggarwal, Young-Joon Surh and Shishir Shishodia. The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease. New York: Springer Science+Business Media, LLC, 2007, pp. 269-300. ISBN-13: 978-0-387-46400-8.
  170. Role of the MRP1/ABCC1 Multidrug Transporter Protein in Cancer. Munoz, Marcia, et al., et al. [ed.] William Whelan and Angelo Azzi. 12, Boston; Miami: John Wiley & Sons, Inc.: International Union of Biochemistry and Molecular Biology, December 2007, IUBMB Life, Vol. 59, pp. 752-757. DOI: 10.1080/15216540701736285; http://onlinelibrary.wiley.com/doi/10.1080/15216540701736285/abstract. ISSN: 1521-6551.
  171. Implications of Cancer Stem Cell Theory for Cancer Chemoprevention by Natural Dietary Compounds. Li, Yanyan, et al., et al. [ed.] Bernhard Hennig. 9, Lexington: Elsevier Inc., September 2011, The Journal of Nutritional Biochemistry, Vol. 22, pp. 799-806. DOI: 10.1016/j.jnutbio.2010.11.001; http://www.sciencedirect.com/science/article/pii/S0955286310002445. ISSN: 0955-2863.
  172. Overcoming Multidrug Resistance in Human Cancer Cells by Natural Compounds. Nabekura, Tomohiro. [ed.] Florian Lang. 6, Basel: MDPI Publishing, May 28, 2010, Toxins, Vol. 2, pp. 1207-1224. DOI: 10.3390/toxins2061207; http://www.mdpi.com/2072-6651/2/6/1207. ISSN: 2072-6651.
  173. Flavonoids Are Inhibitors of Breast Cancer Resistance Protein (ABCG2)-Mediated Transport. Zhang, Shuzhong, Yang, Xinning and Morris, Marilyn E. [ed.] Paul A. Insel. 5, Bethesda: American Society for Pharmacology and Experimental Therapeutics, May 2004, Molecular Pharmacology, Vol. 65, pp. 1208-1216. DOI: 10.1124/mol.65.5.1208; http://molpharm.aspetjournals.org/content/65/5/1208. ISSN: 1521-0111.
  174. Potential applications of curcumin and its novel synthetic analogs and nanotechnology-based formulations in cancer prevention and therapy. Mimeault, Murielle and Batra, Surinder K. [ed.] Siu-wai Leung. 31, Macao: BioMed Central Ltd.: International Society for Chinese Medicine, August 23, 2011, Chinese Medicine, Vol. 6. DOI: 10.1186/1749-8546-6-31; http://www.cmjournal.org/content/6/1/31. ISSN: 1749-8546.
  175. The Effect of Curcumin Pre-Treatment on Drosophila melanogaster Fecundity and Ovary Impairment when Exposed to Methotrexate. Semnani, Sahar. <[ed.] Mahtab Jafari. Irvine: University of California, 2007. 14th Annual UCI Undergraduate Research Symposium. Poster #089.
  176. Modification of radiation-induced acute oral mucositis in the rat. Rezvani, M., Ross, G.A. Richard P. Hill and A. Michael Rauth. 2, Toronto: Informa Plc, February 2004, International Journal of Radiation Biology, Vol. 80, pp. 177-182. DOI: 10.1080/09553000310001654693; http://informahealthcare.com/doi/abs/10.1080/09553000310001654693. ISSN: 0955-3002.
  177. Topical curcumin can inhibit deleterious effects of upper respiratory tract bacteria on human oropharyngeal cells in vitro: potential role for patients with cancer therapy induced mucositis? Lüer, S., Troller, R., Jetter, M., Spaniol, V., Aebi, C. [ed.] Fred Ashbury. 6, Toronto: Springer-Verlag, June 1, 2011, Supportive Care in Cancer, Vol. 19, pp. 799-806. DOI: 10.1007/s00520-010-0894-x; http://link.springer.com/article/10.1007%2Fs00520-010-0894-x. ISSN: 0941-4355.
  178. Mattox, Todd W. and Goetz, Dawn E. Pharmacologic Management of Cancer Cachexia-Anorexia and Other Gastrointestinal Toxicities Associated with Cancer Treatments. [ed.] Mary Marian and Susan Roberts. Clinical Nutrition for Oncology Patients. Sudbury: Jones and Bartlett Publishers, LLC, 2010, 15, pp. 379-408. ISBN-13: 978-0-7637-5512-6.
  179. Sharma, Ricky A., Steward, William P. and Gescher, Andreas J. Pharmacokinetics and Pharmacodynamics of Curcumin. [ed.] Bharat B. Aggarwal, Young-Joon Surh and Shishir Shishodia. Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease. New York: Springer Science+Business Media, LLC, 2007, pp. 453-470. ISBN-13: 978-0-387-46400-8.
  180. Curcumin: An Anti-Inflammatory Molecule from a Curry Spice on the Path to Cancer Treatment. Basnet, Purusotam and Skalko-Basnet, Natasa. [ed.] Derek J. McPhee. 6, Emeryville: MDPI AG, June 3, 2011, Molecules, Vol. 16, pp. 4567-4598. DOI: 10.3390/molecules16064567; http://www.mdpi.com/1420-3049/16/6/4567. ISSN: 1420-3049.
  181. The Role of Nutraceuticals in Chemoprevention and Chemotherapy and Their Clinical Outcomes. Saldanha, Sabita N. and Tollefsbol, Trygve O. [ed.] Julian J. Raffoul. Article ID 192464, Atlanta: Hindawi Publishing Corporation, August 25, 2012, Journal of Oncology, Vol. 2012, pp. 1-23. DOI: 10.1155/2012/192464;http://www.hindawi.com/journals/jo/2012/192464/. ISSN: 1687-8469.
  182. A Phase I/II Study of Complementary Therapy Using Curcumin for Patients with Gemcitabine-Resistant Pancreatic Cancer. Kanai, Masashi, et al., et al. [ed.] H. Newell and E.A. Sausville. 1, Newcastle; Baltimore: Springer-Verlag, July 1, 2011, Cancer Chemotherapy and Pharmacology, Vol. 68, pp. 157-164. DOI: 10.1007/s00280-010-1470-2; http://link.springer.com/article/10.1007%2Fs00280-010-1470-2. ISSN: 0344-5704.
  183. Combined xanthorrhizol-curcumin exhibits synergistic growth inhibitory activity via apoptosis induction in human breast cancer cells MDA-MB-231. Cheah, Yew H., et al., et al. [ed.] Denys Wheatley. 1, Inverurie: BioMed Central Ltd., January 2, 2009, Cancer Cell International, Vol. 9. DOI: 10.1186/1475-2867-9-1; http://www.cancerci.com/content/9/1/1. ISSN: 1475-2867.
  184. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Shoba, G., et al., et al. [ed.] Adolf Nahrstedt. 4, Münster: Georg Thieme Verlag KG, May 1998, Planta Medica , Vol. 64, pp. 353-356. DOI: 10.1055/s-2006-957450; https://www.thieme-connect.de/DOI/DOI?10.1055/s-2006-957450. ISSN: 0032-0943.
  185. A synergistic antiproliferation effect of curcumin and docosahexaenoic acid in SK-BR-3 breast cancer cells: unique signaling not explained by the effects of either compound alone. Altenburg, Jeffrey D., et al., et al. [ed.] Christna Chap. 149, London: BioMed Central Ltd, April 21, 2011, BMC Cancer, Vol. 11. DOI: 10.1186/1471-2407-11-149; http://www.biomedcentral.com/1471-2407/11/149. ISSN: 1471-2407.
  186. National Cancer Institute. General Information About Bladder Cancer; Treatment Option Overview; Treatment Options by Stage. Bladder Cancer Treatment (PDQ®). [Online] January 2, 2014. [Cited: October 9, 2014.] http://www.cancer.gov/cancertopics/pdq/treatment/bladder/Patient/page1.
  187. Curcumin Potentiates the Antitumor Effects of Bacillus Calmette-Guerin against Bladder Cancer through the Downregulation of NF-κB and Upregulation of TRAIL Receptors. Kamat, Ashish M., et al., et al. [ed.] Frank J. Rauscher III. 23, Philadelphia: American Association for Cancer Research, December 1, 2009, Cancer Research, Vol. 69, pp. 8958-8966. DOI: 10.1158/0008-5472.CAN-09-2045; http://cancerres.aacrjournals.org/content/69/23/8958. ISSN: 0008-5472.
  188. Curcumin, but not Prima-1, decreased tumor cell proliferation in the syngeneic murine orthotopic bladder tumor model. Watanabe, Fábio T., et al., et al. [ed.] Mauricio Rocha e Silva. 12, São Paulo: Faculdade de Medicina / USP, December 2011, Clinics, Vol. 66. DOI: 10.1590/S1807-59322011001200019; http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322011001200019&lng=en&nrm=iso&tlng=en. ISSN: 1807-5932.
  189. Curcumin Reduced Potato Chips and Roasted Bread Induced Chromosomal Aberrations and Micronuclei Formation in Albino Rats. Ali, Ramadan A.M., Sayed, Nadia H.M. and El-Monem, Dalia D. Abd. [ed.] Changyu Shen. 1, Zhengzhou: Zhengzhou University/Marsland Press, January 25, 2012, Life Science Journal, Vol. 9, pp. 330-336. ISSN: 1097-8135.
  190. Curcumin prevents shock-wave lithotripsy-induced renal injury through inhibition of nuclear factor kappa-B and inducible nitric oxide synthase activity in rats. Bas, Muzaffer, et al., et al. [ed.] William G. Robertson. 3, London: Springer-Verlag, June 1, 2009, Urological Research, Vol. 37, pp. 159-164. DOI: 10.1007/s00240-009-0186-4; http://link.springer.com/article/10.1007%2Fs00240-009-0186-4. ISSN: 2194-7228.
  191. Effect of Curcumin Against Proteus mirabilis During Crystallization of Struvite from Artificial Urine. Prywer, Jolanta and Torzewska, Agnieszka. [ed.] Virginia S. Martino. Article ID 862794, Buenos Aires: Hindawi Publishing Corporation, May 30, 2011, Evidence-Based Complementary and Alternative Medicine, Vol. 2012, pp. 1-7. DOI: 10.1155/2012/862794; http://www.hindawi.com/journals/ecam/2012/862794/. ISSN: 1741-427X.
  192. Moshe, Maya, Lellouche, Jonathan and Banin, Ehud. Curcumin: A Natural Antibiofilm Agent. [ed.] A. Méndez-Vilas. Science and Technology Against Microbial Pathogens: Research, Development and Evaluation. ICAR2010. Danvers: World Scientific Publishing Co. Pte. Ltd., 2011, pp. 89-93. ISBN-13: 978-981-4354-85-1.
  193. Antimicrobial emulsion (coating) based on biopolymer containing neem (Melia azardichta) and turmeric (Curcuma longa) extract for wound covering. Jagannath, J.H. and Radhika, M. [ed.] Takeo Yokobori. 5, Sendai: IOS Press, October 26, 2006, Bio-Medical Materials and Engineering, Vol. 16, pp. 329-336. ISSN: 0959-2989.
  194. Natural products as inducers of apoptosis: Implication for cancer therapy and prevention. Taraphdar, Amit K., Roy, Madhumita and Bhattacharya, R.K. [ed.] P. Balaram. 11, Bangalore: Indian Academy of Sciences, June 10, 2001, Current Science, Vol. 80, pp. 1387-1396. ISSN: 0011-3891.
  195. Tortora, Gerard J. and Derrickson, Bryan. The Cardiovascular System: The Blood. Principles of Anatomy & Physiology. Hoboken: John Wiley & Sons, Inc., 2012, 19, pp. 728-756. ISBN: 13 978-0470-56510-0.
  196. Valdez, Riccardo, et al., et al. Hematopathology. [ed.] Raphael Rubin, David S. Strayer and Emanuel Rubin. Rubin's Pathology: Clinicopathologic Foundations of Medicine. 6. Philadelphia: Wolters Kluwer: Lippincott Williams & Wilkins, 2012, 20, pp. 947-1036. ISBN: 978-1-60547-968-2.
  197. Warren, Jeffrey S. and Strayer, David S. Immunopathology. [ed.] Raphael Rubin, David S. Strayer and Emanuel Rubin. Rubin's Pathology: Clinicopathologic Foundations of Medicine. 6. Philadelphia: Wolters Kluwer: Lippincott Williams & Wilkins, 2012, 4, pp. 115-156. ISBN: 978-1-60547-968-2.
  198. Curcumin induces the apoptosis of human monocytic leukemia THP-1 cells via the activation of JNK/ERK Pathways. Yang, Chu-Wen, et al., et al. [ed.] Thomas A. Rowles. 22, London: BioMed Central Ltd., March 24, 2012, BMC Complementary and Alternative Medicine, Vol. 12. DOI: 10.1186/1472-6882-12-22; http://www.biomedcentral.com/1472-6882/12/22. ISSN: 1472-6882.
  199. Cancer.Net Editorial Board. Leukemia - Chronic T-Cell Lymphocytic: Overview. American Society of Clinical Oncology. [Online] June 2014. [Cited: October 10, 2014.] http://www.cancer.net/cancer-types/leukemia-chronic-t-cell-lymphocytic/overview.
  200. Yu, Yongxiang, et al., et al. Evaluation of Antioxidant Activity of Curcumin-Free Turmeric (Curcuma longa L.) Oil and Identification of Its Antioxidant Constituents. [book auth.] American Chemical Society Symposium Series. [ed.] Takayuki Shibamoto, et al., et al. Functional Food and Health. Washington, D.C.: Oxford University Press, 2008, 14, pp. 152-164. ISBN: 978-0-8412-6982-8.
  201. Neto, Catherine C. and Vinson, Joe A. Cranberry. [ed.] Iris F.F. Benzie and Sissi Wachtel-Galor. Herbal Medicine: Biomolecular and Clinical Aspects. 2. Boca Raton: CRC Press: Taylor and Francis Group, LLC, 2011, 6, pp. 107-130. ISBN: 978-1-4398-0713-2.
  202. Crowley, Leonard. Tumors. Essentials of Human Disease. Sudbury: Jones & Bartlett Learning, 2011, 8, pp. 131-154. ISBN: 978-0-7637-0590-3.
  203. Mayo Clinic staff. Hodgkin's lymphoma (Hodgkin's disease): Definition, Symptoms, Causes, Risk factors. Mayo Foundation for Medical Education and Research. [Online] August 15, 2014. [Cited: October 10, 2014.] http://www.mayoclinic.com/health/hodgkins-disease/DS00186.
  204. Mayo Clinic staff. Non-Hodgkin's lymphoma: Definition, Symptoms, Causes, Risk factors. Mayo Foundation for Medical Education and Research. [Online] July 26, 2013. [Cited: October 10, 2014.] http://www.mayoclinic.org/diseases-conditions/non-hodgkins-lymphoma/basics/definition/con-20027792.
  205. International Myeloma Working Group. Understanding Serum Free Light Chain Assays. Hollywood: International Myeloma Foundation, 2011. pp. 1-27.
  206. Shah, Dhaval and Seiter, Karen. Multiple Myeloma: Background, Pathophysiology, Etiology. Medscape Reference: Drugs, Diseases & Procedures. [Online] June 21, 2014. [Cited: October 10, 2014.] http://emedicine.medscape.com/article/204369-overview#showall.
  207. Monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and curcumin: a randomized, double-blind placebo-controlled cross-over 4g study and an open-label 8g extension study. Golombick, T, Diamond, T.H., Manoharan, A., Ramakrishna, R. [ed.] Carlo Brugnara. 5, Boston: Wiley Periodicals, Inc., May 2012, American Journal of Hematology, Vol. 87, pp. 455-460. DOI: 10.1002/ajh.23159; http://onlinelibrary.wiley.com/doi/10.1002/ajh.23159/abstract. eISSN: 1096-8652.
  208. Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM): novel biological insights and development of treatment strategies. Korde, Neha, Kristinsson, Sigurdur Y. and Landgren, Ola. [ed.] Cynthia E. Dunbar. 21, Bethesda: American Society of Hematology, May 26, 2011, Blood, Vol. 117, pp. 5573-5581. DOI: 10.1182/blood-2011-01-270140.; http://www.bloodjournal.org/content/117/21/5573. ISSN: 0006-4971.
  209. The potential role of curcumin (diferuloylmethane) in plasma cell dyscrasias/paraproteinemia. Golombick, Terry and Diamond, Terry. [ed.] Doris Mangiaracina Benbrook. 1, Oklahoma City: Dove Medical Press Ltd., March 2008, Biologics: Targets & Therapy, Vol. 2, pp. 161-163. eISSN: 1177-5491.
  210. Agraharkar, Mahendra, III, O. David Dellinger and Gangakhedkar, Arun Kumar. Hypercalcemia: Background, Pathophysiology. Medscape Reference: Drugs, Diseases & Procedures. [Online] September 2, 2014. [Cited: October 10, 2014.] http://emedicine.medscape.com/article/240681-overview#showall.
  211. Effect of curcumin on Helicobacter pylori biofilm formation. Pattiyathanee, Panan, Vilaichone, Ratha-korn and Chaichanawongsaroj, Nuntaree. [ed.] George Nkem Ude and N. John Tonukari. 19, Bowie; Abraka: Academic Journals, October 5, 2009, African Journal of Biotechnology, Vol. 8, pp. 5106-5115. ISSN: 1684-5315.
  212. Dietary phytochemicals, HDAC inhibition, and DNA damage/repair defects in cancer cells. Rajendran, Praveen, et al., et al. [ed.] Ulrich Mahlknecht. 4, Solingen: BioMed Central Ltd., October 26, 2011, Clinical Epigenetics, Vol. 3. DOI: 10.1186/1868-7083-3-4; http://www.clinicalepigeneticsjournal.com/content/3/1/4. ISSN: 1868-7083.
  213. Targeting Inflammation-Induced Obesity and Metabolic Diseases by Curcumin and Other Nutraceuticals. Aggarwal, Bharat B. [ed.] Robert J. Cousins. Gainesville: Annual Reviews, August 2010, Annual Review of Nutrition, Vol. 30, pp. 173-199. DOI: 10.1146/annurev.nutr.012809.104755; http://www.annualreviews.org/doi/abs/10.1146/annurev.nutr.012809.104755. ISSN: 0199-9885.
  214. Scanlon, Cathy. Brain Tumors. [ed.] Mary Marian and Susan Roberts. Clinical Nutrition for Oncology Patients. Sudbury: Jones and Bartlett Publishers, LLC, 2010, 13, pp. 321-350. ISBN-13: 978-0-7637-5512-6.
  215. DNA Repair and Resistance of Gliomas to Chemotherapy and Radiotherapy. Frosina, Guido. [ed.] Michael B. Kastan. 7, Durham: American Association for Cancer Research, July 2009, Molecular Cancer Research, Vol. 7, pp. 989-999. DOI: 10.1158/1541-7786.MCR-09-0030; http://mcr.aacrjournals.org/content/7/7/989. ISSN: 1557-3125.
  216. Curcumin-induced HDAC inhibition and attenuation of medulloblastoma growth in vitro and in vivo. Lee, Seung Joon, et al., et al. [ed.] Christna Chap. 1, London: BioMed Central Ltd., April 18, 2011, BMC Cancer, Vol. 11, pp. 144-157. DOI: 10.1186/1471-2407-11-144; http://www.biomedcentral.com/1471-2407/11/144. ISSN: 1471-2407.
  217. Inhibition of nuclear factor kappa-B signaling reduces growth in medulloblastoma in vivo. Spiller, Susan E., et al., et al. [ed.] Christna Chap. 136, London: BioMed Central Ltd., April 14, 2011, BMC Cancer, Vol. 11. DOI: 10.1186/1471-2407-11-136; http://www.biomedcentral.com/1471-2407/11/136. ISSN: 1471-2407.
  218. Cedars-Sinai. Brain Tumors and Brain Cancer. Health Conditions. [Online] [Cited: October 10, 2014.] http://www.cedars-sinai.edu/Patients/Health-Conditions/Brain-Tumors-and-Brain-Cancer.aspx.
  219. Bartoszek, Agnieszka. Genotoxic Food Components. [ed.] Wanda Baer-Dubowska, Agnieszka Bartoszek and Danuta Malejka-Giganti. Carcinogenic and Anticarcinogenic Food Components. Boca Raton: CRC Press: Taylor & Francis Group, 2006, 4, pp. 69-96. ISBN: 978-0-8493-2096-5.
  220. Cross, Amanda J. and Sinha, Rashmi. Impact of Food Preservation, Processing, and Cooking on Cancer Risk. [ed.] Wanda Baer-Dubowska, Agnieszka Bartoszek and Danuta Malejka-Giganti. Carcinogenic and Anticarcinogenic Food Components. Boca Raton: CRC Press: Taylor & Francis Group, 2006, 5, pp. 97-112. ISBN: 978-0-8493-2096-5.
  221. Biziuk, Marek and Bartoszek, Agnieszka. Environmental Contamination of Food. [ed.] Wanda Baer-Dubowska, Agnieszka Bartoszek and Danuta Malejka-Giganti. Carcinogenic and Anticarcinogenic Food Components. Boca Raton: CRC Press: Taylor & Francis Group, 2006, 5, pp. 97-112. ISBN: 978-0-8493-2096-5.
  222. A polymeric nanoparticle formulation of curcumin inhibits growth, clonogenicity and stem-like fraction in malignant brain tumors. Lim, Kah Jing, et al., et al. [ed.] Wafik S. El-Deiry. 5, Hershey: Landes Bioscience, March 1, 2011, Cancer Biology & Therapy, Vol. 11, pp. 464-473. DOI: 10.4161/cbt.11.5.14410; https://www.landesbioscience.com/journals/cbt/article/14410/. ISSN: 1555-8576.
  223. Curcumin inhibits telomerase and induces telomere shortening and apoptosis in brain tumour cells. Khaw, A.K., Hande, M.P., Kalthur, G., Hande, M.P. [ed.] C. Fred Fox, Gary S. Stein and Max M. Burger. 6, Los Angeles; Burlington; Basel: Wiley-Liss, Inc., June 2013, Journal of Cellular Biochemistry, Vol. 114, pp. 1257-1270. DOI: 10.1002/jcb.24466; http://onlinelibrary.wiley.com/doi/10.1002/jcb.24466/abstract. eISSN: 1097-4644.
  224. The curry spice curcumin selectively inhibits cancer cells growth in vitro and in preclinical model of glioblastoma. Zanotto-Filho, A., et al., et al. [ed.] Bernhard Hennig. 6, Lexington: Elsevier Inc., June 2012, Journal of Nutritional Biochemistry, Vol. 23, pp. 591-601. DOI: 10.1016/j.jnutbio.2011.02.015; http://www.jnutbio.com/article/S0955-2863(11)00090-8/abstract. ISSN: 0955-2863.
  225. Systemic Administration of Polymeric Nanoparticle-Encapsulated Curcumin (NanoCurc) Blocks Tumor Growth and Metastases in Preclinical Models of Pancreatic Cancer. Bisht, Savita, et al., et al. [ed.] Napoleone Ferrara. 8, Philadelphia: American Association for Cancer Research, Inc., August 2010, Molecular Cancer Therapeutics, Vol. 9, pp. 2255-2264. DOI: 10.1158/1535-7163.MCT-10-0172; http://mct.aacrjournals.org/content/9/8/2255. ISSN: 1535-7163.
  226. Telomerase and its potential for therapeutic intervention. Phatak, P. and Burger, A.M. [ed.] H.P. Rang. 7, London: Nature Publishing Group, December 2007, British Journal of Pharmacology, Vol. 152, pp. 1003-1011. DOI: 10.1038/sj.bjp.0707374; http://onlinelibrary.wiley.com/doi/10.1038/sj.bjp.0707374/abstract. eISSN: 1476-5381.
  227. Boik, John. Natural Compounds in Cancer Therapy: Promising Nontoxic Antitumor Agents from Plants & Other Natural Sources. [ed.] Silvine Farnell. s.l.: Oregon Medical Press, LLC, 2001. ISBN: 0-9648280-1-4.
  228. Signorelli, Paola and Ghidoni, Riccardo. Resveratrol as an Antiproliferative Agent for Cancer. [ed.] Bharat B. Aggarwal and Shishir Shishodia. Resveratrol in Health and Disease. Boca Raton: CRC Press: Taylor & Francis Group, LLC, 2006, 4, pp. 57-83. ISBN: 978-0-8493-3371-2.
  229. Antioxidative Properties of Curcuma longa Leaf Extract in Accelerated Oxidation and Deep Frying Studies. Nor, Fatihanim Mohd, et al., et al. [ed.] Richard W. Hartel. 2, Madison: Springer-Verlag, February 1, 2009, Journal of the American Oil Chemists' Society, Vol. 86, pp. 141-147. DOI: 10.1007/s11746-008-1335-6; http://link.springer.com/article/10.1007%2Fs11746-008-1335-6. ISSN: 0003-021X.
  230. Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer. Bayet-Robert, Mathilde, et al., et al. [ed.] Wafik S. El-Deiry. 1, Hershey: Landes Bioscience, January 1, 2010, Cancer Biology & Therapy, Vol. 9, pp. 8-14. ISSN: 1538-4047.
  231. The Potential Utility of Curcumin in the Treatment of HER-2-Overexpressed Breast Cancer: An In Vitro and In Vivo Comparison Study with Herceptin. Lai, Hung-Wen, et al., et al. [ed.] Jae Youl Cho. Article ID 486568, Seoul: Hindawi Publishing Corporation, June 6, 2011, Evidence-Based Complementary and Alternative Medicine, Vol. 2012, pp. 1-12. DOI: 10.1155/2012/486568; http://www.hindawi.com/journals/ecam/2012/486568/. ISSN: 1741-427X.
  232. Aggarwal, Bharat B., Kumar, Anushree and Bharti, Alok Chandra. Therapeutic Potential of Curcumin Derived from Turmeric (Curcuma longa). [ed.] Lester Packer, Choon Nam Ong and Barry Halliwell. Herbal and Traditional Medicine: Molecular Aspects of Health. New York: Marcel Dekker, 2004, 36, pp. 781-812. ISBN: 0-8247-5436-0.
  233. Mosley, Cara A., Liotta, Dennis C. and Snyder, James P. Highly Active Anticancer Curcumin Analogues. [ed.] Bharat B. Aggarwal, Young-Joon Surh and Shishir Shishodia. The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease. New York: Springer Science+Business Media, LLC, 2007, pp. 77-104. ISBN-13: 978-0-387-46400-8.
  234. Obesity and Breast Cancer Outcome: Adding to the Evidence. Chlebowski, Rowan T. [ed.] Stephen A. Cannistra. 2, Boston: American Society of Clinical Oncology, December 5, 2011, Journal of Clinical Oncology, Vol. 30, pp. 124-126. DOI: 10.1200/JCO.2011.38.5500; http://jco.ascopubs.org/content/30/2/124. ISSN: 0732-183X.
  235. Prognostic Effect of Circulating Adiponectin in a Randomized 2 × 2 Trial of Low-Dose Tamoxifen and Fenretinide in Premenopausal Women at Risk for Breast Cancer. Macis, Debora, et al., et al. [ed.] Stephen A. Cannistra. 2, Boston: American Society of Clinical Oncology, January 10, 2012, Journal of Clinical Oncology, Vol. 30, pp. 151-157. DOI: 10.1200/JCO.2011.35.2237; http://jco.ascopubs.org/content/30/2/151. ISSN: 0732-183X.
  236. Adiponectin: A Risk Biomarker and Attractive Target for Chemoprevention. Fabian, Carol J. [ed.] Stephen A. Cannistra. 2, Boston: American Society of Clinical Oncology, January 10, 2012, Journal of Clinical Oncology, Vol. 30, pp. 124-126. DOI: 10.1200/JCO.2011.38.5500; http://jco.ascopubs.org/content/30/2/124. ISSN: 0732-183X.
  237. The study of insulin resistance and leptin resistance on the model of simplicity obesity rats by curcumin. Yu, Y., Hu, S.K. and Yan, H. [ed.] Junshi Chen. 11, Beijing: Chinese Medical Association, November 2008, Chinese Journal of Preventive Medicine, Vol. 42, pp. 818-822. ISSN: 0253-9624.
  238. Curcumin reverses breast tumor exosomes mediated immune suppression of NK cell tumor cytotoxicity. Zhang, Huang-Ge, et al., et al. [ed.] Dennis E. Vance. 7, Edmonton: Elsevier, July 2007, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, Vol. 1773, pp. 1116-1123. DOI: 10.1016/j.bbamcr.2007.04.015; http://www.sciencedirect.com/science/article/pii/S0167488907000997. ISSN: 0167-4889.
  239. Curcumin inhibits telomerase activity through human telomerase reverse transcritpase in MCF-7 breast cancer cell line. Ramachandran, Cheppail, et al., et al. [ed.] Manfred Schwab. 1, Heidelberg: Elsevier Ireland Ltd., October 8, 2002, Cancer Letters, Vol. 184, pp. 1-6. DOI: 10.1016/S0304-3835(02)00192-1;http://www.cancerletters.info/article/S0304-3835(02)00192-1/abstract. ISSN: 0304-3835.
  240. Curcumin and cancer: An ''old-age" disease with an ''age-old" solution. Anand, Preetha, et al., et al. [ed.] Manfred Schwab. 1, Heidelberg: Elsevier Ireland Ltd., August 18, 2008, Cancer Letters, Vol. 267, pp. 133-164. DOI: 10.1016/j.canlet.2008.03.025; http://www.cancerletters.info/article/S0304-3835(08)00231-0/abstract. ISSN: 0304-3835.
  241. Curcumin down-regulates visfatin expression and inhibits breast cancer cell invasion. Kim, Su-Ryun, et al., et al. [ed.] Jeffrey D. Blaustein. 2, Boston: The Endocrine Society, December 20, 2011, Endocrinology, Vol. 153, pp. 554-563. DOI: 10.1210/en.2011-1413; http://press.endocrine.org/doi/abs/10.1210/en.2011-1413. ISSN: 0013-7227.
  242. Modulation of the BRCA1 Protein and Induction of Apoptosis in Triple Negative Breast Cancer Cell Lines by the Polyphenolic Compound Curcumin. Rowe, Danica L., et al., et al. [ed.] Goberdhan P. Dimri. Washington, DC: Libertas Academica, September 2, 2009, Breast Cancer: Basic and Clinical Research, Vol. 3, pp. 61-75. ISSN: 1178-2234.
  243. Vaccination with Listeria-Mage-b and Curcumin is Highly Effective Against Metastatic Breast Cancer. Singh, Manisha, et al., et al. [ed.] Bronx, NY Albert Einstein College of Medicine. New York City: International Immunotherapy Symposia Series of the Cancer Research Institute, 2011. Cancer Immunotherapy 2011: Immune Effector Mechanisms in Tumor Immunity. P127.
  244. Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment. Fasching, Peter A., et al., et al. [ed.] Christna Chap. London: BioMed Central Ltd., November 14, 2011, BMC Cancer, Vol. 486. DOI: 10.1186/1471-2407-11-486; http://www.biomedcentral.com/1471-2407/11/486. ISSN: 1471-2407.
  245. Newsholme, Eric A. and Leech, Tony R. Nutrition: Biochemistry, Physiology and Pathology. Functional Biochemistry in Health and Disease. Chichester: Wiley-Blackwell: John Wiley & Sons, Ltd, 2010, 15, pp. 331-362. ISBN: 978-0-471-98820-5.
  246. Estrogen Metabolism: A Complex Web. Liska, DeAnn J. and Leupp, Lisa R. [ed.] Mark Houston. 3, Birmingham: American Nutraceutical Association, Summer 2002, The Journal of the American Nutraceutical Association, Vol. 5, pp. 4-14. ISSN: 1521-4524.
  247. Griffin, Bruce A. and Cunnane, Stephen C. Nutrition and Metabolism of Lipids Human Nutrition. [ed.] Michael J. Gibney, et al., et al. Introduction to Human Nutrition. 2. West Sussex: Wiley-Blackwell: John Wiley & Sons, Ltd, 2009, 6, pp. 86-121. ISBN: 978-1-4051-6807-6.
  248. Thompson, Janice L., Manore, Melinda M. and Vaughan, Linda A. Lipids: Essential Energy-Supplying Nutrients. The Science of Nutrition. San Francisco: Pearson Benjamin Cummings: Pearson Education, Inc., 2011, 5, pp. 167-208. ISBN: 978-0-321-64316-2.
  249. Germacrone inhibits the proliferation of breast cancer cell lines by inducing cell cycle arrest and promoting apoptosis. Zhong, Zhangfeng, et al., et al. [ed.] FP. Nijkamp. 1-3, Utrecht: Elsevier B.V., September 30, 2011, European Journal of Pharmacology, Vol. 667, pp. 50-55. DOI: 10.1016/j.ejphar.2011.03.041; http://www.sciencedirect.com/science/article/pii/S0014299911003578. ISSN: 0014-2999.
  250. Tumor Angiogenesis as a Target for Dietary Cancer Prevention. Li, William W., et al., et al. [ed.] Kalpna Gupta. Article ID 879623, Minneapolis: Hindawi Publishing Corporation, September 29, 2011, Journal of Oncology, Vol. 2012, pp. 1-23. DOI: 10.1155/2012/879623; http://www.hindawi.com/journals/jo/2012/879623/. ISSN: 1687-8469.
  251. Clinical Evaluation of Oral Curcumin in Prevention of Acute Dermatitis in Breast Cancer Radiotherapy. Hemati, Simin and Saeedi, Armin. [ed.] Roya Kelishadi. 152, Isfahan: Isfahan University of Medical Sciences, October 2011, Journal of Isfahan Medical School, Vol. 29, pp. 1129-1136. ISSN: 1027-7595.
  252. Memorial Sloan-Kettering Cancer Center. About Herbs: Turmeric. Memorial Sloan-Kettering Cancer Center. [Online] June 17, 2014. [Cited: October 11, 2014.] http://www.mskcc.org/cancer-care/herb/turmeric.
  253. Stargrove, Mitchell Bebel, Treasure, Jonathan and McKee, Dwight L. Herb, Nutrient, and Drug Interactions. St. Louis: Elsevier Health Sciences, 2008. ISBN-13: 978-0323029643.
  254. Dietary Curcumin Inhibits Chemotherapy-induced Apoptosis in Models of Human Breast Cancer. Somasundaram, Sivagurunathan, et al., et al. [ed.] Frank J. Rauscher III. 13, Philadelphia: American Association for Cancer Research, July 1, 2002, Cancer Research, Vol. 62, pp. 3868-3875. ISSN: 0008-5472.
  255. Synergistic Effects of 5-Fluorouracil (FU) and Curcumin on Human Cervical Cancer Cells. Ahn, Seong-Ho, et al., et al. [ed.] Chang-Sub Uhm. 4, Seoul: Korean Society of Microscopy, 2010, Korean Journal of Microscopy, Vol. 40, pp. 229-235. ISSN: 1225-6773.
  256. Boardman, Cecelia H. and Matthews, Jr., Kirk J. Cervical Cancer. Medscape Reference: Drugs, Diseases & Procedures. [Online] August 15, 2014. [Cited: October 11, 2014.] http://emedicine.medscape.com/article/253513-overview#showall.
  257. Pharmacological effects of curcumin. Mullaicharam, A.R. and Maheswaran, A. [ed.] M. Mohamed Essa. 2, Muscat: Medknow: Wolters Kluwer Health, May 9, 2012, International Journal of Nutrition, Pharmacology, Neurological Diseases, Vol. 2, pp. 92-99. DOI: 10.4103/2231-0738.95930; http://www.ijnpnd.com/article.asp?issn=2231-0738;year=2012;volume=2;issue=2;spage=92;epage=99;aulast=Mullaicharam. ISSN: 2231-2722.
  258. Antitumor action of curcumin in human papillomavirus associated cells involves downregulation of viral oncogenes, prevention of NFkB and AP-1 translocation, and modulation of apoptosis. Divya, Chandrasekhar S. and Pillai, Radhakrishna. [ed.] John DiGiovanni. 5, Austin: Wiley-Liss, Inc.: John Wiley & Sons, Inc., May 8, 2006, Molecular Carcinogenesis, Vol. 45, pp. 320-332. DOI: 10.1002/mc.20170; http://onlinelibrary.wiley.com/doi/10.1002/mc.20170/abstract. ISSN: 1098-2744.
  259. Das, Bhudev C., Bharti, Alok C. and Hedau, Suresh. Institute of Cytology and Preventive Oncology Annual Report: Transcriptional Regulation of Human Papillomavirus Gene Expression in Human Cervical Cancer Cells. Indian Council of Medical Research. s.l.: Indian Council of Medical Research, 2003. pp. 3-4.
  260. Metabolic risk factors and cervical cancer in the metabolic syndrome and cancer project (Me-Can). Ulmer, Hanno, et al., et al. [ed.] Beth Y. Karlan. 2, West Hollywood: Elsevier B.V., May 2012, Gynecologic Oncology, Vol. 125, pp. 330-335. DOI: 10.1016/j.ygyno.2012.01.052; http://www.gynecologiconcology-online.net/article/S0090-8258(12)00085-6/abstract. ISSN: 0090-8258.
  261. Chattopadhyay, Debprasad. Ethnomedicinal Antivirals: Scope and Opportunity. [ed.] Iqbal Ahmad, Farrukh Aqil and Mohammad Owais. Modern Phytomedicine: Turning Medicinal Plants into Drugs. Weinheim: Wiley-VCH Verlag GmbH & Co. KGaA, 2006, 15, pp. 313-340. ISBN-13: 978-3-527-31530-7.
  262. Recent advances in the investigation of curcuminoids. Itokawa, Hideji, et al., et al. [ed.] Siu-wai Leung. 11, Macao: BioMed Central Ltd.: International Society for Chinese Medicine, September 17, 2008, Chinese Medicine, Vol. 3. DOI: 10.1186/1749-8546-3-11; http://www.cmjournal.org/content/3/1/11. ISSN: 1749-8546.
  263. Schnitzler, Paul, Astani, Akram and Reichling, Jϋrgen. Antiviral Effects of Plant-Derived Essential Oils and Pure Oil Components. [ed.] Halldor Thromar. Lipids and Essential Oils as Antimicrobial Agents. West Sussex: John Wiley & Sons, Ltd, 2011, 10, pp. 239-254. ISBN: 978-0-470-74178-8.
  264. Effect of Antioxidant (Turmeric, Turmerin and Curcumin) on Human Immunodeficiency Virus. Cohly, H.H.P., et al., et al. [ed.] Jerzy Lesczcynski. 2, Basel: MDPI AG, January 31, 2003, International Journal of Molecular Sciences, Vol. 4, pp. 22-33. DOI: 10.3390/i4020022; http://www.mdpi.com/1422-0067/4/2/22. ISSN: 1422-0067.
  265. Letters to the Editor: Curcumin-A Natural Herb With Anti-HIV Activity. Jordan, W.C. and Drew, C.R. 6, s.l.: National Medical Association, June 1996, Journal of the National Medical Association, Vol. 88, pp. 333-335. PMCID: PMC2608099.
  266. Curcuminoids exert glucose-lowering effect in type 2 diabetes by decreasing serum free fatty acids: a double-blind, placebo-controlled trial. Na, Li-Xin, et al., et al. [ed.] Hans-Ulrich Humpf. 9, Weinheim: WILEY-VCH Verlag GmbH & Co. KGaA, September 2013, Molecular Nutrition & Food Research, Vol. 57, pp. 1569-1577. DOI: 10.1002/mnfr.201200131; http://onlinelibrary.wiley.com/doi/10.1002/mnfr.201200131/abstract. ISSN: 1613-4133.
  267. A novel curcumin-based vaginal cream Vacurin selectively eliminates apposed human cervical cancer cells. Debata, Priya Ranjan, et al., et al. [ed.] Beth Y. Karlan. 1, West Hollywood: Elsevier B.V., December 9, 2012, Gynecologic Oncology, Vol. 129, pp. 145-153. DOI: 10.1016/j.ygyno.2012.12.005; http://www.gynecologiconcology-online.net/article/S0090-8258(12)00952-3/abstract. ISSN: 0090-8258.
  268. Reichling, Jϋrgen. Plant-Microbe Interactions and Secondary Metabolites with Antibacterial, Antifungal and Antiviral Properties. [ed.] Maria Teresa Giardi, Giuseppina Rea and Bruno Berra. Bio-Farms for Nutraceuticals: Functional Food and Safety Control by Biosensors. Austin: Landes Bioscience and Springer Science+Business Media, LLC, 2010, 4, pp. 214-347. ISBN: 978-1-4419-7346-7.
  269. Impact of Dietary Polyphenols on Carbohydrate Metabolism. Hanhineva, Kati, et al., et al. [ed.] Andrei Alexandrescu. 4, Basel: MDPI AG, March 31, 2010, International Journal of Molecular Sciences, Vol. 11, pp. 1365-1402. DOI: 10.3390/ijms11041365; http://www.mdpi.com/1422-0067/11/4/1365. ISSN: 1422-0067.
  270. Pressman, Alan H. and Buff, Sheila. The Complete Idiot's Guide to Vitamins and Minerals. New York: Alpha Books - Macmillan, Inc., 1997. ISBN: 0-02-862116-6.
  271. Amelioration of Obesity, Glucose Intolerance, and Oxidative Stress in High-Fat Diet and Low-Dose Streptozotocin-Induced Diabetic Rats by Combination Consisting of "Curcumin with Piperine and Quercetin". Kaur, Ginpreet and Chintamaneni, Meena. [ed.] T. Kumai and M.A. Prendergast. Article ID 957283, Mumbai: Hindawi Publishing Corporation, March 8, 2012, ISRN Pharmacology, Vol. 2012, pp. 1-7. DOI: 10.5402/2012/957283; http://www.hindawi.com/journals/isrn/2012/957283/. ISSN: 2090-5165.
  272. Pharmacodynamic and Pharmacokinetic Study of Oral Curcuma Extract in Patients with Colorectal Cancer. Sharma, Ricky A., et al., et al. [ed.] John Mendelsohn. 7, Houston: American Association for Cancer Research, July 2001, Clinical Cancer Research, Vol. 7, pp. 1894-1900. ISSN: 1078-0432.
  273. Combination treatment with curcumin and quercetin of adenomas in familial adenomatous polyposis. Cruz-Correa, M., et al., et al. [ed.] Michael Camilleri. 8, Rochester: Elsevier Inc., August 2006, Clinical Gastroenterology and Hepatology, Vol. 4, pp. 1035-1038. DOI: 10.1016/j.cgh.2006.03.020; http://www.cghjournal.org/article/S1542-3565(06)00278-3/abstract. ISSN: 1542-3565.
  274. Curcumin for chemoprevention of colon cancer. Johnson, Jeremy James and Mukhtar, Hasan. [ed.] Manfred Schwab. 2, Heidelberg: Elsevier Ireland Ltd., October 8, 2007, Cancer Letters, Vol. 255, pp. 170-181. DOI: 10.1016/j.canlet.2007.03.005; http://www.cancerletters.info/article/S0304-3835(07)00105-X/abstract. ISSN: 0304-3835.
  275. Cancer-linked targets modulated by curcumin. Hasima, Noor and Aggarwal, Bharat B. [ed.] Jian-Ting Zhang. 4, Indianapolis: e-Century Publishing Corporation, December 24, 2012, International Journal of Biochemistry and Molecular Biology, Vol. 3, pp. 328-351. ISSN: 1357-2725.
  276. Phase I Clinical Trial of Oral Curcumin: Biomarkers of Systemic Activity and Compliance. Sharma, Ricky A., et al., et al. [ed.] John Mendelsohn. 20, Houston: American Association for Cancer Research, October 15, 2004, Clinical Cancer Research, Vol. 10, pp. 6847-6854. DOI: 10.1158/1078-0432.CCR-04-0744; http://clincancerres.aacrjournals.org/content/10/20/6847. ISSN: 1078-0432.
  277. Curcumin ameliorates oxaliplatin-induced chemoresistance in HCT116 colorectal cancer cells in vitro and in vivo. Howells, Lynne M., et al., et al. [ed.] Peter Lichter. 2, DKFZ, Germany: John Wiley & Sons, Inc.: UICC, July 15, 2011, International Journal of Cancer, Vol. 129, pp. 476-486. DOI: 10.1002/ijc.25670; http://onlinelibrary.wiley.com/doi/10.1002/ijc.25670/abstract. ISSN: 1097-0215.
  278. Chemopreventive potential of curcumin in prostate cancer. Teiten, Marie-Hélène, et al., et al. [ed.] Giuditta Perozzi, et al., et al. 1, Rome; Lausanne; Utrecht: Springer-Verlag, March 1, 2010, Genes & Nutrition, Vol. 5, pp. 61-74. DOI: 10.1007/s12263-009-0152-3; http://link.springer.com/article/10.1007%2Fs12263-009-0152-3. ISSN: 1555-8932.
  279. American Cancer Society. Colorectal Cancer: Causes, Risk Factors, and Prevention Topics. Cancer.org. [Online] January 31, 2014. [Cited: October 11, 2014.] http://www.cancer.org/cancer/colonandrectumcancer/detailedguide/colorectal-cancer-risk-factors.
  280. Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial. Hanai, H., et al., et al. [ed.] Michael Camilleri. 12, Rochester: Elselvier: Saunders, December 2006, Clinical Gastroenterology and Hepatology, Vol. 4, pp. 1502-1506. DOI: 10.1016/j.cgh.2006.08.008; http://www.cghjournal.org/article/S1542-3565(06)00800-7/abstract. ISSN: 1542-3565.
  281. Phase IIa Clinical Trial of Curcumin for the Prevention of Colorectal Neoplasia. Carroll, Robert E., et al., et al. [ed.] Scott M. Lippman. 3, Philadelphia: American Association for Cancer Research, March 2011, Cancer Prevention Research, Vol. 4, pp. 354-364. DOI: 10.1158/1940-6207.CAPR-10-0098; http://cancerpreventionresearch.aacrjournals.org/content/4/3/354. ISSN: 1940-6207.
  282. Chronic Inflammation and Cancer: The Role of the Mitochondria. Kamp, David W., Shacter, Emily and Weitzman, Sigmund A. [ed.] James O. Armitage, et al., et al. 5, London: UBM Medica LLC, April 30, 2011, Oncology, Vol. 25, pp. 400-10, 413. ISSN: 0890-9091.
  283. The Relationship between Nonalcoholic Fatty Liver Disease and Colorectal Cancer: The Future Challenges and Outcomes of the Metabolic Syndrome. Muhidin, Said O., et al., et al. [ed.] Ahmed Almobarak. Article ID 637538, Baghdad: Hindawi Publishing Corporation, December 10, 2012, Journal of Obesity, Vol. 2012, pp. 1-8. DOI: 10.1155/2012/637538; http://www.hindawi.com/journals/jobe/2012/637538/. ISSN: 2090-0716.
  284. Increased Frequency of Serrated Aberrant Crypt Foci Among Smokers. Anderson, Joseph C., et al., et al. [ed.] William D. Chey and Paul Moayyedi. 7, Ann Arbor; Hamilton: Nature Publishing Group: American College of Gastroenterology, July 2010, The American Journal of Gastroenterology, Vol. 105, pp. 1648-1654. DOI: 10.1038/ajg.2010.109; http://www.nature.com/ajg/journal/v105/n7/full/ajg2010109a.html. ISSN: 0002-9270.
  285. National Cancer Institute. Colon Cancer Treatment (PDQ®): Stage IV and Recurrent Colon Cancer Treatment. Cancer. [Online] June 5, 2014. [Cited: October 12, 2014.] http://www.cancer.gov/cancertopics/pdq/treatment/colon/HealthProfessional/page9.
  286. Alcohol Intake and Colorectal Cancer: A Pooled Analysis of 8 Cohort Studies. Cho, Eunyoung, et al., et al. [ed.] Harold C. Sox. 8, Lebanon: American College of Physicians, April 20, 2004, Annals of Internal Medicine, Vol. 140, pp. 603-613. DOI: 10.7326/0003-4819-140-8-200404200-00007; http://annals.org/article.aspx?articleid=717373. ISSN: 0003-4819.
  287. Helicobacter pylori Infection and Colorectal Cancer Risk: Evidence From a Large Population-based Case-Control Study in Germany. Zhang, Yan, et al., et al. [ed.] Moyses Szklo. 5, Baltimore: Johns Hopkins Bloomberg School of Public Health, March 1, 2012, American Journal of Epidemiology, Vol. 175, pp. 441-450. DOI: 10.1093/aje/kwr331; http://aje.oxfordjournals.org/content/175/5/441. ISSN: 0002-9262.
  288. Molecular and cellular pathways associated with chromosome 1p deletions during colon carcinogenesis. Payne, Claire M., Crowley-Skillicorn, Cheray, Bernstein, Carol, Holubec, Hana and Bernstein, Harris. [ed.] Ronnie Fass. Los Angeles: Dove Medical Press, May 3, 2011, Clinical and Experimental Gastroenterology, Vol. 4, pp. 75-119. DOI: 10.2147/CEG.S17114; http://www.dovepress.com/molecular-and-cellular-pathways-associated-with-chromosome-1p-deletion-peer-reviewed-article-CEG. ISSN: 1178-7023.
  289. Curcumin Inhibits Proliferation of Colorectal Carcinoma by Modulating Akt/mTOR Signaling. Johnson, Sara M., et al., et al. [ed.] Gen-Ichiro Soma. 8, Takamatsu: The International Institute of Anticancer Research, August 2009, Anticancer Research, Vol. 29, pp. 3185-3190. ISSN: 0250-7005.
  290. Preventive Effects of Curcumin on the Development of Azoxymethane-Induced Colonic Preneoplastic Lesions in Male C57BL/KsJ-db/db Obese Mice. Kubota, Masaya, et al., et al. [ed.] Leonard A. Cohen. 1, Valhalla: Taylor and Francis, 2012, Nutrition and Cancer, Vol. 64, pp. 72-79. DOI: 10.1080/01635581.2012.630554; http://www.tandfonline.com/doi/abs/10.1080/01635581.2012.630554#.VDq8izZOVD8. ISSN: 0163-5581.
  291. Innovative Preparation of Curcumin for Improved Oral Bioavailability. Sasaki, Hiroki, et al., et al. 5, s.l.: Pharmaceutical Society of Japan, May 2011, Biological and Pharmaceutical Bulletin, Vol. 34, pp. 660-665. ISSN: 0918-6158.
  292. Molecular Targets of Dietary Polyphenols with Anti-inflammatory Properties. Yoon, Joo-Heon and Baek, Seung Joon. [ed.] Kwan Chul Tark. 5, Seoul: Yonsei University College of Medicine, October 31, 2005, Yonsei Medical Journal, Vol. 46, pp. 585-596. DOI: 10.3349/ymj.2005.46.5.585; http://synapse.koreamed.org/DOIx.php?id=10.3349/ymj.2005.46.5.585. ISSN: 0513-5796.
  293. Current Understanding of the Role of PPARγ in Gastrointestinal Cancers. Zou, Bing, Qiao, Liang and Wong, Benjamin C.Y. [ed.] Mostafa Zaki Badr. Article ID 816957, Kansas City: Hindawi Publishing Corporation, October 26, 2009, PPAR Research, Vol. 2009, pp. 1-8. DOI: 10.1155/2009/816957; http://www.hindawi.com/journals/ppar/2009/816957/. ISSN: 1687-4765.
  294. Consumption of the Putative Chemopreventive Agent Curcumin by Cancer Patients: Assessment of Curcumin Levels in the Colorectum and their Pharmacodynamic Consequences. Garcea, Giuseppe, et al., et al. [ed.] David S. Alberts and John D. Potter. 1, Tuscon; Seattle: American Association for Cancer Research, January 2005, Cancer Epidemiology, Biomarkers & Prevention, Vol. 14, pp. 120-125. ISSN: 1055-9965.
  295. Upregulation of p53 Expression in Patients with Colorectal Cancer by Administration of Curcumin. He, Zhen-Yu, et al., et al. [ed.] Gary H. Lyman. 3, Seattle: Informa Plc, March 2011, Cancer Investigation, Vol. 29, pp. 208-213. DOI: 10.3109/07357907.2010.550592; http://informahealthcare.com/doi/abs/10.3109/07357907.2010.550592. ISSN: 0735-7907.
  296. The Relationship Between Inflammation and Cancer is Analagous to That Between Fuel and Fire. Aggarwal, Bharat B. and Sung, Bokyung. 5, s.l.: UBM Medica, LLC, April 30, 2011, Oncology, Vol. 25, pp. 414-418. ISSN: 0890-9091.
  297. Colon Cancer Survival With Herbal Medicine and Vitamins Combined With Standard Therapy in a Whole-Systems Approach: Ten-Year Follow-up Data Analyzed With Marginal Structural Models and Propensity Score Methods. McCulloch, Michael, et al., et al. [ed.] Keith I. Block. 3, Chicago: SAGE Publications, September 30, 2011, Integrative Cancer Therapies, Vol. 10, pp. 240-259. DOI: 10.1177/1534735411406539; http://ict.sagepub.com/content/10/3/240. eISSN: 1552-695X.
  298. Cost Implications of New Treatments for Advanced Colorectal Cancer. Wong, Yu-Ning, et al., et al. [ed.] Raphael E. Pollock. 10, Houston: John Wiley & Sons, Inc.: American Cancer Society, May 15, 2009, Cancer, Vol. 115, pp. 2081-2091. DOI: 10.1002/cncr.24246; http://onlinelibrary.wiley.com/doi/10.1002/cncr.24246/abstract. eISSN: 1097-0142.
  299. Wolters Kluwer Health. Mesalamine. Drugs.com. [Online] September 2014. [Cited: October 12, 2014.] http://www.drugs.com/ppa/mesalamine-5-aminosalicylic-acid-5-asa.html.
  300. --. Celecoxib. Drugs.com. [Online] September 2014. [Cited: October 12, 2014.] http://www.drugs.com/ppa/celecoxib.html.
  301. U.S. National Library of Medicine. CELEBREX (celecoxib) capsule. Daily Med. [Online] April 2011. [Cited: October 12, 2014.] http://nccs-dailymed-1.nlm.nih.gov/dailymed/lookup.cfm?setid=0e3ae600-374f-4ddb-9454-dae0d8076987. NDC Code(s): 50436-7801-1.
  302. Irinotecan combined with infusional 5-fluorouracil/folinic acid or capecitabine plus celecoxib or placebo in the first-line treatment of patients with metastatic colorectal cancer. EORTC study 40015. Köhne, C.-H., et al., et al. [ed.] David Kerr. 5, Oxford: Oxford University Press: European Society Medical Oncology, December 6, 2007, Annals of Oncology, Vol. 19, pp. 920-926. DOI: 10.1093/annonc/mdm544; http://annonc.oxfordjournals.org/content/19/5/920. ISSN: 0923-7534.
  303. American Cancer Society, Inc. Stomach Cancer. Cancer.org. [Online] May 27, 2014. [Cited: September 18, 2014.] http://www.cancer.org/acs/groups/cid/documents/webcontent/003141-pdf.pdf.
  304. Helicobacter pylori and gastric cancer: Indian enigma. Misra, Vatsala, et al., et al. [ed.] Damian Garcia-Olmo, et al., et al. 6, Madrid; Orlando; Stockholm; Long Beach: Baishideng Publishing Group Co., Limited, February 14, 2014, World Journal of Gastroenterology, Vol. 20, pp. 1503-1509. DOI: 10.3748/wjg.v20.i6.1503; http://www.wjgnet.com/1007-9327/full/v20/i6/1503.htm. ISSN: 1007-9327.
  305. Non-microbial approach for Helicobacter pylori as faster track to prevent gastric cancer than simple eradication. Park, Sang-Ho, et al., et al. [ed.] Lian-Sheng Ma. 47, Beijing: Baishideng Publishing Group Co., Limited, December 21, 2013, World Journal of Gastroenterology, Vol. 19, pp. 8986-8995. DOI: 10.3748/wjg.v19.i47.8986; http://www.wjgnet.com/1007-9327/full/v19/i47/8986.htm.
  306. Calebin-A induces apoptosis and modulates MAPK family activity in drug resistant human gastric cancer cells. Li, Yan, et al., et al. [ed.] W.H. Gispen and F.P. Nijkamp. 1-3, Utrecht: Elsevier B.V., September 4, 2008, European Journal of Pharmacology, Vol. 591, pp. 252-258. DOI: 10.1016/j.ejphar.2008.06.065; http://www.sciencedirect.com/science/article/pii/S0014299908006729. ISSN: 0014-2999.
  307. Pattern-recognition receptors and gastric cancer. Castaño-Rodríguez, imageNatalia, Kaakoush, Nadeem O. and Mitchell, Hazel M. [ed.] Kendall Smith. Article 336, New York: Frontiers Media S.A., July 33, 2014, Frontiers in Immunology, Vol. 5, pp. 1-23. DOI: 10.3389/fimmu.2014.00336; http://journal.frontiersin.org/Journal/10.3389/fimmu.2014.00336/full. eISSN: 1664-3224.
  308. Curcumin induces the differentiation of myeloid-derived suppressor cells and inhibits their interaction with cancer cells and related tumor growth. Tu, Shui Ping, et al., et al. [ed.] Scott M. Lippman. 2, Philadelphia: American Association for Cancer Research, February 1, 2012, Cancer Prevention Research, Vol. 5, pp. 205-215. DOI: 10.1158/1940-6207.CAPR-11-0247; http://cancerpreventionresearch.aacrjournals.org/content/5/2/205. ISSN: 1940-6207.
  309. Impact of Turmeric as Dietary approach on HER2 expression in blood of Gastric cancer Patients. Srivastava, Akhileshwar Kumar, et al., et al. [ed.] J.N. Eloff. 2, Pretoria: Advanced Research Journals, 2014, International Journal of Phytomedicine, Vol. 6. ISSN: 0975-0185.
  310. Ganci, Federica, et al., et al. Molecular Genetics and Biology of Head and Neck Squamous Cell Carcinoma: Implications for Diagnosis, Prognosis and Treatment. [ed.] Mark Agulnik. Head and Neck Cancer. Rijeka: InTech, 2012, 3, pp. 73-122. ISBN: 978-953-51-0236-6.
  311. A retrospective clinicopathological study on oral lichen planus and malignant transformation: Analysis of 518 cases. Shen, Zheng-Yu, et al., et al. [ed.] Jose V. Bagan and Crispian Scully. 6, Valencia; London: Sociedad Española de Medicina Oral, Sociedad Española de Odontoestomatología para el Minusválido y Pacientes Especiales, Sociedad Española de Cirugía Bucal, Academia Iberoamericana de Patología y Medicinal Bucal, November 1, 2012, Medicina Oral Patologia Oral y Cirugia Bucal, Vol. 17, pp. e943-947. DOI: 10.4317/medoral.17778; http://www.medicinaoral.com/pubmed/medoralv17_i6_p943.pdf. ISSN: 1698-4447.
  312. Possible action mechanism for curcumin in pre-cancerous lesions based on serum and salivary markers of oxidative stress. Rai, Balwant, et al., et al. [ed.] Noriaki Koshikawa. 2, Tokyo: Nihon University School of Dentistry, June 2010, Journal of Oral Science, Vol. 52, pp. 251-256. DOI: 10.2334/josnusd.52.251; https://www.jstage.jst.go.jp/article/josnusd/52/2/52_2_251/_article. ISSN: 1343-4934.
  313. Chemopreventive Mechanisms of Natural Products in Oral, Mammary and Skin Carcinogenesis: An Overview. Manoharan, S., Singh, R.B. and Balakrishnan, S. [ed.] Ram B. Singh. Moradabad: Bentham Open, January 2009, The Open Nutraceuticals Journal, Vol. 2, pp. 52-63. DOI: 10.2174/1876396000902010052; https://benthamopen.com/ABSTRACT/TONUTRAJ-2-52. ISSN: 1876-3960.
  314. Thioredoxin Reductase-1 Mediates Curcumin-Induced Radiosensitization of Squamous Carcinoma Cells. Javvadi, Prashanthi, et al., et al. [ed.] George C. Prendergast. 5, Wynnewood: American Association for Cancer Research, March 1, 2010, Cancer Research, Vol. 70, pp. 1941-1950. DOI: 10.1158/0008-5472.CAN-09-3025; http://cancerres.aacrjournals.org/content/70/5/1941. ISSN: 1538-7445.
  315. Curcumin Treatment Suppresses IKKβ Kinase Activity of Salivary Cells of Patients with Head and Neck Cancer: A Pilot Study. Kim, Suejung G., et al., et al. [ed.] Kenneth C. Anderson. 18, Philadelphia: American Association for Cancer Research, September 15, 2011, Clinical Cancer Research, Vol. 17, pp. 5953-5961. DOI: 10.1158/1078-0432.CCR-11-1272; http://clincancerres.aacrjournals.org/content/17/18/5953. ISSN: 1078-0432.
  316. National Cancer Institute. Renal Cell Cancer Treatment (PDQ®). Cancer.gov. [Online] February 21, 2014. [Cited: September 30, 2014.] http://www.cancer.gov/cancertopics/pdq/treatment/renalcell/HealthProfessional/page1/AllPages#1.
  317. --. General Information About Renal Cell Cancer. Cancer.gov. [Online] July 23, 2014. [Cited: September 30, 2014.] http://www.cancer.gov/cancertopics/pdq/treatment/renalcell/Patient.
  318. Cancer is a Preventable Disease that Requires Major Lifestyle Changes. Anand, Preetha, et al., et al. [ed.] Vincent H.L Lee. 9, Hong Kong: Springer US, September 1, 2008, Pharmaceutical Research, Vol. 25, pp. 2097-2116. DOI: 10.1007/s11095-008-9661-9; http://link.springer.com/article/10.1007%2Fs11095-008-9661-9. ISSN: 0724-8741.
  319. Metabolic syndrome and renal cell carcinoma. Zhang, Gui-Ming, Zhu, Yao and Ye, Ding-Wei. [ed.] Manoj Pandey. 236, Bhopal: BioMed Central Ltd., July 29, 2014, World Journal of Surgical Oncology, Vol. 12, pp. 1-9. DOI: 10.1186/1477-7819-12-236; http://www.wjso.com/content/12/1/236. ISSN: 1477-7819.
  320. Lawrence, Leah. Rates of Renal, Thyroid Carcinomas Increasing in Children, Adolescents. Cancer Network. [Online] September 16, 2014. [Cited: October 1, 2014.] http://www.cancernetwork.com/renal-cell-carcinoma/rates-renal-thyroid-carcinomas-increasing-children-adolescents.
  321. Role of Curcumin in Cancer Therapy. Shishodia, Shishir, Chaturvedi, Madan M. and Aggarwal, Bharat B. [ed.] Peter A.S. Johnstone. 4, Atlanta: Elsevier Inc., July-August 2007, Current Problems in Cancer, Vol. 31, pp. 243-305. DOI: 10.1016/j.currproblcancer.2007.04.001; http://www.cpcancer.com/article/S0147-0272(07)00021-9/abstract. ISSN: 0147-0272.
  322. Influence of Curcumin on HOTAIR-Mediated Migration of Human Renal Cell Carcinoma Cells. Pei, Chang-Song, et al., et al. [ed.] Malcolm A. Moore. 10, Goyang-si Gyeonggi-do: Asian Pacific Organization for Cancer Prevention, May 2014, Asian Pacific Journal of Cancer Prevention, Vol. 15, pp. 4239-4243. DOI: 10.7314/APJCP.2014.15.10.4239; http://koreascience.or.kr/article/ArticleFullRecord.jsp?cn=POCPA9_2014_v15n10_4239. ISSN: 1513-7368.
  323. Suppressive effects of dietary curcumin on the increased activity of renal ornithine decarboxylase in mice treated with a renal carcinogen, ferric nitrilotriacetate. Okazaki, Yasumasa, Iqbal, Mohammad and Okada, Shigeru. [ed.] Peter C. van der Vliet. 3, Utrecht: Elsevier B.V., June 10, 2005, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, Vol. 1740, pp. 357-366. DOI: 10.1016/j.bbadis.2004.09.006; http://www.sciencedirect.com/science/article/pii/S0925443904001644. ISSN: 0925-4439.
  324. Curcumin Prevents High Fat Diet Induced Insulin Resistance and Obesity via Attenuating Lipogenesis in Liver and Inflammatory Pathway in Adipocytes. Shao, Weijuan, et al., et al. [ed.] Regine Schneider-Stock. 1, Nuremberg: Public Library of Science, January 9, 2012, PLoS ONE, Vol. 7, p. e28784. DOI: 10.1371/journal.pone.0028784; http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0028784. ISSN: 1932-6203.
  325. Curcumin molecular targets in obesity and obesity-related cancers. Shehzad, Adeeb, Khan, Salman and Lee, Young Sup. [ed.] Ron Allison and Adam Dicker. 2, Greenville; Philadelphia: Future Medicine Ltd, February 2012, Future Oncology, Vol. 8, pp. 174-190. DOI: 10.2217/fon.11.145; http://www.futuremedicine.com/doi/abs/10.2217/fon.11.145. ISSN: 1479-6694.
  326. Down-regulation of Notch1 signaling inhibits tumor growth in human hepatocellular carcinoma. Ning, Li, et al., et al. [ed.] Wen-Hwa Lee. 4, Irvine: e-Century Publishing Corporation, July 10, 2009, American Journal of Translational Research, Vol. 1, pp. 358-366. ISSN: 1943-8141.
  327. Curcumin inhibits hepatitis C virus replication via suppressing the Akt-SREBP-1 pathway. Kim, KyeongJin, et al., et al. [ed.] Felix Wieland. 4, Heidelberg: Elsevier B.V., February 19, 2010, FEBS Letters, Vol. 584, pp. 707-712. DOI: 10.1016/j.febslet.2009.12.019; http://www.febsletters.org/article/S0014-5793(09)01065-5/abstract. ISSN: 0014-5793.
  328. Reversal of aflatoxin induced liver damage by turmeric and curcumin. Soni, K.B., Rajan, A., Kuttan, R. [ed.] Manfred Schwab. 2, Heidelberg: Elsevier Ireland Ltd., September 30, 1992, Cancer Letters, Vol. 66. DOI: 10.1016/0304-3835(92)90223-I; http://www.cancerletters.info/article/0304-3835(92)90223-I/abstract. ISSN: 0304-3835.
  329. Chemical, Physical and Biological Approaches to Prevent Ochratoxin Induced Toxicoses in Humans and Animals. Varga, János, et al., et al. [ed.] Florian Lang. 7, Basel: MDPI, July 1, 2010, Toxins, Vol. 2, pp. 1718-1750. DOI: 10.3390/toxins2071718; http://www.mdpi.com/2072-6651/2/7/1718. ISSN: 2072-6651.
  330. Supercritical Carbon Dioxide Extraction of Aromatic Turmerone from Curcuma longa Linn. Induces Apoptosis through Reactive Oxygen Species-Triggered Intrinsic and Extrinsic Pathways in Human Hepatocellular Carcinoma HepG2 Cells. Cheng, Shao-Bin, et al., et al. [ed.] James N. Seiber. 38, Davis: American Chemical Society, September 12, 2012, Journal of Agricultural and Food Chemistry, Vol. 60, pp. 9620-9630. DOI: 10.1021/jf301882b; http://pubs.acs.org/doi/abs/10.1021/jf301882b. ISSN: 0021-8561.
  331. Resveratrol: A review of preclinical studies for human cancer prevention. Athar, Mohammad, et al., et al. [ed.] Michael P. Waalkes. 3, Research Triangle Park: Elsevier Inc., January 3, 2007, Toxicology and Applied Pharmacology, Vol. 224, pp. 274-283. DOI: 10.1016/j.taap.2006.12.025; http://www.sciencedirect.com/science/article/pii/S0041008X06005035. ISSN: 0041-008X.
  332. Comparison of inhibitive effects of Curcumin and Calebin-A on human hepatoma cell line HepG2. Liang, Chen, et al., et al. [ed.] Dai-Ming Fan. 1, Xi'an: CAB Direct, 2009, Journal of the Fourth Military Medical University, Vol. 30, pp. 7-10. Record Number: 20093079175. ISSN: 1000-2790.
  333. Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells. Anggakusuma, et al., et al. [ed.] Emad El-Omar. 7, Aberdeen: BMJ Publishing Group Ltd & British Society of Gastroenterology, July 13, 2014, Gut, Vol. 63, pp. 11374-1149. DOI: 10.1136/gutjnl-2012-304299; http://gut.bmj.com/content/63/7/1137. eISSN: 1468-3288.
  334. Chemoprevention of liver cancer by plant polyphenols. Stagos, Dimitrios, et al., et al. [ed.] A. Wallace Hayes. 6, Andover: Elsevier Inc, June 2012, Food and Chemical Toxicology, Vol. 50, pp. 2155-2170. DOI: 10.1016/j.fct.2012.04.002; http://www.sciencedirect.com/science/article/pii/S0278691512002748. ISSN: 0278-6915.
  335. Chemoprevention by essential oil of turmeric leaves (Curcuma longa L.) on the growth of Aspergillus flavus and aflatoxin production. Sindhu, S., et al., et al. [ed.] A. Wallace Hayes. 5, Andover: Elsevier Inc, May 2011, Food and Chemical Toxicology, Vol. 49, pp. 1188-1192. DOI: 10.1016/j.fct.2011.02.014; http://www.sciencedirect.com/science/article/pii/S0278691511000585. ISSN: 0278-6915.
  336. Chaumont, Jean-Pierre. Antimycotic Essential Oils: Impact on Skin Microflora. [ed.] Mahendra Rai and Donatella Mares. Plant-Derived Antimycotics: Current Trends and Future Prospects. Binghamton: Food Products Press®: The Haworth Press, Inc., 2003, 14, pp. 357-366. ISBN: 1-56022-926-8.
  337. Pandey, A.K. and Rai, Mahendra. Antimycotic Potential in Some Naturally Occurring Essential Oils. [ed.] Mahendra Rai and Donatella Mares. Plant-Derived Antimycotics: Current Trends and Future Prospects. Binghamton: Food Products Press®: The Haworth Press, Inc., 2003, 13, pp. 343-356. ISBN: 1-56022-926-8.
  338. A Controlled Clinical Study between Hepatic Arterial Infusion with Embolized Curcuma Aromatic Oil and Chemical Drugs in Treating Primary Liver Cancer. Cheng, Jian-hua, et al., et al. [ed.] Chen Ke-ji. 2, Beijing: Chinese Association of Traditional and Western Medicine, China Academy of Chinese Medical Sciences, June 1, 2001, Chinese Journal of Integrated Traditional and Western Medicine, Vol. 7, p. 141. ISSN: 1006-6497.
  339. The effectiveness of fermented turmeric powder in subjects with elevated alanine transaminase levels: a randomised controlled study. Kim, Sang-Wook, et al., et al. [ed.] Tom Rowles. 58, London: BioMed Central Ltd.: International Society for Complementary Medicine Research, March 8, 2013, BMC Complementary and Alternative Medicine, Vol. 13. DOI: 10.1186/1472-6882-13-58; http://www.biomedcentral.com/1472-6882/13/58. ISSN: 1472-6882.
  340. The increased cellular uptake and biliary excretion of curcumin by quercetin: a possible role of albumin binding interaction. Kim, Han Gyul, et al., et al. [ed.] Edward T. Morgan. 8, Atlanta: American Society for Pharmacology and Experimental Therapeutics, August 2012, Drug Metabolism & Disposition, Vol. 40, pp. 1452-1455. DOI: 10.1124/dmd.111.044123; http://dmd.aspetjournals.org/content/40/8/1452. ISSN: 1521-009X.
  341. Sears, Dawn, et al., et al. Fatty Liver: Overview; Treatment & Management. Medscape Refernece: Drugs, Diseases & Procedures. [Online] August 16, 2012. [Cited: October 3, 2014.] http://emedicine.medscape.com/article/175472-overview#showall.
  342. Targeting collagen expression in alcoholic liver disease. Thompson, Kyle J., McKillop, Iain H. and Schrum, Laura W. [ed.] Lian-Sheng Ma. 20, Beijing: Baishideng Publishing Group Co., Limited, May 28, 2011, World Journal of Gastroenterology, Vol. 17, pp. 2473-2481. DOI: 10.3748/wjg.v17.i20.2473; http://www.wjgnet.com/1007-9327/full/v17/i20/2473.htm. ISSN: 1007-9327.
  343. Pharmacological actions of curcumin in liver diseases or damage. Rivera-Espinoza, Yadira and Muriel, Pablo. [ed.] Rajiv Jalan. 10, Calgary: John Wiley & Sons Ltd, November 2009, Liver International, Vol. 29, pp. 1457-1466. DOI: 10.1111/j.1478-3231.2009.02086.x; http://onlinelibrary.wiley.com/doi/10.1111/j.1478-3231.2009.02086.x/abstract. eISSN: 1478-3231.
  344. Effect of Vitamin E and Alpha Lipoic Acid in Nonalcoholic Fatty Liver Disease: A Randomized, Placebo-Controlled, Open-Label, Prospective Clinical Trial (VAIN Trial). Basu, Patrick P., et al., et al. [ed.] Weizhen Zhang. 5, Beijing: Scientific Research Publishing Inc., May 2, 2014, Open Journal of Gastroenterology, Vol. 4, pp. 1-9. DOI: 10.4236/ojgas.2014.45030; OJGas_2014051613330305.pdf. ISSN: 2163-9450.
  345. Curcumin Induces EGFR Degradation in Lung Adenocarcinoma and Modulates p38 Activation in Intestine: The Versatile Adjuvant for Gefitinib Therapy. Lee, Jen-Yi, et al., et al. [ed.] Mikhail Blagosklonny. 8, Buffalo: Public Library of Science, August 17, 2011, PLoS ONE, Vol. 6, p. e23756. DOI: 10.1371/journal.pone.0023756; http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0023756. eISSN: 1932-6203.
  346. Curcumin suppresses growth of mesothelioma cells in vitro and in vivo, in part, by stimulating apoptosis. Wang, Ying, et al., et al. [ed.] Naranjan S. Dhalla. 1-2, Winnipeg: Springer Science+Business Media, November 1, 2011, Molecular and Cellular Biochemistry, Vol. 357, pp. 83-94. DOI: 10.1007/s11010-011-0878-2; http://link.springer.com/article/10.1007%2Fs11010-011-0878-2. ISSN: 0300-8177.
  347. Curcumin: Updated Molecular Mechanisms and Intervention Targets in Human Lung Cancer. Ye, Ming-Xiang, et al., et al. [ed.] Andrei Alexandrescu. 3, Basel: MDPI AG, March 22, 2012, International Journal of Molecular Sciences, Vol. 13, pp. 3959-3978. DOI: 10.3390/ijms13033959; http://www.mdpi.com/1422-0067/13/3/3959. ISSN: 1422-0067.
  348. Study to Evaluate Molecular Mechanics behind Synergistic Chemo-Preventive Effects of Curcumin and Resveratrol during Lung Carcinogenesis. Malhotra, Anshoo, Nair, Praveen and Dhawan, Devinder Kumar. [ed.] Aditya Bhushan Pant. 4, Lucknow: Public Library of Science, April 4, 2014, PLoS ONE, Vol. 9, p. e93820. DOI: 10.1371/journal.pone.0093820; http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0093820. eISSN: 1932-6203; PMCID: PMC3976304.
  349. Dietary Curcumin Increases Antioxidant Defenses in Lung, Ameliorates Radiation-Induced Pulmonary Fibrosis, and Improves Survival in Mice. Lee, James C., et al., et al. [ed.] Sara Rockwell. 5, New Haven: Radiation Research Society, May 2010, Radiation Research, Vol. 173, pp. 590-601. DOI: 10.1667/RR1522.1; http://www.bioone.org/doi/abs/10.1667/RR1522.1. ISSN: 0033-7587.
  350. Curcumin: A Novel Stat 3 Pathway Inhibitor for Chemoprevention of Lung Cancer. Alexandrow, Mark G., et al., et al. [ed.] Jaak Ph Janssens. 5, Hasselt: Lippincott Williams & Wilkins, September 2012, European Journal of Cancer Prevention, Vol. 21, pp. 407-412. DOI: 10.1097/CEJ.0b013e32834ef194; http://journals.lww.com/eurjcancerprev/pages/articleviewer.aspx?year=2012&issue=09000&article=00001&type=abstract. ISSN: 0959-8278.
  351. Anti-metastatic activity of curcumin and catechin. Menon, Lata G., Kuttan, Ramadasan and Kuttan, Girija. 1-2, s.l.: Elsevier Ireland Ltd., July 1, 1999, Cancer Letters, Vol. 141, pp. 159-165. DOI: 10.1016/S0304-3835(99)00098-1; http://www.cancerletters.info/article/S0304-3835(99)00098-1/abstract. ISSN: 0304-3835.
  352. Discovery of selective inhibitors of fibroblast growth factor receptor 1 kinase with potent anti-human lung carcinoma activity. Liang, Guang, et al., et al. [ed.] Gerald Weissmann. 601.6, New York: Federation of American Societies for Experimental Biology, April 2013, The FASEB Journal, Vol. 27. ISSN: 0892-6638.
  353. Dual inhibition of phosphatidylinositol 3-kinase/Akt and mammalian target of rapamycin signaling in human nonsmall cell lung cancer cells by a dietary flavonoid fisetin. Khan, Naghma, et al., et al. [ed.] Peter Lichter. 7, DKFZ, Germany: John Wiley & Sons, Inc.: UICC, April 1, 2012, International Journal of Cancer, Vol. 130, pp. 1695-1705. ISSN: 1097-0215.
  354. Mechanism for Possible Chemopreventive Effects of Natural Dietary Compounds on Smoking-induced Tumorigenesis. Lai, Ching-Shu and Pan, Min-Hsiung. 6, Taipei Medical University, Kaohsiung: Elsevier Taiwan LLC., 2011, Journal of Experimental and Clinical Medicine, Vol. 3, pp. 262-271. ISSN. 1878-3317.
  355. Dietary supplementation with curcumin enhances metastic growth of Lewis lung carcinoma in mice. Yan, Lin. [ed.] Peter Lichter. 2, DKFZ, Germany: John Wiley & Sons, Inc.: UICC, January 15, 2013, International Journal of Cancer, Vol. 132, pp. 269-275. DOI: 10.1002/ijc.27683; http://onlinelibrary.wiley.com/doi/10.1002/ijc.27683/abstract. ISSN: 1097-0215.
  356. Curcumin-cyclodextrin complexes potentiate gemcitabine effects in an orthotopic mouse model of lung cancer. Rocks, N., et al., et al. [ed.] Adrian L. Harris. 7, London: Nature Publishing Group, September 25, 2012, British Journal of Cancer, Vol. 107, pp. 1083-1092. DOI: 10.1038/bjc.2012.379; http://www.nature.com/bjc/journal/v107/n7/full/bjc2012379a.html. ISSN: 0007-0920.
  357. Safe and targeted anticancer therapy for ovarian cancer using a novel class of curcumin analogs. Rath, Kellie S., et al., et al. [ed.] David T. Curiel, et al., et al. 35, St. Louis; Louisville; Modena; Ottawa: BioMed Central Ltd, May 11, 2013, Journal of Ovarian Research, Vol. 6, pp. 1-12. DOI: 10.1186/1757-2215-6-35; http://www.ovarianresearch.com/content/6/1/35. ISSN: 1757-2215.
  358. Altgelt, Johanna, Ly, Helen and McCulloch, Michael. Ovarian Cancer, Chemotherapy, & Antioxidants. Pine Street Foundation. [Online] October 5, 2009. [Online] September 22, 2008. [Cited: December 19, 2014.] http://pinestreetfoundation.org/ovarian-cancer-chemotherapy-antioxidants/.
  359. Cytotoxic Activity from Curcuma zedoaria Through Mitochondrial Activation on Ovarian Cancer Cells. Shin, Yujin and Lee, Yongkyu. [ed.] Byung-Hoon Lee. 4, Seoul: The Korean Society of Toxicology, December 31, 2013, Toxicological Research, Vol. 29, pp. 257-261. DOI: 10.5487/TR.2013.29.4.257; http://koreascience.or.kr/article/ArticleFullRecord.jsp?cn=DSHHBQ_2013_v29n4_257. ISSN: 1976-8257.
  360. Antiproliferation and apoptosis induced by curcumin in human ovarian cancer cells. Shi, Mingxin, et al., et al. [ed.] Denys Wheatley. 3, Aberdeen: Elsevier Ltd.: International Federation for Cell Biology, March 2006, Cell Biology International, Vol. 30, pp. 221-226. DOI: 10.1016/j.cellbi.2005.10.024; http://onlinelibrary.wiley.com/doi/10.1016/j.cellbi.2005.10.024/abstract. ISSN: 1065-6995.
  361. New Perspectives of Curcumin in Cancer Prevention. Park, Wungki, et al., et al. [ed.] Scott M. Lippman. 5, Philadelphia: American Association for Cancer Research, May 2013, Cancer Prevention Research, Vol. 6, pp. 387-400. DOI: 10.1158/1940-6207.CAPR-12-0410; http://cancerpreventionresearch.aacrjournals.org/content/6/5/387. ISSN: 1940-6207.
  362. Modulation of inflammatory signaling pathways by phytochemicals in ovarian cancer. Kim, Mi-Kyung, et al., et al. [ed.] Giuditta Perozzi, et al., et al. 2, Rome; Lausanne; Utrecht: Springer-Verlag, May 2011, Genes & Nutrition, Vol. 6, pp. 109-115. DOI: 10.1007/s12263-011-0209-y; http://link.springer.com/article/10.1007%2Fs12263-011-0209-y. ISSN: 1555-8932.
  363. Fatty acid synthase as a potential therapeutic target in cancer. Flavin, Richard, et al., et al. [ed.] Ron Allison and Adam Dicker. 4, Greenville; Philadelphia: Future Medicine Ltd, April 2010, Future Oncology, Vol. 6, pp. 551-562. DOI: 10.2217/fon.10.11; http://www.futuremedicine.com/doi/abs/10.2217/fon.10.11. ISSN: 1479-6694.
  364. Chemopreventive effects of dietary phytochemicals against cancer invasion and metastasis: Phenolic acids, monophenol, polyphenol, and their derivatives. Weng, Chia-Jui and Yen, Gow-Chin. [ed.] R.A. Stahel and N. Pavlidis. 1, Zurich; Ioannina: Elsevier Inc., February 2012, Cancer Treatment Reviews, Vol. 38, pp. 76-87. DOI: 10.1016/j.ctrv.2011.03.001; http://www.cancertreatmentreviews.com/article/S0305-7372(11)00041-7/abstract. ISSN: 0305-7372.
  365. Das, Samarjit, Vasanthi, Hannah R. and Das, Dipak K. Resveratrol: Biochemistry and Functions. [ed.] Cesar G. Fraga. Plant Phenolics and Human Health: Biochemistry, Nutrition, and Pharmacology. Hoboken: John Wiley & Sons, Inc., 2010, 14, pp. 299-330. ISBN: 978-0-470-28721-7.
  366. Jiao, Li and Li, Donghui. Epidemiology and Prospects for Prevention of Pancreatic Cancer. [ed.] John P. Neoptolemos, et al., et al. Pancreatic Cancer. New York: Springer Science+Business Media, LLC, 2010, Vol. 1, 1, pp. 1-26. ISBN: 978-0-387-77497-8.
  367. National Cancer Institute. Targeted Therapies May Be Effective Against Rare Pancreatic Cancer. Clinical Trials: Results. [Online] October 5, 2009. [Online] April 8, 2011. [Cited: December 23, 2014.] http://www.cancer.gov/clinicaltrials/results/summary/2011/panNET-Therapy0411.
  368. Phase 1 clinical trials in 83 patients with pancreatic cancer. Vaklavas, Christos, et al., et al. [ed.] Raphael E. Pollock. 1, Houston: John Wiley & Sons, Inc.: American Cancer Society, January 1, 2011, Cancer, Vol. 117, pp. 77-85. DOI: 10.1002/cncr.25346; http://onlinelibrary.wiley.com/doi/10.1002/cncr.25346/abstract. eISSN: 1097-0142.
  369. Development of curcumin as an epigenetic agent. Fu, Siqing and Kurzrock, Razelle. [ed.] Raphael E. Pollock. 20, Houston: John Wiley & Sons, Inc.: American Cancer Society, October 15, 2010, Cancer, Vol. 116, pp. 4670-4676. DOI: 10.1002/cncr.25414; http://onlinelibrary.wiley.com/doi/10.1002/cncr.25414/abstract. eISSN: 1097-0142.
  370. Novel Curcumin Loaded Magnetic Nanoparticles for Pancreatic Cancer Treatment. Yallapu, Murali M., et al., et al. [ed.] Napoleone Ferrara. 8, Philadelphia: American Association for Cancer Research, Inc., August 2013, Molecular Cancer Therapeutics, Vol. 12, pp. 1471-1480. DOI: 10.1158/1535-7163.MCT-12-1227; http://mct.aacrjournals.org/content/12/8/1471. ISSN: 1535-7163.
  371. Prevention and Treatment of Pancreatic Cancer by Curcumin in Combination With Omega-3 Fatty Acids. Swamy, Malisetty V., et al., et al. [ed.] Leonard A. Cohen. S1, Valhalla: Taylor and Francis, November 10, 2008, Nutrition and Cancer, Vol. 60, pp. 81-89. DOI: 10.1080/01635580802416703; http://www.tandfonline.com/doi/abs/10.1080/01635580802416703#.VKHD59BkGA. ISSN: 0163-5581.
  372. Kanai, Masashi, Guha, Sushovan and Aggarwal, Bharat B. The Potential Role of Curcumin for Treatment of Pancreatic Cancer. [ed.] Sanjay Srivastava. Pancreatic Cancer - Molecular Mechanism and Targets. Delhi: InTech, 2012, 12, pp. 213-224. ISBN: 978-953-51-0410-0.
  373. Food-Derived Polyphenols Inhibit Pancreatic Cancer Growth Through Mitochondrial Cytochrome C Release and Apoptosis. Mouria, Michelle, et al., et al. [ed.] Harald zur Hausen. 5, Heidelberg: John Wiley & Sons, Inc.: UICC, April 10, 2002, International Journal of Cancer, Vol. 98, pp. 761-769. DOI: 10.1002/ijc.10202; http://onlinelibrary.wiley.com/doi/10.1002/ijc.10202/abstract. ISSN: 1097-0215.
  374. Curcumin Potentiates Antitumor Activity of Gemcitabine in an Orthotopic Model of Pancreatic Cancer through Suppression of Proliferation, Angiogenesis, and Inhibition of Nuclear Factor-κB-Regulated Gene Products. Kunnumakkara, Ajaikumar B., et al., et al. [ed.] Frank J. Rauscher III. 8, Philadelphia: American Association for Cancer Research, April 15, 2007, Cancer Research, Vol. 67, pp. 3853-3861. DOI: 10.1158/0008-5472.CAN-06-4257; http://cancerres.aacrjournals.org/content/67/8/3853. ISSN: 0008-5472.
  375. Parsons, Henrique A. The Effects of Curcumin on Body Composition of Patients with Advanced Pancreatic Cancer. Health Science Center at Houston; MD Anderson Cancer Center Graduate School of Biomedical Sciences, The University of Texas. Houston: Texas Medical Center Library, 2011. pp. 1-71, UT GSBS Dissertations and Theses. Paper 124.
  376. Curcumin and Gemcitabine in Patients With Advanced Pancreatic Cancer. Epelbaum, Ron, et al., et al. [ed.] Leonard A. Cohen. 8, Valhalla: Taylor and Francis, November 6, 2010, Nutrition and Cancer, Vol. 62, pp. 1137-1141. DOI: 10.1080/01635581.2010.513802; http://www.tandfonline.com/doi/abs/10.1080/01635581.2010.513802#.VJyEf9BkGA. ISSN: 0163-5581.
  377. Dose translation from animal to human studies revisited. Reagan-Shaw, Shannon, Nihal, Minakshi and Ahmad, Nihal. [ed.] Gerald Weissmann. 3, New York: Federation of American Societies for Experimental Biology, March 1, 2008, The FASEB Journal, Vol. 22, pp. 659-661. DOI: 10.1096/fj.07-9574LSF; http://www.fasebj.org/content/22/3/659. ISSN: 0892-6638.
  378. Expression of Smac, Bcl-2 and Ki-67 in pancreatic carcinoma and its prognostic significance. ShengMian, Li, et al., et al. 11, s.l.: CAB Direct, November 2009, Tumor, Vol. 29, pp. 1076-1081. Record Number 20093349254. ISSN: 1000-7431.
  379. Hubbard, Sylvia Booth. Pancreatic Cancer Killed Steve Jobs, the Truth About How You Can Prevent It. Newsmax. [Online] October 5, 2009. [Online] October 12, 2011. [Cited: December 23, 2014.] http://www.newsmax.com/US/Pancreatic-Cancer-Steve-Jobs/2011/10/14/id/414542.
  380. Bertagna, Xavier, et al., et al. Cushing's disease. [ed.] Shlomo Melmed. The Pituitary. 3rd. London: Academic Press: Elsevier Inc., 2011, 16, pp. 533-618. ISBN: 978-0-12-380926-1.
  381. Cracknell, Grant, Hassed, Craig and Phelps, Kerryn. Endocrinology. [ed.] Kerryn Phelps and Craig Hassed. General Practice: The Integrative Approach. Chatswood: Elsevier Australia, 2010, 29, pp. 339-364. ISBN-13: 978-0-72-953804-6.
  382. Johns Hopkins Pituitary Center. Pituitary Tumors: What is a pituitary tumor?; Types of Tumors. Johns Hopkins Medicine. [Online] October 5, 2009. [Online] [Cited: February 4, 2015.] http://www.hopkinsmedicine.org/neurology_neurosurgery/centers_clinics/pituitary_center/pituitary-tumor/index.html.
  383. PPAR-γ receptor ligands: novel therapy for pituitary adenomas. Heaney, Anthony P., Fernando, Manory and Melmed, Shlomo. [ed.] Laurence A. Turka. 9, New York: American Society for Clinical Investigation, May 1, 2003, The Journal of Clinical Investigation, Vol. 111, pp. 1381-1388. DOI: 10.1172/JCI200316575; http://www.jci.org/articles/view/16575. ISSN: 0021-9738.
  384. Greene, Stanley A. Sittig's Handbook of Pesticides and Agricultural Chemicals. Norwich: William Andrew, Inc., 2005. ISBN: 0-8155-1516-2.
  385. Rosack, Jim. FDA Assesses Antipsychotic's Link to Certain Tumors. American Psychiatric Association: Psychiatric News. [Online] October 5, 2009. [Online] October 10, 2014. [Cited: February 4, 2015.] http://psychnews.psychiatryonline.org/doi/full/10.1176/pn.40.15.00400035.
  386. Comparison of Short Term Effects of Risperidone and Paliperidone on Serum Prolactin Levels in Female Patients. Albayrak, Yakup, et al., et al. [ed.] Haluk A. Savas. 1, Gaziantep: Yerkure Tanitim ve Yayincilik Hizmetleri A.S., 2014, Journal of Mood Disorders, Vol. 4, pp. 7-13. ISSN: 2146-1473.
  387. Molecular mechanisms for anti-aging by natural dietary compounds. Pan, Min-Hsiung, et al., et al. [ed.] Hans-Ulrich Humpf. 1, Weinheim: WILEY-VCH Verlag GmbH & Co. KGaA, January 2012, Molecular Nutrition & Food Research, Vol. 56, pp. 88-115. DOI: 10.1002/mnfr.201100509; http://onlinelibrary.wiley.com/doi/10.1002/mnfr.201100509/abstract. ISSN: 1613-4133.
  388. mTOR Inhibitor Torin1 Induces Antiproliferative Effects on MtT/E Cell Line and Human Pituitary Tumors. Rubinfeld, Hadara, et al., et al. Florence: BioScientifica, May 5-9, 2012, Endocrine Abstracts: 15th International & 14th European Congress of Endocrinology, Vol. 29, p. P1340. ISSN: 1470-3947.
  389. Metabolic syndrome associated with hyperprolactinemia: A new indication for dopamine agonist treatment? Bernabeu, Ignacio and Casanueva, Felipe F. [ed.] Andrea Giustina. 2, Brescia: Springer US, October 1, 2013, Endocrine: International Journal of Basic and Clinical Endocrinology, Vol. 44, pp. 273-274. DOI: 10.1007/s12020-013-9914-1; http://link.springer.com/article/10.1007%2Fs12020-013-9914-1. ISSN: 1355-008X.
  390. Modulation of PPAR-γ by Nutraceutics as Complementary Treatment for Obesity-Related Disorders and Inflammatory Diseases. Sahagún, D. Ortuño, et al., et al. [ed.] Bruce Blumberg. Article ID 318613, Guadalajara: Hindawi Publishing Corporation, October 23, 2012, PPAR Research, Vol. 2012, pp. 1-17. DOI: 10.1155/2012/318613; http://www.hindawi.com/journals/ppar/2012/318613/. ISSN: 1687-4757.
  391. Baumann, Leslie and Saghari, Sogol. Skin Pigmentation and Pigmentation Disorders. [ed.] Leslie, Saghari, Sogol, Weisberg, Edmund Baumann. Cosmetic Dermatology: Principles and Practice. 2nd. New York: The McGraw-Hill Companies, Inc., 2009, 13, pp. 98-108. ISBN: 978-0-07-164128-9.
  392. Bowen, R. Pathophysiology of the Endocrine System: Adrenocorticotropic Hormone (ACTH, corticotropin). Colorado State University. [Online] September 20, 1998. [Cited: January 4, 2015.] http://www.vivo.colostate.edu/hbooks/pathphys/endocrine/hypopit/acth.html.
  393. Handog, Evangeline B. and Macarayo, Maria Juliet E. Melasma. [ed.] Antonella Tosti, Pearl E. Grimes and Maria Pia De Padova. Color Atlas of Chemical Peels. 2. s.l.: Springer-Verlag Berlin Heidelberg, 2012, 15, pp. 123-140. ISBN: 978-3-642-20269-8.
  394. Efficacy and Safety of Curcuminoids Loaded Solid Lipid Nanoparticles Facial Cream as an Anti-aging Agent. Plianbangchang, Pinyupa, Tungpradit, Watcharaphorn and Tiyaboonchai, Waree. [ed.] Sakchai Wihayaareekul. 2, Mueang District: Naresuan University, May-August 2007, Naresuan University Journal, Vol. 15, pp. 73-81. ISSN: 0858-7418.
  395. Wegmann, Michael, et al., et al. Cellular Protection: Protective turmerones from Curcuma longa. Essen:Evonik Industries Personal Care, 2009, pp. 1-4.
  396. Growth Suppression of Mouse Pituitary Corticotroph Tumor AtT20 Cells by Curcumin: A Model for Treating Cushing's Disease. Bangaru, Madhavi Latha Yadav, et al., et al. [ed.] Wen-Liang Zhou. 4, Guangzhou: Public Library of Science, April 13, 2010, PLoS ONE, Vol. 5, p. e9893. DOI: 10.1371/journal.pone.0009893; http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0009893. eISSN: 1932-6203.
  397. Foods for the prevention of diabetes: how do they work? Thomas, Theodoros and Pfeiffer, Andreas F.H. [ed.] Jesse Roth. 1, Manhasset: John Wiley & Sons, Ltd., January 3, 2012, Diabetes Metabolism Research and Reviews, Vol. 28, pp. 25-49. DOI: 10.1002/dmrr.1229; http://onlinelibrary.wiley.com/doi/10.1002/dmrr.1229/abstract. ISSN: 1520-7552.
  398. Hypoglycemic Effects of Turmeric (Curcuma longa L. Rhizomes) on Genetically Diabetic KK-Ay Mice. Kuroda, Minpei, et al., et al. 5, Tokyo: International Academic Printing Co., Ltd.: The Pharmaceutical Society of Japan, May 2005, Biological and Pharmaceutical Bulletin, Vol. 28, pp. 937-939. DOI: 10.1248/bpb.28.937; https://www.jstage.jst.go.jp/article/bpb/28/5/28_5_937/_article. ISSN: 0918-6158.
  399. Curcumin (Diferuloylmethane) Inhibits Cell Proliferation, Induces Apoptosis, and Decreases Hormone Levels and Secretion in Pituitary Tumor Cells. Miller, Matthew, et al., et al. [ed.] Jeffrey D. Blaustein. 8, Boston: The Endocrine Society, August 2008, Endocrinology, Vol. 149, pp. 4158-4167. DOI: 10.1210/en.2007-1760; http://press.endocrine.org/doi/abs/10.1210/en.2007-1760. ISSN: 0013-7227.
  400. Radioprotective action of curcumin extracted from Curcuma longa LINN: inhibitory effect on formation of urinary 8-hydroxy-2′-deoxyguanosine, tumorigenesis, but not mortality, induced by γ-ray irradiation. Inano, Hiroshi and Onoda, Makoto. [ed.] James D. Cox. 3, Houston: Elsevier Inc., July 1, 2002, International Journal of Radiation Oncology, Vol. 53, pp. 735-743. DOI: 10.1016/S0360-3016(02)02794-3; http://www.redjournal.org/article/S0360-3016(02)02794-3/abstract. ISSN: 0360-3016.
  401. mTOR-regulated senescence and autophagy during reprogramming of somatic cells to pluripotency: A roadmap from energy metabolism to stem cell renewal and aging. Menendez, Javier A., et al., et al. [ed.] M.V. Blagosklonny. 21, Buffalo: Landes Bioscience, November 1, 2011, Cell Cycle, Vol. 10, pp. 3658-3677. DOI: 10.4161/cc.10.21.18128; http://www.tandfonline.com/doi/abs/10.4161/cc.10.21.18128#.VPTMJjZOWpo. ISSN: 1538-4101.
  402. Angiogenesis in Pituitary Adenomas: Human Studies and New Mutant Mouse Models. Cristina, Carolina, et al., et al. [ed.] Daizo Yoshida. Article ID 608497, Tokyo: Hindawi Publishing Corporation, November 18, 2014, International Journal of Endocrinology, Vol. 2014, pp. 1-11. DOI: 10.1155/2014/608497; http://www.hindawi.com/journals/ije/2014/608497/. ISSN: 1687-8337.
  403. Chronic Diseases Caused by Chronic Inflammation Require Chronic Treatment: Anti-inflammatory Role of Dietary Spices. Prasad, Sahdeo and Aggarwal, Bharat B. [ed.] Charles J. Malemud. 4:238, Cleveland: OMICS Group, August 2014, Journal of Clinical & Cellular Immunology, Vol. 5, pp. 1-11. DOI: 10.4172/2155-9899.1000238; http://omicsonline.org/open-access/chronic-diseases-caused-by-chronic-inflammation-require-chronic-treatment-2155-9899.1000238.php?aid=28021. ISSN: 2155-9899.
  404. Advances in Androgen Receptor Targeted Therapy for Prostate Cancer. Ahmed, Alia, Ali, Shadan and Sarkar, Fazlul H. [ed.] Gary S. Stein, Harvey M. Florman and Constance E. Brinckerhoff. 3, Burlington; Worcester; Dartmouth: Wiley Periodicals, Inc., March 2014, Journal of Cellular Physiology, Vol. 229, pp. 271-276. DOI: 10.1002/jcp.24456; http://onlinelibrary.wiley.com/doi/10.1002/jcp.24456/abstract. eISSN: 1097-4652.
  405. Baliga, Manjeshwar Shrinath, et al., et al. Indian Vegetarian Diet and Cancer Prevention. [ed.] Ronald Ross Watson and Victor R. Preedy. Bioactive Foods and Extracts - Cancer Treatment and Prevention. Boca Raton: CRC Press: Taylor & Francis Group, 2011, 5, pp. 67-86. ISBN-13: 978-1-4398-1621-9.
  406. Mulholland, Helen G., Murray, Liam J. and Cantwell, Marie M. Glycemic Index, Glycemic Load, and Cancer Risk. [ed.] Ronald Ross Watson and Victor R. Preedy. Bioactive Foods and Extracts - Cancer Treatment and Prevention. Boca Raton: CRC Press: Taylor & Francis Group, 2011, 18, pp. 301-318. ISBN-13: 978-1-4398-1621-9.
  407. Cancer. [book auth.] Vicki Kotsirilos, Luis Vitetta and Avni Sali. A Guide to Evidence-Based Integrative and Complementary Medicine. Chatswood: Churchill Livingstone: Elsevier Australia, 2011, 9, pp. 200-247. ISBN: 978-0-7295-3908-1.
  408. Frankenfield, David and Smith, J. Stanley. Nutritional Management of Cachexia of Chronic Illness. [ed.] Felix Bronner. Nutritional and Clinical Management of Chronic Conditions and Diseases. Boca Raton: CRC Press: Taylor & Francis Group, 2006, 13, pp. 265-276. ISBN-13: 978-0-8493-2765-0.
  409. Maru, Girish B., et al., et al. Curcumin-Mediated Cellular Responses in Chemical Carcinogenesis: In Vivo Studies. [ed.] Ronald Ross Watson and Victor R. Preedy. Bioactive Foods and Extracts - Cancer Treatment and Prevention. Boca Raton: CRC Press: Taylor & Francis Group, LLC, 2011, 10, pp. 181-204. ISBN-13: 978-1-4398-1621-9.
  410. Apoptosis by dietary agents for prevention and treatment of prostate cancer. Khan, Naghma, Adhami, Vaqar Mustafa and Mukhtar, Hasan. [ed.] James A. Fagin. 1, New York: Society for Endocrinology, March 1, 2010, Endocrine-Related Cancer, Vol. 17, pp. R39-R52. DOI: 10.1677/ERC-09-0262; http://erc.endocrinology-journals.org/content/17/1/R39. ISSN: 1351-0088.
  411. Nutrition, dietary interventions and prostate cancer: the latest evidence. Lin, Pao-Hwa, Aronson, William and Freedland, Stephen J. [ed.] Sabina Alam. 3, London: BioMed Central Ltd, January 8, 2015, BMC Medicine, Vol. 13. DOI: 10.1186/s12916-014-0234-y; http://www.biomedcentral.com/1741-7015/13/3. ISSN: 1741-7015.
  412. Combined inhibitory effects of soy isoflavones and curcumin on the production of prostate-specific antigen. Ide, Hisamitsu, et al., et al. [ed.] John T. Isaacs. 10, Baltimore: Wiley-Liss, Inc., July 1, 2010, The Prostate, Vol. 70, pp. 1127-1133. DOI: 10.1002/pros.21147; http://onlinelibrary.wiley.com/doi/10.1002/pros.21147/abstract. ISSN: 0270-4137.
  413. Cell cycle control as a basis for cancer chemoprevention through dietary agents. Meerana, Syed Musthapa and Katiyar, Santosh Kumar. [ed.] Siamak Tabibzadeh. 1, Irvine: Frontiers in Bioscience, January 1, 2008, Frontiers in Bioscience - Landmark, Vol. 13, pp. 2191-2202. ISSN: 1093-9946.
  414. Curcumin Inhibits Prostate Cancer Bone Metastasis by Up-Regulating Bone Morphogenic Protein-7 in Vivo. Dorai, Thambi, et al., et al. [ed.] Sibu P. Saha. 4, Lexington: Scientific Research Publishing Inc., April 1, 2014, Journal of Cancer Therapy, Vol. 5, pp. 369-386. DOI: 10.4236/jct.2014.54044. ISSN: 2151-1934.
  415. Curcumin-free turmeric exhibits anti-inflammatory and anticancer activities: Identification of novel components of turmeric. Aggarwal, Bharat B., et al., et al. [ed.] Hans-Ulrich Humpf. 9, Weinheim: WILEY-VCH Verlag GmbH & Co. KGaA, September 2013, Molecular Nutrition & Food Research, Vol. 57, pp. 1529-1542. DOI: 10.1002/mnfr.201200838; http://onlinelibrary.wiley.com/doi/10.1002/mnfr.201200838/abstract. eISSN: 1613-4133.
  416. Geraniol inhibits prostate cancer growth by targeting cell cycle and apoptosis pathways. Kim, Su-Hwa, et al., et al. [ed.] William J. Lennarz. 1, Stony Brook: Elsevier Inc., April 1, 2011, Biochemical and Biophysical Research Communications, Vol. 407, pp. 129-134. DOI: 10.1016/j.bbrc.2011.02.124; http://www.sciencedirect.com/science/article/pii/S0006291X11003433. ISSN: 0006-291X.
  417. Waladkhani, Ali-Reza. Dietary Phytochemicals in Prevention and during Cancer Treatment. [ed.] Ronald Ross Watson and Victor R. Preedy. Bioactive Foods and Extracts - Cancer Treatment and Prevention. Boca Raton: CRC Press: Taylor & Francis Group, LLC, 2011, 14, pp. 237-256. ISBN-13: 978-1-4398-1621-9.
  418. Plasma Phospholipid Fatty Acids and Prostate Cancer Risk in the SELECT Trial. Brasky, Theodore M., et al., et al. [ed.] Carmen J. Allegra. 15, Gainesville: Oxford University Press, August 7, 2013, Journal of the National Cancer Institute, Vol. 105, pp. 1132-1141. DOI: 10.1093/jnci/djt174; http://jnci.oxfordjournals.org/content/105/15/1132. ISSN: 0027-8874.
  419. Characterizing components of the Saw Palmetto Berry Extract (SPBE) on prostate cancer cell growth and traction. Scholtysek, Carina, et al., et al. [ed.] William J. Lennarz. 3, Stony Brook: Elsevier Inc., February 13, 2009, Biochemical and Biophysical Research Communications, Vol. 379, pp. 795-798. DOI: 10.1016/j.bbrc.2008.11.114; http://www.sciencedirect.com/science/article/pii/S0006291X0802305X. ISSN: 0006-291X.
  420. Differential effects of resveratrol on androgen-responsive LNCaP human prostate cancer cells in vitro and in vivo. Wang, Thomas T.Y., et al., et al. [ed.] Curtis C. Harris. 10, Bethesda: Oxford University Press, October 2008, Carcinogenesis, Vol. 29, pp. 2001-2010. DOI: 10.1093/carcin/bgn131; http://carcin.oxfordjournals.org/content/29/10/2001. ISSN: 0143-3334.
  421. Resveratrol Enhances Antitumor Activity of TRAIL in Prostate Cancer Xenografts through Activation of FOXO Transcription Factor. Ganapathy, Suthakar, et al., et al. [ed.] Hiranmoy Das. 12, Columbus: Public Library of Science, December 28, 2010, PLoS ONE, Vol. 5, p. e15627. DOI: 10.1371/journal.pone.0015627; http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0015627. ISSN: 1932-6203.
  422. Prasad, Kedar N. Micronutrients for Improvement of the Standard Therapy in Cancer. Micronutrients in Health and Disease. Boca Raton: CRC Press: Taylor & Francis Group, LLC, 2011, 8, pp. 133-166. ISBN: 978-1-4398-2106-0.
  423. Yafi, Faysal A. and Kassouf, Wassim. Bioactive Foods and Extracts in Prostate Cancer Prevention. [ed.] Ronald Ross Watson and Victor R. Preedy. Bioactive Foods and Extracts: Cancer Treatment and Prevention. Boca Raton: CRC Press: Taylor & Francis Group, LLC, 2011, 19, pp. 319-328. ISBN: 978-1-4398-1621-9.
  424. A double-blind, placebo-controlled randomised trial evaluating the effect of a polyphenol-rich whole food supplement on PSA progression in men with prostate cancer--the UK NCRN Pomi-T study. Thomas, R., et al., et al. [ed.] Stephen J. Freedland. 2, Durham: Nature Publishing Group, June 2014, Prostate Cancer and Prostatic Disease, Vol. 17, pp. 180-186. DOI: 10.1038/pcan.2014.6; http://www.nature.com/pcan/journal/v17/n2/full/pcan20146a.html. ISSN: 1365-7852.
  425. A Pilot Clinical Trial of Radioprotective Effects of Curcumin Supplementation in Patients with Prostate Cancer. Jalal Hejazi1, Reza Rastmanesh, et al., et al. [ed.] Sudhakar Akul Yakkanti. 10, Omaha: OMICS Publishing Group, October 9, 2013, Journal of Cancer Science & Therapy, Vol. 5, pp. 320-324. DOI: 10.4172/1948-5956.1000223; http://omicsonline.org/vitamin-c-and-k-combination-causes-enhanced-anticancer-activity-against-rt-bladder-cancer-cells-1948-5956.1000223.php?aid=19597. ISSN: 1948-5956.
  426. Curcumin: A Challenge in Cancer Treatment. Basnet, Purusotam and Skalko-Basnet, Natasa. [ed.] Rajendra Gyawali. 1, Kathmandu: Nepal Pharmaceutical Association, March 2012, Journal of Nepal Pharmaceutical Association, Vol. 26, pp. 19-47. DOI: 10.3126/jnpa.v26i1.6631; http://www.nepjol.info/index.php/JNPA/article/view/6631. ISSN: 0253-8261.
  427. Targeting Sarcoplasmic/Endoplasmic Reticulum Ca2+-ATPase 2 by Curcumin Induces ER Stress-Associated Apoptosis for Treating Human Liposarcoma. Wang, Lu, et al., et al. [ed.] Napoleone Ferrara. 3, Philadelphia: American Association for Cancer Research, Inc., March 2011, Molecular Cancer Therapeutics, Vol. 10, pp. 461-471. DOI: 10.1158/1535-7163.MCT-10-0812; http://mct.aacrjournals.org/content/10/3/461. ISSN: 1535-7163.
  428. Reticulum Cell Sarcoma: Two Complete 'Spontaneous' Regressions, in Reponse to High-Dose Ascorbic Acid Therapy. Campbell, A., Jack, T. and Cameron, E. [ed.] M. Markman. 6, Houston: S. Karger AG, Basel, 1991, Oncology: International Journal of Cancer Research and Treatment, Vol. 48, pp. 495-497. DOI: 10.1159/000226988; http://www.karger.com/Article/Abstract/226988. ISSN: 0030-2414.
  429. Resveratrol and diallyl disulfide enhance curcumin-induced sarcoma cell apoptosis. Masuelli, Laura, et al., et al. [ed.] Siamak Tabibzadeh. Irvine: Frontiers in Bioscience, January 1, 2012, Frontiers in Bioscience - Landmark, Vol. 17, pp. 498-508. DOI: 10.2741/3940; https://www.bioscience.org/2012/v17/af/3940/list.htm. ISSN: 1093-9946.
  430. Balch, James and Stengler, Mark. Prescription for Natural Cures: A Self-Care Guide for Treating Health Problems with Natural Remedies Including Diet and Nutrition, Nutritional Supplements, Bodywork, and More. Hoboken: John Wiley & Sons, Inc., 2004. ISBN: 0-471-49088-1.
  431. Tretyakova, Danuta Malejka-Giganti and Natalia. Molecular Mechanisms of Carcinogenesis. [ed.] Wanda Baer-Dubowska, Agnieszka Bartoszek and Danuta Malejka-Giganti. Carcinogenic and Anticarcinogenic Food Components. Boca Raton: CRC Press: Taylor & Francis Group, 2006, 2, pp. 13-36. ISBN: 978-0-8493-2096-5.
  432. Warshowsky, Allan. Uterine Fibroids (Leiomyomata). [ed.] David Rakel. Integrative Medicine. 3rd. Philadelphia: Saunders: Elsevier Inc., 2012, 55, pp. 515-528.e1. ISBN: 978-1-4377-1793-8.
  433. Cardioprotective effects of Curcuma longa L. extracts against doxorubicin-induced cardiotoxicity in rats. El-Sayed, Eman M., et al., et al. [ed.] Akah Peter Achunike. 17, Nsukka: Academic Journals, September 2011, Journal of Medicinal Plants Research, Vol. 5, pp. 4049-4058. ISSN: 1996-0875.
  434. Some effects of the essential fatty acids linoleic acid and alpha-linolenic acid and of their metabolites gamma-linolenic acid, arachidonic acid, eicosapentaenoic acid, docosahexaenoic acid, and of prostaglandins A1 and E1 on the proliferation of human osteogenic sarcoma cells in culture. Booyens, J., et al., et al. 1, s.l.: Elsevier Ltd., July 1984, Prostaglandins, Leukotrienes and Medicine, Vol. 15, pp. 15-33. DOI: 10.1016/0262-1746(84)90053-2; http://www.sciencedirect.com/science/article/pii/0262174684900532. ISSN: 0952-3278.
  435. Studies on the Antitumor Bisabolane Sesquiterpenoi Isolated from Curcuma xanthorrhiza. Itokawa, Hideji, et al., et al. 8, s.l.: The Pharmaceutical Society of Japan, 1985, Chemical & pharmaceutical bulletin, Vol. 33, pp. 3488-3492. ISSN: 1347-5223.
  436. Dietary phytochemicals in cancer prevention and therapy: a complementary approach with promising perspectives. Margarita González-Vallinas, Marta González-Castejón, Arantxa Rodríguez-Casado, and Ana Ramírez de Molina. [ed.] Naomi K. Fukagawa. 9, Burlington: Wiley: International Life Sciences Institute, September 1, 2013, Nutrition Reviews, Vol. 71, pp. 585-599. DOI: 10.1111/nure.12051; http://nutritionreviews.oxfordjournals.org/content/71/9/585. ISSN: 0029-6643.
  437. Curcumin Induces Cross-Regulation Between Autophagy and Apoptosis in Uterine Leiomyosarcoma Cells. Li, Bin, et al., et al.. [ed.] Uziel Beller. 5, Jeruslam: Lippincott Williams & Wilkins, June 2013, International Journal of Gynecological Cancer, Vol. 23, pp. 803-808. DOI: 10.1097/IGC.0b013e31828c9581; http://journals.lww.com/ijgc/pages/articleviewer.aspx?year=2013&issue=06000&article=00007&type=abstract. ISSN: 1048-891X.
  438. Curcumin induces cell apoptosis in human chondrosarcoma through extrinsic death receptor pathway. Lee, Hsiang-Ping, et al., et al.. [ed.] J.E. Talmadge. 2, Omaha: Elsevier B.V., June 2012, International Immunopharmacology, Vol. 13, pp. 163-169. DOI: 10.1016/j.intimp.2012.04.002; http://www.sciencedirect.com/science/article/pii/S1567576912001014. ISSN: 1567-5769.
  439. Adjuvant Therapy with Bioavailability-Boosted Curcuminoids Suppresses Systemic Inflammation and Improves Quality of Life in Patients with Solid Tumors: A Randomized Double-Blind Placebo-Controlled Trial. Panahi, Yunes, et al., et al. [ed.] Elizabeth M. Williamson, et al., et al. 10, Reading; Naples; Seoul; Charleston: John Wiley & Sons, Ltd., October 2014, Phytotherapy Research, Vol. 28, pp. 1461-1467. DOI: 10.1002/ptr.5149; http://onlinelibrary.wiley.com/doi/10.1002/ptr.5149/abstract. eISSN: 1099-1573.
  440. Targeting the Wingless Signaling Pathway with Natural Compounds as Chemopreventive or Chemotherapeutic Agents. Teiten, Marie-Hélène, et al., et al. [ed.] Zeno Foldes-Papp. 1, Koeln-Wipperfuerth: Bentham Science Publishers, January 2012, Current Pharmaceutical Biotechnology, Vol. 13, pp. 245-254. DOI: 10.2174/138920112798868593; http://www.eurekaselect.com/76076/article. ISSN: 1389-2010.
  441. Anticancer Activities of Essential Oils Constituents and Synergy with Conventional Therapies: A Review. Lesgards, Jean-François, et al., et al. [ed.] Elizabeth M. Williamson, et al., et al. 10, Reading; Naples; Seoul; Charleston: John Wiley & Sons, Ltd., October 2014, Phytotherapy Research, Vol. 28, pp. 1423-1446. DOI: 10.1002/ptr.5165; http://onlinelibrary.wiley.com/doi/10.1002/ptr.5165/abstract. eISSN: 1099-1573.
  442. Modulation of multidrug resistance p-glycoprotein activity by flavonoids and honokiol in human doxorubicin- resistant sarcoma cells (MES-SA/DX-5): implications for natural sedatives as chemosensitizing agents in cancer therapy. Angelini, A., et al., et al. [ed.] Pio Conti. 2, Chieti: BioLife, s.a.s., April-June 2010, Journal of Biological Regulators and Homeostatic Agents, Vol. 24, pp. 197-206. ISSN: 0393-974X.
  443. Skin Cancer: Dance of Death. Saha, Dibyajyoti, et al., et al. [ed.] Pio Conti. 2, Chieti: BioLife, s.a.s., April-June 2010, Journal of Biological Regulators and Homeostatic Agents, Vol. 24, pp. 197-206. ISSN: 0393-974X.
  444. Phytoconstituents as photoprotective novel cosmetic formulations. Saraf, S. and Kaur, C.D. [ed.] B.G. Shivananda. 7, Bangalore: Wolters Kluwer: Medknow, July 10, 2010, Pharmacognosy Review, Vol. 4, pp. 1-11. DOI: 10.4103/0973-7847.65319; http://www.phcogrev.com/article.asp?issn=0973-7847;year=2010;volume=4;issue=7;spage=1;epage=11;aulast=Saraf. ISSN: 0973-7847.
  445. Preparation of Curcumin-Loaded Liposomes and Evaluation of Their Skin Permeation and Pharmacodynamics. Chen, Yan, et al., et al. [ed.] Derek J. McPhee. 5, Emeryville: MDPI AG, May 18, 2012, Molecules, Vol. 17, pp. 5972-5987. DOI: 10.3390/molecules17055972; http://www.mdpi.com/1420-3049/17/5/5972. ISSN: 1420-3049.
  446. Cooking enhances curcumin anti-cancerogenic activity through pyrolytic formation of "deketene curcumin". Dahmke, Indra N., et al., et al. [ed.] G.G. Birch. Reading: Elsevier Ltd., May 15, 2014, Food Chemistry, Vol. 151, pp. 514-519. DOI: 10.1016/j.foodchem.2013.11.102; http://www.sciencedirect.com/science/article/pii/S0308814613017901. ISSN: 0308-8146.
  447. Comparative Potencies of Nutraceuticals in Chemically Induced Skin Tumor Prevention. Villaseñor, Irene M., Simon, Ma Karenina B. and Villanueva, Ainstein M. A. [ed.] Leonard A. Cohen. 1, Valhalla: Taylor and Francis, 2002, Nutrition and Cancer, Vol. 44, pp. 66-70. DOI: 10.1207/S15327914NC441_9; http://www.tandfonline.com/doi/abs/10.1207/S15327914NC441_9. ISSN: 0163-5581.
  448. Synergistic Apoptosis-Inducing Effects on A375 Human Melanoma Cells of Natural Borneol and Curcumin. Chen, Jianping, et al., et al. [ed.] Robert Lafrenie. 6, Sudbury: Public Library of Science, June 27, 2014, PLoS ONE, Vol. 9, p. e101277. DOI: 10.1371/journal.pone.0101277; http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0101277. eISSN: 1932-6203.
  449. Innovations in natural ingredients and their use in skin care. Fowler, Joseph F., Jr., et al., et al. [ed.] Perry Robins. 6 Suppl, New York: s.n., June 1, 2010, Journal of Drugs in Dermatology, Vol. 9, pp. S72-81. ISSN: 1545-9616.
  450. α-Pinene isolated from Schinus terebinthifolius Raddi (Anacardiaceae) induces apoptosis and confers antimetastatic protection in a melanoma model. Matsuo, Alisson L., et al., et al. [ed.] William J. Lennarz. 2, Stony Brook: Elsevier Inc., July 29, 2011, Biochemical and Biophysical Research Communications, Vol. 411, pp. 449-454. DOI: 10.1016/j.bbrc.2011.06.176; http://www.sciencedirect.com/science/article/pii/S0006291X11011892. ISSN: 0006-291X.
  451. Beta-elemene inhibits melanoma growth and metastasis via suppressing vascular endothelial growth factor-mediated angiogenesis. Chen, Wenxing, et al., et al. [ed.] H. Newell and E.A. Sausville. 4, Newcastle; Baltimore: Springer-Verlag, April 1, 2011, Cancer Chemotherapy and Pharmacology, Vol. 67, pp. 799-808. DOI: 10.1007/s00280-010-1378-x; http://link.springer.com/article/10.1007%2Fs00280-010-1378-x. ISSN: 0344-5704.
  452. Visible Light Is a Better Co-Inducer of Apoptosis for Curcumin-Treated Human Melanoma Cells than UVA. Buss, Stephan, et al., et al. [ed.] Andrzej T. Slominski. 11, Memphis: Public Library of Science, November 8, 2013, PLoS ONE, Vol. 8, p. e79748. DOI: 10.1371/journal.pone.0079748; http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0079748. eISSN: 1932-6203.
  453. Ki-67 expression is superior to mitotic count and novel proliferation markers PHH3, MCM4 and mitosin as a prognostic factor in thick cutaneous melanoma. Ladstein, Rita G., et al., et al. [ed.] Christna Chap. 140, London: BioMed Central Ltd., April 14, 2010, BMC Cancer, Vol. 10. DOI: 10.1186/1471-2407-10-140; http://www.biomedcentral.com/1471-2407/10/140. ISSN: 1471-2407.
  454. Botanicals for the prevention and treatment of cutaneous melanoma. Syed, Deeba N. and Mukhtar, Hasan. [ed.] Ze'ev Ronai. 4, La Jolla: John Wiley & Sons A/S, August 2011, Pigment Cell & Melanoma Research, Vol. 24, pp. 688-702. DOI: 10.1111/j.1755-148X.2011.00851.x; http://onlinelibrary.wiley.com/doi/10.1111/j.1755-148X.2011.00851.x/full. eISSN: 1755-148X.
  455. Curcumin-Loaded Lipid and Polymeric Nanocapsules Stabilized by Nonionic Surfactants: An In Vitro and In Vivo Antitumor Activity on B16-F10 Melanoma and Macrophage Uptake Comparative Study. Mazzarino, Letícia, et al., et al. [ed.] Omathanu Perumal. 3, Brookings: American Scientific Publishers, June 1, 2011, Journal of Biomedical Nanotechnology, Vol. 7, pp. 406-414. DOI: 10.1166/jbn.2011.1296; http://www.ingentaconnect.com/content/asp/jbn/2011/00000007/00000003/art00010. ISSN: 1550-7033.
  456. Curcuminoids Activate p38 Map Kinases and Promote UVB-Dependent Signaling in Keratinocytes. Ayli, Elias E., et al., et al. [ed.] M. Maurer. 6, Berlin: John Wiley & Sons Ltd., June 2010, Experimental Dermatology, Vol. 19, pp. 493-500. DOI: 10.1111/j.1600-0625.2010.01081.x; http://onlinelibrary.wiley.com/doi/10.1111/j.1600-0625.2010.01081.x/abstract. eISSN: 1600-0625.
  457. Inhibition of nuclear factor-kappaB and nitric oxide by curcumin induces G2/M cell cycle arrest and apoptosis in human melanoma cells. Zheng, Mingzhong, et al., et al. [ed.] Ferdy J. Lejeune and Walter J. Storkus. 3, Lausanne; Pittsburgh: Lippincott Williams & Wilkins, Inc., June 2004, Melanoma Research, Vol. 14, pp. 165-171. ISSN: 0960-8931.
  458. Curcumin induces apoptosis through mitochondrial pathway and caspases activation in human melanoma cells. Jiang, Ai-Jun, et al., et al. [ed.] Nilanjana Maulik. 1, Farmington: Springer Netherlands, January 1, 2015, Molecular Biology Reports, Vol. 42, pp. 267-275. DOI: 10.1007/s11033-014-3769-2; http://link.springer.com/article/10.1007%2Fs11033-014-3769-2. ISSN: 0301-4851.
  459. Coupling to a cancer cell-specific antibody potentiates tumoricidal properties of curcumin. Langone, Phyllis, et al., et al. [ed.] Peter Lichter. 4, DKFZ, Germany: John Wiley & Sons, Inc.: UICC, August 15, 2012, International Journal of Cancer, Vol. 131, pp. E569-E578. DOI: 10.1002/ijc.26479; http://onlinelibrary.wiley.com/doi/10.1002/ijc.26479/abstract. ISSN: 1097-0215.
  460. Curcumin induces apoptosis in human melanoma cells through a Fas receptor/caspase-8 pathway independent of p53. Bush, Jason A., Jr., K-John J. Cheung and Li, Gang. 2, s.l.: Elsevier Science (USA), December 10, 2001, Experimental Cell Research, Vol. 271, pp. 305-314. DOI: 10.1006/excr.2001.5381; http://www.sciencedirect.com/science/article/pii/S0014482701953819. ISSN: 0014-4827.
  461. In vitro and in vivo anti-tumoral effect of curcumin against melanoma cells. Odot, Johann, et al., et al. [ed.] Harald zur Hausen. 3, Heidelberg: John Wiley & Sons, Inc.: UICC, September 1, 2004, International Journal of Cancer, Vol. 111, pp. 381-387. DOI: 10.1002/ijc.20160; http://onlinelibrary.wiley.com/doi/10.1002/ijc.20160/abstract. ISSN: 1097-0215.
  462. Coupling endoplasmic reticulum stress to the cell death program in mouse melanoma cells: effect of curcumin. Bakhshi, Jason, et al., et al. [ed.] Mels Sluyser. 7, Amsterdam: Springer US, July 1, 2008, Apoptosis: An International Journal on Programmed Cell Death, Vol. 13, pp. 904-914. DOI: 10.1007/s10495-008-0221-x; http://link.springer.com/article/10.1007%2Fs10495-008-0221-x. ISSN: 1360-8185.
  463. Curcumin Induces Cell Death in Human Uveal Melanoma Cells through Mitochondrial Pathway. Lu, Chengwei, et al., et al. [ed.] Robert Linsenmeier and Gerd Geerling. 4, Chicago; Wurzburg: Informa Plc, April 2010, Current Eye Research, Vol. 35, pp. 352-360. DOI: 10.3109/02713680903521944; http://informahealthcare.com/doi/abs/10.3109/02713680903521944. ISSN: 0271-3683.
  464. Curcumin-induced melanoma cell death is associated with mitochondrial permeability transition pore (mPTP) opening. Qiu, Ying, et al., et al. [ed.] Ernesto Carafoli. 1, Padua: Elsevier Inc., May 23, 2014, Biochemical and Biophysical Research Communications, Vol. 448, pp. 15-21. DOI: 10.1016/j.bbrc.2014.04.024; http://www.sciencedirect.com/science/article/pii/S0006291X1400655X?np=y. ISSN: 0006-291X.
  465. Turmeric Toxicity in A431 Epidermoid Cancer Cells Associates with Autophagy Degradation of Anti-apoptotic and Anti-autophagic p53 Mutant. Thongrakard, Visa, et al., et al. [ed.] Elizabeth M. Williamson, et al., et al. 12, Reading; Naples; Seoul; Charleston: John Wiley & Sons, Ltd., December 2014, Phytotherapy Research, Vol. 28, pp. 1761-1769. DOI: 10.1002/ptr.5196; http://onlinelibrary.wiley.com/doi/10.1002/ptr.5196/abstract. eISSN: 1099-1573.
  466. MST1 activation by curcumin mediates JNK activation, Foxo3a nuclear translocation and apoptosis in melanoma cells. Yu, Teng, Ji, Jiang and Guo, Yong-li. [ed.] Ernesto Carafoli. 1, Padua: Elsevier Inc., November 8, 2013, Biochemical and Biophysical Research Communications, Vol. 441, pp. 53-58. DOI: 10.1016/j.bbrc.2013.10.008; http://www.sciencedirect.com/science/article/pii/S0006291X13016689. ISSN: 0006-291X.
  467. Curcumin Intake Affects miRNA Signature in Murine Melanoma with mmu-miR-205-5p Most Significantly Altered. Dahmke, Indra N., et al., et al. [ed.] Soheil S. Dadras. 12, Farmington: Public Library of Science, December 12, 2013, PLoS ONE, Vol. 8, p. e81122. DOI: 10.1371/journal.pone.0081122; http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0081122. eISSN: 1932-6203.
  468. Chemo-resistant melanoma sensitized by tamoxifen to low dose curcumin treatment through induction of apoptosis and autophagy. Chatterjee, Sudipa June and Pandey, Siyaram. [ed.] Wafik S. El-Deiry. 2, Philadelphia: Landes Bioscience, January 15, 2011, Cancer Biology & Therapy, Vol. 11, pp. 216-228. DOI: 10.4161/cbt.11.2.13798; http://www.tandfonline.com/doi/abs/10.4161/cbt.11.2.13798#.VY90GjZOWpo. ISSN: 1538-4047.
  469. Apoptosis induced by curcumin and its effect on c-myc and caspase-3 expressions in human melanoma A375 cell line. Qiu, Shi, et al., et al. 12, s.l.: Guangzhou Shi Tonghe Zhen, December 2005, Journal of First Military Medical University, Vol. 25, pp. 1517-1521. ISSN: 1000-2588.
  470. An Anticancer Effect of Curcumin Mediated by Down-Regulating Phosphatase of Regenerating Liver-3 Expression on Highly Metastatic Melanoma Cells. Wang, Lu, et al., et al. [ed.] Jeffrey Conn. 6, Nashville: American Society for Pharmacology and Experimental Therapeutics, December 2009, Molecular Pharmacology, Vol. 76, pp. 1238-1245. DOI: 10.1124/mol.109.059105; http://molpharm.aspetjournals.org/content/76/6/1238. ISSN: 1521-0111.
  471. Anti-human papillomavirus therapeutics: Facts & future. Qiu, Shi, et al., et al. 12, s.l.: Guangzhou Shi Tonghe Zhen, December 2005, Journal of First Military Medical University, Vol. 25, pp. 1517-1521. ISSN: 1000-2588.
  472. Curcumin induces proapoptotic effects against human melanoma cells and modulates the cellular response to immunotherapeutic cytokines. Bill, Matthew A., et al., et al. [ed.] Michael B. Kastan. 9, Durham: American Association for Cancer Research, September 1, 2009, Molecular Cancer Research, Vol. 8, pp. 2726-2735. DOI: 10.1158/1535-7163.MCT-09-0377; http://mct.aacrjournals.org/content/8/9/2726. ISSN: 1557-3125.
  473. Anti-proliferative effect of curcumin on melanoma cells is mediated by PDE1A inhibition that regulates the epigenetic integrator UHRF1. Abusnina, Abdurazzag, et al., et al. [ed.] Hans-Ulrich Humpf. 11, Weinheim: WILEY-VCH Verlag GmbH & Co. KGaA, November 2011, Molecular Nutrition & Food Research, Vol. 55, pp. 1677-1689. DOI: 10.1002/mnfr.201100307; http://onlinelibrary.wiley.com/doi/10.1002/mnfr.201100307/abstract. ISSN: 1613-4133.
  474. Inhibition of lung metastasis in mice induced by B16F10 melanoma cells by polyphenolic compounds. Menon, Lata G., Kuttan, Ramadasan and Kuttan, Girija. 1-2, Heidelberg: Elsevier Ireland Ltd., August 16, 1995, Cancer Letters, Vol. 95, pp. 221-225. DOI: 10.1016/0304-3835(95)03887-3; http://www.cancerletters.info/article/0304-3835(95)03887-3/abstract#. ISSN: 0304-3835.
  475. Overexpression of the ATP binding cassette gene ABCA1 determines resistance to Curcumin in M14 melanoma cells. Bachmeier, Beatrice E., et al., et al. [ed.] Christophe Nicot and Alan Storey. 129, Kansas City; Oxford: Biomed Central Ltd., December 23, 2009, Molecular Cancer, Vol. 8. DOI: 10.1186/1476-4598-8-129; http://www.molecular-cancer.com/content/8/1/129. ISSN: 1476-4598.
  476. Inhibition of Human Melanoma Cell Growth by the Dietary Flavonoid Fisetin Is Associated with Disruption of Wnt/β-Catenin Signaling and Decreased Mitf Levels. Syed, Deeba N., et al., et al. [ed.] Barbara A. Gilchrest. 6, Boston: Nature Publishing Group, June 2011, Journal of Investigative Dermatology, Vol. 131, pp. 1291-1299. DOI: 10.1038/jid.2011.6; http://www.nature.com/jid/journal/v131/n6/full/jid20116a.html. ISSN: 0022-202X.
  477. Chemopreventive potential of geraniol in 7,12-dimethylbenz(a) anthracene (DMBA) induced skin carcinogenesis in Swiss albino mice. Manoharan, S. and Selvan, M. Vasantha. [ed.] Vikas Nagar. 2, Lucknow,: Triveni Enterprises, March 2012, Journal of Environmental Biology, Vol. 33, pp. 255-260. ISSN: 0254-8704.
  478. Effect of naturally occurring monoterpenes carvone, limonene and perillic acid in the inhibition of experimental lung metastasis induced by B16F-10 melanoma cells. Raphael, T.J. and Kuttan, G. [ed.] Mauro Castelli. 3, Rome: BioMed Central Ltd, September 2003, Journal of Experimental and Clinical Cancer Research, Vol. 22, pp. 419-424. ISSN: 1756-9966.
  479. Flavonoids apigenin and quercetin inhibit melanoma growth and metastatic potential. Caltagirone, Sara, et al., et al. [ed.] Harald zur Hausen. 4, Heidelberg: John Wiley & Sons, Inc.: UICC, August 15, 2000, International Journal of Cancer, Vol. 87, pp. 595-600. DOI: 10.1002/1097-0215(20000815)87:4<595::AID-IJC21>3.0.CO;2-5; http://onlinelibrary.wiley.com/doi/10.1002/1097-0215(20000815)87:4%3C595::AID-IJC21%3E3.0.CO;2-5/abstract. ISSN: 1097-0215.
  480. Chemopreventive effect of turmeric against stomach and skin tumors induced by chemical carcinogens in Swiss mice. Azuine, Magnus A. and Bhide, Sumati V. 1, s.l.: Taylor and Francis, 1992, Nutrition and Cancer, Vol. 17, pp. 77-83. DOI: 10.1080/01635589209514174; http://www.tandfonline.com/doi/abs/10.1080/01635589209514174. ISSN: 0163-5581.
  481. Curcumin Modulates miR-19/PTEN/AKT/p53 Axis to Suppress Bisphenol A-induced MCF-7 Breast Cancer Cell Proliferation. Li, Xiaoting, et al., et al. [ed.] Elizabeth M. Williamson, et al., et al. 10, Reading; Naples; Seoul; Charleston: John Wiley & Sons, Ltd., October 2014, Phytotherapy Research, Vol. 28, pp. 1553-1560. DOI: 10.1002/ptr.5167; http://onlinelibrary.wiley.com/doi/10.1002/ptr.5167/abstract. eISSN: 1099-1573.
  482. The Epigenome as a Potential Mediator of Cancer Prevention by Dietary Phytochemicals: the Fetus as a Target. Kaur, Pushpinder, et al., et al. [ed.] Naomi K. Fukagawa. 7, Burlington: Oxford University Press: International Life Sciences Institute, July 2013, Nutrition Reviews, Vol. 71, pp. 441-457. DOI: 10.1111/nure.12030; http://nutritionreviews.oxfordjournals.org/content/71/7/441. ISSN: 0029-6643.
  483. Photoageing: mechanism, prevention and therapy. Yaar, M. and Gilchrest, B.A. 5, s.l.: John Wiley & Sons, Inc.: British Association of Dermatologists, April 16, 2007, British Journal of Dermatology, Vol. 157, pp. 874-887. DOI: 10.1111/j.1365-2133.2007.08108.x; http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2133.2007.08108.x/abstract.eISSN: 1365-2133.
  484. Jalian, H. Ray and Kim, Jenny. Immunology of the Skin. [ed.] Leslie, Saghari, Sogol, Weisberg, Edmund Baumann. Cosmetic Dermatology: Principles and Practice. 2nd. New York: The McGraw-Hill Companies, Inc., 2009, 4, pp. 22-29. ISBN: 978-0-07-164128-9.
  485. Curcumin targeted signaling pathways: basis for anti-photoaging and anti-carcinogenic therapy. Heng, Madalene C.Y. [ed.] Lawrence E. Gibson. 6, Rochester: The International Society of Dermatology, June 2010, International Journal of Dermatology, Vol. 49, pp. 608-622. DOI: 10.1111/j.1365-4632.2010.04468.x; http://onlinelibrary.wiley.com/doi/10.1111/j.1365-4632.2010.04468.x/abstract.ISSN: 0011-9059.
  486. Intratumoral Concentrations and Effects of Orally Administered Micellar Curcuminoids in Glioblastoma Patients. Dützmann, Stephan, et al., et al. [ed.] Leonard A. Cohen. 6, Valhalla: Taylor and Francis Group, LLC, June 24, 2016, Nutrition and Cancer, Vol. 68, pp. 943-948. DOI: 10.1080/01635581.2016.1187281; http://www.tandfonline.com/doi/full/10.1080/01635581.2016.1187281. ISSN: 0163-5581.
  487. The Use of Oncolytic Vesicular Stomatitis Virus in Conjunction with Natural Products for the Treatment of Cervical Cancers. Ahmed, Maryam, Patel, Chirayu M. and Fehl, Dylan J. [ed.] Shawn Chen Qiang. 2, Tempe: OMICS International, August 31, 2015, Advanced Techniques in Biology & Medicine, Vol. 3, p. 133. DOI: 10.4172/2379-1764.1000133; http://www.esciencecentral.org/journals/the-use-of-oncolytic-vesicular-stomatitis-virus-in-conjunction-with-natural-products-for-the-treatment-of-cervical-cancers-2379-1764-1000133.php?aid=58798. ISSN: 2379-1764.

Join the 1000s of People Who Are Discovering the Benefits of Turmeric.



New Vegan, Cruelty Free, Non GMO, Stearate Free, Gluten Free Turmeric Health Supplement Made in the USA in a GMP-certified, FDA-approved facility.

Healthceuticals® Turmeric Curcumin Complex

100% Certified
Organic ingredients

  • Organic Turmeric Extract - standardized to 95% curcuminoids.
  • Organic Whole Turmeric - provides full spectrum antioxidant, anti-inflammatory turmeric benefits, including turmerones and numerous vitamins, minerals, and phytonutrients
  • Organic Black Pepper Extract - standardized to 95% piperine; dramatically enhances bioavailablity.
  • Organic Phospholipids - markedly improve absorption.
  • Organic Ginger - works synergistically with turmeric to provide more powerful benefits.
  • Absolutely FREE of potentially harmful additives and fillers such as magnesium stearate.
Vegan | Cruelty Free | Non GMO | Stearate Free | Gluten Free Made in the USA in a GMP-certified, FDA-approved facility
Disclaimer: This website is not intended to replace professional consultation, diagnosis, or treatment by a licensed physician. If you require any medical related advice, contact your physician promptly. Information at this website is exclusively of a general reference nature. Do not disregard medical advice or delay treatment as a result of accessing information at this site.